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Abstract
For over a century, cardiac electrophysiology modelling has been widely used for studying
various problems of normal or abnormal heart rhythm, which is essential for understanding the
disease mechanisms, provide accurate diagnoses and develop a new treatment. This thesis focuses
on several analysis and applications of models in single-cell cardiac electrical excitation. In
particular, I aim to study some typical challenges present in cardiac electrophysiology modelling,
which is, variability in action potentials (AP) and their effects on cardiac anti-arrhythmic drugs,
mechanisms of cardiac alternans and efficient numerical solver. To address the problems, I use
various action potential models initially a range of biophysically detailed models, then focusing
on a single simplified model.
This thesis consists of two main parts, excluding the part for background and introductory
materials. The first and most important part, in terms of effort and time spent, is devoted to the
investigation of action potential variability in a population of rabbit ventricular myocytes and
their effects on cardiac anti-arrhythmic drugs. To determine the distributions of ion channel
conductance values that capture the electrophysiological heterogeneity measured in large popula-
tions of cells, I apply the experimentally-calibrated population of models introduced by Britton
et al. (2013), constructing from randomly varied ion conductances combinations. The model
population is further used to quantitatively predict the range of response to the application of
hERG and L-type calcium channel blocks. I implement the methodologies on three different AP
models to study the capability of the cell models in predicting the drug effects. The models are
a rabbit AP model by Shannon et al. (2004) and two human AP models by Ten Tusscher et al.
(2004) and O’Hara et al. (2011). The AP responses following channel blocks are compared and
analysed.
The second part of the thesis covers the analysis and application of a simplified ionic cardiac
model. The model used is a modified version of caricature Noble model by Biktashev et al. (2008).
Our first task is to propose the model as a generic model of cardiac electrophysiology by using a
parameter estimation method. The model’s parameters are adjusted so that it can reproduce AP
morphologies of various cell types. In particular, the model is fitted to three different AP models
which are Purkinje model by Noble (1962), ventricular model by Luo and Rudy (1991) and atrial
model by Courtemanche et al. (1998). The action potential duration restitution curve of targeted
models are also reproduced. The similar model template now can be used for various regions
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of the heart by changing the parameter values. Furthermore, the modified caricature Noble
model is fitted to experimental measurements of healthy and failing myocytes by McIntosh et al.
(2000). I analyse the difference between parameter values from fitting works intending to find the
physiological meaning for AP differences shown in experimental recordings. Parameter fitting of
modified caricature Noble model demonstrates that it can replace other more complicated models,
and it can also be used as a prototype to look for cardiac alternans and to construct an efficient
numerical method.
The modified caricature Noble model is further used to develop an efficient numerical method
for simulation of cardiac action potential model by taking into account the asymptotic solutions
of the system. In order to achieve this, I implement the heterogenous multiscale method proposed
by Weinan and Engquist (2003). The proposed method exhibits better stability and efficiency
compared to other numerical solvers. The drawbacks of the method are also explained. Finally,
the application of the model is extended by utilising it to study the mechanisms of cardiac
alternans. The objective is to determine parameters and variables in the model that are responsible
for generating action potential duration alternans. Using the slow-slow-time system of the model,
an explicit discrete restitution map is derived and their equilibrium branches and bifurcations
are studied. The bifurcations of equilibria of these maps are studied to identify regions in the
parameter space of the model where normal response and alternans exhibit. Also, using the full
system of the model, a framework formulated in terms of a boundary value problem is developed,
which can be used to construct various branches of the action potential duration restitution map.
At the end of the work, I perform some numerical simulations by fitting the caricature Noble
model to models of normal response and alternans. The differences in parameter values are
analysed and used to understand the onset of alternans. Importantly, the result shows that the
magnitude of time-dependent potassium current can induce or suppress alternans.
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Background and thesis goals
1
Chapter 1
Introduction
1.1 Context and motivation
The heart is a muscular organ and serves as a pump to circulate the blood through the blood
vessels of the circulatory system. Like other muscles, the heart can mechanically contract and
relax to serve its purposes. The mechanical contraction is triggered by the electrical excitation
of cardiac cells, the so-called ‘action potential (AP)’. Figure 1.1 exhibits AP phenotypes at a
different region of the heart. Due to its important role, it cannot truly rest or lose its rhythm as this
would lead to loss of cardiac output, affecting the body’s organ systems including the heart itself.
The heart has been a focus of intensive study, probably because heart failure, either mechanical or
electrical, has caused millions of deaths globally. For instance, in the United Kingdom (UK) alone,
cardiovascular disease was the main caused of death in 2012 and resulted in more than 50,000
deaths (Townsend et al. 2014). Hence, knowledge concerning the electrophysiology of the heart
is important for the understanding of many aspects of the physiological and pathophysiological
cardiac behaviour, and the problem has been actively investigated by many researchers.
For over a century, cardiac electrophysiology modelling has become a vital tool for studying
normal and abnormal cardiac functions. Investigations at various levels of the membrane, cellular,
tissue and organ have contributed to the development of a large number of biophysically detailed
cardiac action potential models for various types of cardiac cells and species. Overall long term
goal of the research community is to make a fully-integrated electro-mechanical model of the
human heart that is fast-enough and fine-tuned enough to enable general clinical use, to provide
accurate diagnoses and to study disease mechanism at the molecular, cell, tissue and organ level
simultaneously. Nevertheless, at each scale and each model pose significant mathematical and
technical problems that are of interest on their own. The models also will demand continu-
ous alteration of new elements, such as model redesign and evaluation, improvements in the
computational time of biophysically detailed models, implementation of standard protocols for
comparison with experimental measurements, and investing in efforts to make sure the modelling
results are repeatable and consistent.
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Figure 1.1: Electrical system and action potential phenotypes in different cell types of human
heart. Figure was taken from Bartos et al. (2015).
More specifically, the topics covered in the thesis focus on the analysis of single-cell models
of the AP and their applications in cardiac electrophysiology. The creation of a cardiac action
potential model starts typically with the development of a representation of the underlying
transmembrane currents. The mathematical structure of such a model is formulated as an ordinary
differential equation (ODE),
dV
dt
=−Iion
Cm
, (1.1)
where Iion is the sum of all transmembrane currents and Cm is the membrane capacitance. The
negative sign is important since, by convention, the inward currents are negative, and the outward
currents are positive, such that the inward depolarizing current is negative but also increases the
membrane potential. The number and type of ionic currents incorporated in each AP model are
varied, depending on the experimental data available at the time of constructing the model. More
detailed models also may include descriptions of intracellular ion concentrations and processes.
An overview of modelling these different components will be discussed in details in Chapter 2.
The ground-breaking action potential model by Hodgkin and Huxley (1952) took the quanti-
tative and computational interpretation of physiological function to a whole new level. Precise
measurements of sodium and potassium ion channel kinetics were used to formulate differential
equations that were then solved to provide precise predictions of the nerve impulse voltage
waveform and its conduction velocity. This work paved the way for the development of more
accurate and complete ionic models with the introduction of important new mechanisms and
involved major reformulations. In parallel, with the extension of the voltage clamp technique
to the heart, various ion channels could be measured, including multiple delayed rectification
channels (Noble and Tsien 1968; 1969a;b), calcium channels (Reuter 1967), and the incorporation
of the sodium-potassium (Gadsby 1980) and sodium-calcium (Reuter and Seitz 1968) exchangers.
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To date, hundreds of cardiac action potential models have been developed (Noble et al. 2012)
to characterise the dynamic response of membrane potential under healthy and arrhythmias
conditions.
There are now various ionic representations of SAN pacemaker cells (Demir et al. 1994,
Lovell et al. 2004), atrial myocytes (Aslanidi et al. 2009a, Courtemanche et al. 1998), ventricular
myocytes (Mahajan et al. 2008, Shannon et al. 2004) and Purkinje fibres (Noble 1962, Noble and
Tsien 1969a;b). Different applications will lay stress on the accuracy of the different aspects of
cell models. That is one of the reasons why so many models are now available. Each of them has
its own strengths and weaknesses.
In reality, however, detailed AP models of cardiac excitation are extremely complicated, in the
sense that complex models may not be suitable for simulations of cardiac tissue electrophysiology
in clinical applications which require a faster outcome for the clinicians to make an instant
decision. Parameters in the model also need to be re-estimated to fit the available clinical data,
in which the process is not straightforward due to large parameters and variables included in
the model. These complex models are also not amenable for theoretical works because of
the nonlinearity of the kinetic terms that describe the process, suggesting a need for reduced
complexity of the cardiac AP. Many attempts have been made to develop simplified mathematical
models of cardiac action potential that do not aim to model sub-cellular processes, but rather
to produce an action potential at a minimal cost. To mention a few of them, see reduced
membrane models by FitzHugh (1961), Mitchell and Schaeffer (2003), Barkley (1991), Aliev and
Panfilov (1996), Rogers and McCulloch (1994) and Fenton and Karma (1998). Unlike detailed
ionic cardiac models which were initially developed following Hodgkin-Huxley formulation,
simplified cardiac models are often based on the elegant Fitzhugh-Nagumo two-variable reduction
of the Hodgkin-Huxley model. A common approach is either to make an appropriate functional
generalisation of the FitzHugh-Nagumo system (Franzone et al. 2014), or directly truncate a
detailed ionic model.
An attractive feature of these models is that, along with a reasonable description of excitability,
threshold, plateau, and refractoriness, they focus on generic formulations that can often be treated
analytically. Further examples of such impressive theoretical works using a simplified model
can be obtained in Biktashev et al. (2008), Simitev and Biktashev (2011; 2006), Mitchell and
Schaeffer (2003) and Tolkacheva et al. (2002). In addition, a simplified model may improve
the computational tractability of large-scale tissue simulations (Clayton et al. 2011) and could
also be used for whole heart simulation with various cell types (Balakrishnan et al. 2015, Sovilj
et al. 2013). The common disadvantage of these models, however, is their lack of an explicit
correspondence between model components and constituent parts of the biological system, e.g.,
ion channels, transporter proteins and ion concentrations. This hampers our ability to understand
the physiology behind particular AP behaviour when the information is needed. A good simplified
model must have the ability to reproduce important properties of action potential, including AP
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duration and conduction velocity (CV) restitution curves, but computationally more efficient than
other detailed models (Bueno-Orovio et al. 2008).
To date, mathematical models of cardiac electrophysiology already play a variety of roles,
including the performing of ‘test series’ for verification of suitability of experimental designs,
identification of targets for more detailed research, interpretation of experimental data, and
description of causal relationships in complex biological responses (Thompson et al. 2000).
Specifically, many types of research involving mathematical models of action potential have been
conducted to understand the complex interaction between abnormal structure and function that
underlies the development of cardiac arrhythmias (Clayton 2001). Cardiac alternans, for example,
is an important precursor to arrhythmia and has also been linked to the incidence of ventricular
fibrillation and sudden cardiac death (Bayer et al. 2016, Ten Tusscher et al. 2007, Trayanova and
Boyle 2014, Trayanova and Chang 2016). Alternans is typically linked to oscillation of action
potential duration and calcium cycling, particularly in the sarcoplasmic reticulum. To date, while
APD restitution properties is widely used to observe the onset, the mechanism of the behaviour is
not yet fully understood. Advances in experimental techniques have allowed us to get more data
and visualise the electrical behaviour of the heart in more detail, hence, making the observation
and understanding of lethal arrhythmia, including cardiac alternans more plausible.
The term ‘heterogeneity’ quite often signifies various features in cardiac physiology, including
both electrical and mechanical properties of the cells. Distinctions in the intracellular expression
of various ion channel ensure a pattern of cellular electrical heterogeneity. In particular, car-
diac cells may have different expressions of the voltage-dependent sodium channels, potassium
channels and L-type channels which can alter the balance of the ionic currents. In consequence,
this may result in significant differences in the morphology and duration of the action potential
(Muszkiewicz et al. 2016, Ni et al. 2018). Cell-to-cell variation present in the cardiac electro-
physiology may influence the cell responses to cardiac drugs which could potentially lead to
pro-arrhythmic effects. Due to recent advances in experimental and computational techniques,
many studies have taken into account physiological variability and started to move beyond the
traditional cardiac model-building scheme. The methodology is important and can be applied to
study the mechanisms of cardiac arrhythmias, with a special emphasis on atrial fibrillation, and
improve the assessment of pro-arrhythmic risk and drug response.
In conclusion, computational models of action potential are potentially robust tools for study-
ing normal and pathological processes of cardiac functions. Most of the tools for constructing
accurate models are well established and are being used increasingly in tandem with experimental
and clinical studies. Despite this positive progress in cardiac modelling, the underlying problem,
in most cases, remained constant, and the problem should be placed under further investigation.
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1.2 Goals of thesis
In the thesis, we aim to solve several unresolved issues in cardiac electrophysiology using either
detailed biophysically or simplified models of action potential, depending on the state of the
respective problems. The problems may be grouped into several topics as following;
Variability in action potential and drug pharmacodynamics
In this topic, our goals are;
• to determine the distributions of ion channel conductance values that capture the electro-
physiological heterogeneity measured in large populations of rabbit ventricular cardiomy-
ocytes
• to investigate the effects of action potential heterogeneity on the application of drug
blocking of hERG and L-type calcium channels
• to study the capability of cell models in predicting the drug effects.
The action potential of excitable cells, for example, cardiac cells and neurons, reflects the
orchestrated activity of various ion channels and electrogenic transporters. In many studies,
including both experimental and computational modelling, have shown that there is significant
inter-individual variability in the combinations of molecular-input parameters that can generate
very similar integrated outputs (Britton et al. 2013; 2017b, Romero et al. 2009, Sobie 2009). The
traditional way to construct a cardiac cell model is by using the mean behaviour of available
experimental data, technically from the species and cell type being modelled. The model is
then represented the typical or average response of an isolated cardiac cell, creating a ‘cell-
specific model’ with a unique parameter set. Unfortunately, this model cannot reproduce output
for different experimental data taken from other laboratories due to difference in experimental
protocols and conditions such as temperature and solution concentration, which can influence
the dynamics of ionic currents. This has led to a paradigm shift in computational modelling
of cardiac electrophysiology that relies not on generating idealised output based on mean data
but rather development of populations of models that account for the observed variability in
molecular inputs.
As shown in Figure 1.2, the action potential recordings from a population of mouse ventricular
cells are significantly different, even being stimulated at similar external stimuli and conditions.
Cell variability in cardiac electrophysiology occurs due to many factors. A likely source of this
behavioural variability is differences in the levels of ion channels, pumps, and transporters, which
arise as the cellular expression system interacts with stochastic effects (Zaniboni et al. 2000),
pathological processes (Rahm et al. 2018), local environmental effects (Muszkiewicz et al. 2016),
and extrinsic effects such circadian rhythm (Jeyaraj et al. 2012). Variability in action potentials
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Figure 1.2: Traces of action potentials of isolated mouse ventricular cells paced at 4 Hz under
current clamp. The recordings illustrate the typical degree of cell-to-cell variability of AP
waveform observed in a population of cells. Figure originally from Rees et al. (2018).
is a vital phenomenon as it usually happens in nature but yet poorly understood. Besides, the
limited ability of experimental techniques to probe complex interactions between components has
hindered our understanding of the factors that cause a range of behaviours within cell populations.
Previous studies to modelling variability have incorporated variation in the strength of
ionic currents in a cardiac cell but did not fully link the modelled variability to variability
observed in experimental measurements (Romero et al. 2009, Sarkar and Sobie 2010; 2011,
Sobie 2009). Hence, following the work, Britton et al. (2013) introduced a new experimentally-
calibrated population-based approach and developed a population of models in order to exhibit
the variability in rabbit Purkinje cells. The model population was further used to study the
effect of AP variability to potassium block. Their results, however, were limited to small sample
size (12 different Purkinje fibres), which could possibly mask the level of variation seen in the
experiments, suggesting large sample size is needed to improve estimates of variation.
Our collaborators (lead by Prof. Godfrey Smith) based in Institute of Cardiovascular and
Medical Sciences, University of Glasgow have developed a medium/high throughput assay using
optical fluorescence techniques which can be used to measure the electrical and mechanical
response within large of populations of cardio-myocytes ranging from 100 to 500 cells per heart
(Lachaud 2019). These large datasets show very pronounced heterogeneity in the electrophysio-
logical signatures of individual ventricular myocytes, including heterogeneity in response to drug
blocking of hERG and L-type calcium channels. Using these experimental measurements and
several biophysically detailed action potential models, we construct a population of rabbit ven-
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tricular models and then use them to study the impact of variability in cellular electrophysiology
on hERG and L-type calcium blocks. Also, quantitative comparison of effects of these channel
blocks between three different ventricular models are investigated.
Estimation of parameters in models of single-cell cardiac action potential
In this topic, the goals are,
• to demonstrate parameter estimation method and fitting protocols with multiple objective
functions.
• to introduce the caricature Noble model as a generic action potential model by fitting
the model to various detailed action potential models and experimental measurements of
healthy and failing myocytes.
• to compare the AP morphologies and restitution curves with the respective models and
experimental data.
• to provide the parameter interpretation of the fitting results and essential differences
between models.
Often, action potential models compose of a large number of parameters and variables using a set
of ordinary differential equations (ODEs) to describe the interacting ion currents and calcium
handling mechanisms. This, however, makes the process of understanding the relationship
between model outputs and model parameters more complicated, suggesting a need for simple,
reduced-complexity cardiac AP models. Simplified AP model is a representation of more
biophysically complex models and contains a small number of equations with less parameter
and variable. Despite its simplicity, it still preserves the important fundamental characteristics
of cardiac electrophysiology. Some even allow for analytical works (Biktashev et al. 2008,
Mitchell and Schaeffer 2003, Simitev and Biktashev 2011). Another obvious advantage of the
simplified model is that the small number of parameters in the model makes parameter fitting less
complicated, as many parameters govern/contribute to only a single property. The model usually
is not limited to fitting to experimental data only, but the model parameters can be adjusted to
fit data from more detailed models of various cell types and species (Bueno-Orovio et al. 2008,
Groenendaal et al. 2015, Guo et al. 2013). Owing to the several number of free parameters in
action potential models, these parameters, in practice, can be modified, so that the model can be
used to reproduce different AP morphologies (Clayton et al. 2011).
An example of a generic model like the Fitzhugh-Nagumo type system lacks important
cardiac properties, including a realistic APD restitution curve (Clayton 2001, Kogan et al. 1991),
and fails to reproduce some qualitative features of cardiac action potential (Biktashev et al. 2008).
Hence, using the modified version of caricature Noble model by Biktashev et al. (2008), we
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aim to reproduce action potential morphologies and restitution curves from even more complex
electrophysiological models of various cell types, like Purkinje fibre, ventricular and atrial cell.
In addition to fitting to more biophysically detailed models, the model can also be used to fit data
from the experimental data of healthy and failing myocytes, since this model only focuses on
reproducing the dynamical properties of AP rather than detailed ion currents. The results can be
used further to investigate the cause of AP behaviours.
In this study, we show that the modified caricature Noble model is flexible enough to accurately
capture the electrical properties of cardiac myocytes by adjusting the parameter values. The
model also has the advantage of being less computational demanding than other biophysically
detailed action potential models. Fitting qualitatively different models to a common mathematical
structure offers a number of advantages for their use and interpretation as well essential differences
in their AP waveform can be identified. The model also is amenable for further mathematical
analysis, for instance, to develop an efficient numerical method and study the mechanisms of
cardiac alternans.
Efficient numerical method for the solution of the modified caricature No-
ble model
In this topic, the goals are,
• to develop an efficient numerical method for simulation of cardiac action potential model
using its asymptotic structures.
• to compare the stability and efficiency of such method with other numerical methods.
The wide variety of existing cardiac cell models encompasses many different properties, including
the complexity of the model and the degree of stiffness (Spiteri and Dean 2010). Accordingly,
no single numerical method can be expected to be the most efficient for every model. One such
challenge is that the ionic model is usually a stiff, non-linear set of ODEs that must be solved
for each node in the simulation. This causes the simulation to be computationally expensive and
time-consuming. Large scale 3D virtual heart model, for instance, may involve millions of grid
points, and the solution has to be evolved over tens of thousands of time steps. Such enormous
computational demands can only be solved with the aid of advanced numerical techniques and
parallel computing approaches. However, even with current supercomputing facilities, execution
times are still slow, lagging real-time by roughly a factor of 104 to 105 (Plank et al. 2009).
Berenfeld and Jalife (1998) also demonstrated that simulation for Purkinje-muscle reentry in a
3-dimensional Fitzhugh-Nagumo model required about 1.5 hours to run 10 ms of cardiac activity.
Generally speaking, simulations involving tissue samples and observation of longer period are
expensive, and further significant performance improvements are needed. Other than using a
simplified model, constructing a robust numerical algorithm is considered to be the most effective
way to speed up the simulation time.
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To date, various numerical schemes have been implemented to solve action potential models
(Ji and Fenton 2016, Roy et al. 2017, Victorri et al. 1985). A typical method like explicit Euler
method is one of the conventional method used to solve the system due to its easy implementation,
but its stability is stringent in the sense that user needs to use a relatively small size of time-step,
leading to longer computational times. Another advanced method, for example, fully implicit
solvers are faster than explicit method but require the solution of a nonlinear system of equations.
Hence, developing the most robust numerical method with easy implementation has remained a
popular endeavour among researchers. In the thesis, we aim to develop a robust numerical method
for an efficient simulation taking advantage of the fast and slow manifolds of a cardiac model.
The method is the implementation of a conventional method by Weinan and Engquist (2003), the
so-called ‘heterogeneous multiscale method’. It is a method for solving a mathematical model
with multiple time scales. We will apply the method on the modified caricature Noble model and
then compare the result with other available numerical schemes. To our knowledge, no research
in cardiac electrophysiology has applied this approach on an action potential model and hence,
motivating us to explore the feasibility of the method.
Mechanisms of cardiac alternans
In this topic, the goals are,
• to identify the parameters and variables in the model that are responsible for generating
action potential duration alternans.
• to derive an analytical formula to construct the restitution curve in both normal and alternans
conditions.
• to develop a framework formulated in terms of boundary value problems for studying
cardiac restitution.
• to validate the theoretical work derived in this chapter by fitting the caricature Noble model
to models of alternans and no alternans.
Cardiac electrophysiology models have made significant contributions to our understanding
of how the electrophysiological heterogeneities predispose to various types of cardiac arrhyth-
mias. This includes the mechanisms that govern the beginning, maintenance and elimination
of arrhythmia, which are still not fully understood. As a consequence, treatment of cardiac
arrhythmia remains disappointingly ineffective compared to other pharmacological therapies,
emerging a significant potential for improvement (Trayanova 2014). There are many types of
arrhythmias, and this thesis only focuses on cardiac alternans. This is because repolarisation
alternans, or alternans that manifests during ventricular repolarisation has been linked with an
increased vulnerability to ventricular arrhythmias and sudden cardiac death under a wide range
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of pathophysiologic conditions, for example, myocardial ischemia (Armoundas et al. 2002). At
the cellular level, cardiac alternans is defined by cyclic, beat-to-beat alternations in contraction
amplitude (mechanical alternans), action potential duration (APD; electrical or APD alternans),
and calcium transient amplitude (calcium alternans) at constant stimulation frequency (Edwards
and Blatter 2014). However, in this study, we will only consider the APD alternans because the
model does not include the calcium current and variable for cell contractility.
For the time being, the most efficient way to study cardiac alternans is by using the restitution
properties of cardiac cells. A restitution curve describes a functional relationship between the
duration of a cardiac action potential and the length of its previous diastolic interval. However,
the experimental protocols for measuring restitution encounter a number of difficulties, including
that of distinguishing the ultimate periodic regime from transient behaviour. This is because
of the presence of cardiac memory (Gilmour et al. 1997, Tolkacheva et al. 2003). Common
experimental protocols like dynamic restitution pacing method require the cell to be periodically
stimulated at a fixed interval of basic cycle length until it settles into a stable periodic response.
Several periodic responses have been recorded in experiments (Hall et al. 1999, Visweswaran
et al. 2013). For instance, every successful stimulus may excite an action potential with identical
shape (1:1 response). However, under certain conditions, only every second stimulus may excite
an action potential and create a 2:1 response. Under different conditions, the action potential
duration may alternate between long and short (alternans 2:2 response). It is commonly assumed
that the 1:1 response represents the healthy function of the cardiac cell; meanwhile, the other
two responses are viewed as ‘instabilities’ of the normal response which may potentially lead
to cardiac arrhythmias (Cherry et al. 2012, Karma 1994). Hence, the action potential duration
(APD) restitution maps can be used to study such instabilities.
With this motivation, we aim to derive an explicit discrete restitution map for caricature
Noble model and study their equilibrium branches and bifurcations. This approach has been
done earlier by Tolkacheva et al. (2002) and Mitchell and Schaeffer (2003) on a simplified
version of Fenton and Karma (1998) model. Nevertheless, the model does not represent the
real physiology of a cardiac cell, unlike the caricature Noble model, which is more realistic and
preserve the fundamental structures of an ionic model (Biktashev et al. 2008). We then explore
the regions in the parameter space of caricature model where normal 1:1 response and alternans
2:2 occur. The parameter space is validated with numerical simulations. We also develop a
framework formulated in terms of boundary value problems for studying cardiac restitution. This
framework can be used to derive analytically or compute numerically different branches of the
action potential duration restitution map from the full excitable models. Finally, our method
is validated by comparing the asymptotic restitution map with the boundary value problem
formulated restitution curves.
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1.3 Structure of thesis
The thesis is composed of four main parts. They are outlined as follows,
Part I (Background and thesis goals) The first part is divided into two chapters. Both chapters
mostly contain the introductory materials which are needed for this thesis. Chapter 1 provides a
brief introduction to cardiac electrophysiology and the motivation behind the works. Importantly,
the objectives and attempted research questions of each project are outlined. In the second chapter,
the background of cardiac electrophysiology is discussed in more detail. The development of
action potential models since the pioneer model by Hodgkin and Huxley (1952) is discussed.
The underlying mathematical equations of cardiac cellular electrophysiology model and the
contribution of particular ionic currents in the AP generation are explained. Moreover, several
experimental techniques used to measure the transmembrane potential in an isolated cardiac
cell is discussed. The chapter is ended by providing some essential information on cardiac
anti-arrhythmic drugs.
Part II (Applications of a detailed models of the cardiac action potential) The second part
consists of two chapters (Chapter 3 and 4) and is the most significant part, in terms of effort and
time spent. In this second part, the focus mostly on the investigation of action potential variability
in a population of rabbit ventricular myocytes and their effects on cardiac anti-arrhythmic drugs.
The second part of this thesis is begun by explaining the experimental data and the experimental
methods used to measure the recordings of APs under control and drug conditions (Chapter 3).
Using the information gathered from the experimental data, the underlying mechanisms in the
variability of action potentials in a population of rabbit cardio-myocytes is studied. In order to
achieve this, an experimentally calibrated population of models is constructed and the population
is used to investigate how the cell-to-cell variability may influence the action of drugs. Several
detailed biophysically ionic models are used, and quantitative comparison of effects of hERG and
L-type calcium blocks between the three models and experimental measurements are carried out.
Part III (Applications of a simplified model of the cardiac action potential) Biophysically
detailed model of action potential is very complex due to a large number of equations and
parameters exist in the model in order to describe the complex process of electrical excitation in a
cardiac cell. Due to this complexity, it is almost impossible to use the model for analytical works.
Hence, such a model can be replaced with a more simple model that has less parameters and
variables but still accurately preserve the essential properties of an action potential. From this
point onwards, I shift from studying the complex model of action potential to studying simpler
model. A modified version of caricature Noble model by Biktashev et al. (2008) is used.
This part consists of three main chapters (Chapter 5–8). In Chapter 5, the governing equations
of modified caricature Noble model is described and its exact analytical and asymptotic solutions
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are derived. The analytical solutions are derived using both initial and boundary value problems.
The phase portrait of the system is illustrated and the excitation conditions of an AP is also
explained. The main work begins in Chapter 6, where a simple parameter estimation method
in single-cell modelling is demonstrated. The modified caricature Noble model is fitted to even
more complex biophysically action potential models of various cell types and experimental
measurements of healthy and failing rabbit ventricular myocytes. Specifically, the focus is to
fit the AP morphology and APD restitution curves of targeted data. Parameter fitting of the
modified caricature Noble model demonstrates that it can be used as substitution to other more
complicated models when other ionic properties are not needed. Moreover, in this thesis, we
show that this model can be used as a prototype to look for cardiac alternans and to develop an
efficient numerical method.
The asymptotic structures of modified caricature Noble model derived in Chapter 5 is exploited
by implementing a conventional numerical method, the so-called ‘heterogeneous multiscale
method’ on this model (Chapter 7). The stability and drawbacks of such method are analysed.
Also, the asymptotic-numerical method is compared with other available numerical methods.
Finally, in Chapter 8, the caricature Noble model is used to study the mechanisms of action
potential duration alternans. In particular, an explicit discrete restitution map for the model
is derived and the parameter region where alternans occurs is identified. Following the fitting
methodologies in Chapter 6, the caricature Noble model is fitted to a canine ventricular model
and the results are used to verify the parameter space where alternans occurs.
Part IV (Conclusion and supporting materials) The final part provides a summary of the
research works and outlines of some future directions. MATLAB codes and some additional
materials are provided in the end of this chapter.
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Chapter 2
Mathematical models and experimental
methods for cardiac electrophysiology
In this chapter we provide essential biological and mathematical background to the topics
discussed in the upcoming chapters. We begin this chapter by explaining the anatomy of
the heart and its function as a muscular pump. We also describe the mechanisms behind the
cardiac electrical excitation and propagation of action potentials. We then explain the general
mathematical description of an action potential model in describing cardiac electrical behaviour
at the cellular level. A brief overview of cardiac cellular electrophysiology model development
since the ground-breaking model by Hodgkin and Huxley (1952) is reviewed. These models are
useful in many ways, for instance, they can serve as a powerful tool for investigating abnormal
heart conditions, from individual cells to the whole heart. Later in this chapter, we outline
some applications of cardiac action potential models to study cardiac diseases and treatment.
Following the overview of cardiac electrophysiology, we end this chapter by discussing some
of the experimental techniques used to measure transmembrane potential and ionic currents of
cardiomyocyte.
2.1 The heart
The heart is a muscular organ consisting of four chambers that are located just to the left of
the midline of the thoracic cavity. The upper two chambers are known as atria, and the bottom
two chambers are called ventricles, as shown in Figure 2.1. The right atrium and ventricle are
separated by the tricuspid valve, whereas, the left atrium and ventricle are separated by the mitral
valve. These valves function to prevent the backward flow of blood. Our heart is a muscular
organ, where its main function is to maintain adequate cardiac output. Cardiac output is the
amount of blood our heart is able to pump in one minute. In particular, the heart function to
deliver ample supply of blood to our body part at adequate pressure to encounter tissue demands
for oxygen and nutrients. The pumped blood also carries metabolic waste such as carbon dioxide
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Figure 2.1: Anatomical structure of the heart. The white arrows indicate the blood flow in the
heart. Reproduced from Gemmell (2014).
to the lungs.
Our heart is auto-rhythmical and the rate is determined by body’s needs via autonomic nerves
(through the vagus nerve and sympathetic trunk that connect to the brain). Particularly, these
nerves act to influence, but not control, the heart rate. The brain signals our heart to beat faster by
sending messages to our heart’s electrical system, which regulates the timing of the heartbeat. If
the cardiac output is low, the adrenal glands will release more hormone adrenaline, which travels
in the bloodstream and stimulates our heart to beat faster. Although this mechanism is important
to maintain cardiac output, but a faster heart rate can be counterproductive as it causes less time
for the ventricle to fill with blood after each heartbeat.
The mechanism of the pumping action of the heart easily understandable. The blood circu-
lation consists of the systemic (left) and pulmonary (right) circulation. Pulmonary circulation
transports blood between the heart to the lungs, whereas systemic circulation moves blood be-
tween the heart and the other part of body. The right heart deoxygenated blood is collected from
two large veins, superior and inferior vena cavae (Figure 2.1) and the blood is then pumped from
right atrium into the right ventricle through tricuspid valve. As right ventricle begins to contract,
the tricuspid valve closes and the blood is pumped into the pulmonary artery and then to the
lungs. The carbon dioxide in the blood is exchanged for oxygen. In the left heart, oxygen-rich
blood is returned to the left atrium through the pulmonary veins. It is then pumped into the left
ventricle via mitral valve. Finally, the oxygenated blood is delivered to the rest of body through a
large artery, aorta.
The muscular tissue surrounding the chambers of the heart is known as myocardium, and
it is responsible for contraction of the heart by providing sufficient pumping force to squeeze
blood from the ventricles. The septum is the middle region of the cardiac wall that separates
the left and right chambers, and its primary function is to prevent the mixing of oxygenated
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and deoxygenated blood. The myocardium is composed mainly of contracting cells, called as
cardiomyocyte. In tissue, they are connected together as a sheet of cells by gap junctions. The
gap junctions permit various molecules and ions to directly travel between individual cells, hence
allow electrical impulses to propagate through cardiac tissue.
The mechanical contraction of the heart is triggered by the electrical excitation of cardiac
cells, the so-called ‘action potential’ (AP) across their membranes. The cardiac AP is a rapid
change in voltage across the cell membrane caused by the movement of charged ions between the
inside and outside of the cell. The electrical signal is generated by the sino-atrial (SA) node (also
known as a pacemaker) which is located at the top of the right atrium (Figure 2.1). The signal
then travels from the SA node to both right and left atria and trigger the atria to contract. As
the atria contracts, the blood is pumped to respective ventricles. After the contraction of atria,
the electrical signal reaches the bottom of the right atrium, called the atrioventricular (AV) node.
At this point, the signal slows down a bit to provide sufficient time for the ventricles to receive
the blood from the atria. The electrical signal then leaves the AV node and moves down to the
bundle of His. The signal is separated into two branches; one branch goes to the left ventricle,
and another goes to the right ventricle, causing the contraction of the right and left ventricles.
This cycle of an electrical signal followed by a contraction represents one heartbeat. In an average
human lifetime, this cycle normally occurs roughly about two billion times, without fail, as any
chronic and/or severe interruptions in normal rhythm may potentially lead to sudden cardiac
arrest.
2.2 The cardiac action potential
There are estimated 2-3 billion cardiac muscle cells in a normal human heart (Tirziu et al. 2010),
and these excitable cells are responsible for the AP generation. All living cells including cardiac
cells have a boundary that separates the intracellular fluid and intracellular organelles from the
outside fluid. The semi-permeable boundary is known as cell membrane, and they are made
up of two layers of phospholipid molecules with embedded protein channels (also called ionic
channels). These pores allow the flow of particular ions such as, Na+, K+, Cl− and Ca2+ which
can only travel through its specific ion channel, each channel type typically displaying high
selectivity to a particular ion and being relatively impermeable to others. The membrane acts
as a barrier to the free flow of ions and preserves concentration differences of these ions. The
gradients of electric charge create a potential difference across the membrane, the transmembrane
potential, which provides the driving force for the ionic currents.
When the cell is not stimulated and in an equilibrium state, most of these ion channels are
closed, prohibiting the ions from moving in and out across the membrane easily. However,
in the presence of the external stimulus, which in the case of cardiac myocytes is membrane
depolarisation from adjacent, connected cells, or experimentally via electrodes, the membrane
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Figure 2.2: Sketch of the five typical phases of an action potential.
potential changes and leads the alterations in membrane permeability of different ions. This
activates the opening of some of the ion channels and allows ions to travel across the cell
membrane. In consequence, it triggers the onset of an action potential. In most of the electrically
excitable cells like a neurons, the action potential occurs for a short duration (at most a few
milliseconds), but in the myocytes, the action potential lasts much longer, typically for a hundred
milliseconds or more, depending on the cell type and species. The longer duration here prevents
the cell from firing another action potential and results in a refractory period for the heart to beat
and then recover.
The action potential morphology is different at the different type of cardiac cells (refer Figure
1.1) and a typical action potential can be divided into five different phases (Santana et al. 2010)
which are depolarisation, post drop, plateau, repolarisation and recovery, as seen in Figure 2.2.
We briefly outline the five phases of an action potential with the dominant current in every phase.
• Phase 0 (Depolarisation): This is the leading edge of the AP and usually is very steep. It
corresponds to the period of rapid depolarisation from the diastolic membrane potential.
The voltage reaches a threshold value due to the rapid activation of sodium ion channels
when the external stimulus is present.
• Phase 1 (Post-drop repolarisation): The transient repolarisation period in phase 1 is pro-
duced by inactivation and closing of sodium channels due to inactivation and the con-
comitant activation of the transient outward potassium, (Ito) and Na+/Ca2+ exchanger
(INaCa) currents. The direction of INaCa transiently reverses where it brings in calcium
Ca2+ and removes sodium ions. Depending on the strength of these currents, the transient
repolarisation may cause a ‘notch’ in the AP where the voltage repolarises slightly below
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the later plateau potential. However, such AP characteristic is species-dependent and differs
between cardiac cells (Di Diego et al. 1996).
• Phase 2 (Plateau): Phase 2 is the long (hundreds of milliseconds) plateau phase of the
action potential during which the membrane potential remains depolarised and changes
more slowly. The plateau region is produced by a balance between inward movement of
calcium ions, the ICa current through L-type calcium channels and outward movement of
potassium ions, IKs current through the slow delayed rectifier potassium channels. The
sodium-calcium exchanger current, INaCa and the sodium-potassium pump current, INaK
also play secondary roles during this phase.
• Phase 3 (Repolarisation): In phase 3, the transmembrane potential begins to drop rapidly.
Ca2+ is reduced due to the inactivation of L-type Ca2+ current channels and continuous
activation of IKs channels have increased the K+ efflux. This ensures a net outward
current, corresponding to a negative change in membrane potential, hence allowing more
types of potassium channels to open. The channels are the rapidly inactivating delayed
rectifier potassium channels (IKr current) and the inwardly rectifying potassium current,
IK1. All these positive current contribute to the repolarisation of the myocyte to the resting
potential. When the voltage value reaches approximately -80 to -85 mV, the delayed
rectifier potassium channels close, whereas IK1 remains activated throughout phase 4,
contributing to set the resting membrane potential (Dhamoon and Jalife 2005).
• Phase 4 (Recovery): Phase 4 is the diastolic membrane potential of an action potential.
INaCa is reactivated during this stage in order to restore the calcium concentration in the cell.
The voltage value stays roughly between -80 to 90 mV until the cell is being stimulated
again by an external electrical stimulus.
2.3 Calcium cycling and signalling
For the time being, our knowledge of calcium as a versatile signalling molecule that is responsible
for electrical-contraction coupling in the heart has grown tremendously. In this section, we briefly
discuss the mechanism of calcium cycling and signalling in cardiac myocytes. Although calcium
involves in regulating diverse functions such as fertilisation, secretion, gene transcription and cell
death, our focus in this section mainly on cell contraction. The details on the calcium signalling
mechanisms can also be found in Bers (2008), Fearnley et al. (2011) and Kaestner (2013).
Regular heart contraction requires electrical stimulation to be converted into mechanical
force and the process demands a coordinated flow of Ca2+ ions at the cardiomyocyte level.
Generation of an action potential is triggered by a rapid influx of sodium ions via voltage-gated
sodium channel, thereby creating the INa current. In consequence, this induces Ca2+ influx
through voltage-activated L-type calcium channels, generating the ICaL current. Flow of calcium
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(a) (b)
Figure 2.3: Diagram of (a) a cellular membrane and (b) a simple electrical circuit. Reproduced
from Franzone et al. (2014).
ions into the cell triggers a much larger calcium release from the sarcoplasmic reticulum (an
organelle that stores the intracellular calcium). Calcium ions are released from SR through
specialised Ca2+-release channels, expressed as ryanodine receptor type-2 (RyR2), and the
process is known as calcium-induced calcium release (CICR). The free cytosolic calcium ions
then bind to cardiac troponin C (TnC), a calcium-sensing protein of the contractile apparatus and
instigate myofilament contraction. Calcium ions are removed from the myocyte by sequestration
into the SR by SR calcium-ATPase type-2a (SERCA2a). Also, sodium-calcium exchanger (NCX)
is responsible for exporting a calcium ion out into the extracellular space, by exchanging with
three sodium ions. The whole process of calcium release and re-uptake forms a calcium wave that
flows through the cardiac cells and is recognised as the calcium transient. The amount of calcium
released from the SR also determines the calcium-transient amplitude, which then influences the
strength of systolic contraction.
2.4 Mathematical models of cellular bioelectrical activity
Cardiac cell models can provide insights into the processes underlying the electrical dynamics
of the cardiac. Such a model begins with a mathematical description that describes the cardiac
electrical behaviour at the cellular level. This model incorporates some formulations of trans-
membrane ionic currents, voltage and ion channels dynamics. In this section, we briefly review
some of the main mathematical compartments used in cellular electrophysiology and we refer
to Franzone et al. (2014), Keener and Sneyd (1991), Sundnes et al. (2006) for a more complete
discussion and additional topics.
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2.4.1 Electrical circuit model of the cellular membrane
In Figure 2.3, we show a schematic representation of the cell membrane as a simple electrical
circuit. The cell membrane serves to separate the intra- and extracellular ion substances and is
thus regarded as a capacitor with capacitance Cm. The capacitance is defined as the ratio between
the charge Q across the capacitor and the voltage potential drop V necessary to hold the charge
Cm =
Q
V
. (2.1)
The current across a capacitance is defined as
Icap =
dQ
dt
(2.2)
and if Cm is constant, we have the following relation,
Icap =
dQ
dt
=Cm
dV
dt
. (2.3)
The cell membrane can be modelled as a capacitor in parallel with some resistors to represent the
ionic currents. Hence, by the current conservation law, the sum of the current across the capacitor
and resistors must be equal to the applied current (external stimulus) Iapp, yielding,
Cm
dV
dt
+∑ Iion = Iapp (2.4)
where V denotes the internal minus the external potential. The basic structure of action potential
models is normally formulated as above. The number of ionic currents incorporated in the model
depends on the available experimental data at the time the model is developed. In essence, for a
given transmembrane potential drop, ionic current flows through a population of ionic channels is
specified in a unit area of a membrane surface. A significant challenge is to determine the form
of Iion. This topic is discussed further shortly.
2.4.2 Models for the current/ionic flux
In general, model for ionic flux can be modelled either using Ohmic or Goldman-Hodgkin-Katz
(GHK) formulation. There is no one ‘correct’ expression for the ionic current as different cells
have different types of ion channels, each of which may have different current-voltage relations.
The choice of which formulation to use for a specific current is depends on which model best fits
the experimental data. The first formulation was given by Hodgkin and Huxley (1952) in their
classic work on squid giant axons and the formulation is described as follows,
IX = g(V, t)φ(V ), (2.5)
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where g(V, t) is the proportion of open channels in a unit area of the membrane surface and φ(V )
is the current-voltage (I-V) relation of a single open channel. Typically, it can be modelled as a
product φ(V ) = gc(V −EX) such that gc is the channel conductance and EX is the equilibrium
potential difference across the membrane (also called as Nernst potential). The equation of Nernst
potential is
EX =
RT
zX F
ln
(
[X ]e
[X ]i
)
, (2.6)
where R is the gas constant, T is the absolute temperature, zX is the charge on the ion X , F is
the Faraday constant, and [X ]e and [X ]i are the extra- and intracellular concentrations of ion X ,
respectively. The Nernst equation does not depend on how the ions travel through the membrane
but depends only on the ratio of concentrations (Keener and Sneyd 1991). The proportion of
open channels in a unit area of the membrane surface can be described as
g(V, t) =
N
S
=
Ntot
S
N
Ntot
, (2.7)
where N is the number of open channels on the membrane surface, Ntot is the total number of
membrane channels and S is the membrane surface area. Hence, ionic current can be formulated
as following,
IX = Ḡcw(V −EX), (2.8)
such that Ḡc = Ntotgc/S is the maximal channel conductance per unit area of the membrane
surface and w = N/Ntot is the probability of open channels (also known as gating variable). We
will explain how to model the gating variable in the next subsection.
A central assumption of Hodgkin-Huxley analysis is that ionic current, IX is linearly pro-
portional to the driving force (V −EX ). This, however, is not always true as numerous studies
(Binstock and Goldman 1971, Clay 1991, Frankenhaeuser 1962, Taglialatela and Stefani 1993)
have shown that ionic current could have a non-linear dependence on (V −EX ) for physiological
conditions which is well described by the Goldman-Hodgkin-Katz equation (Goldman 1943,
Hodgkin and Katz 1949). The GHK current equation for an ion species X is defined as below,
IX = PX zX F
zX FV
RT
( [X ]i− [X ]e exp(−zX FV/RT )
1− exp(−zX FV/RT )
)
. (2.9)
where PX is the permeability of the membrane for ion X and the other constants are as defined
earlier. A study by Clay (2009) has shown both formulation for ionic current may significantly
influence the AP excitation. The revised model of Hodgkin-Huxley (using GHK formulation)
fired only once which showed better agreement with experimental results. In contrast the original
model using Ohmic formulation (2.5) fired an unending train of action potentials in response
to a sustained depolarising current pulse. The analysis given in the paper has demonstrated the
importance of choosing an accurate description of ion channel activation curve, which should be
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kept in mind when constructing models of action potential.
2.4.3 Ion channel gating
Principally speaking, there are many ways to model the gating variable. For the purpose of this
thesis, we only discuss the simplest case which is the single-unit two-state channel. See Franzone
et al. (2014) or Keener and Sneyd (1991) for an extensive discussion.
The simplest approach to model the gating channel is by assuming that the channel can
present in either an open state, So or a closed state, Sc. The transition rate from one state to
another can be represented by some constants, α and β , although in general, the rate is dependent
on the transmembrane potential, V . Thus, we have,
Sc
α(V )

β (V )
So. (2.10)
If So(t) and Sc(t) are the average numbers of channels that at time t are in the open and closed
state, respectively, then by law of mass action, we have,
dSo(t)
dt
= αSc(t)−βSo(t), (2.11)
where So(t)+Sc(t) = S. We set so = So(t)/S and sc = Sc(t)/S, the probability of open and close
channels per unit area of the surface membrane, we then get,
dso(t)
dt
= αsc(t)−β so(t), (2.12)
such that so(t)+ sc(t) = 1. We denote w = so and substitute sc = 1− so into above equation to
yield,
dw
dt
= α(1−w)−βw. (2.13)
The equation can also be written as
dw
dt
=
w∞−w
τw
, (2.14)
where w∞ = α/(α +β ) and τw = 1/(α +β ) are the equilibrium state and the time constant,
respectively.
2.5 Overview of cardiac electrophysiology models
This section is dedicated to state of the art in the development of cardiac cellular electrophysiology
model. Since the last 60 years, the development of cardiac AP models had evolved rapidly, and
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the effort to develop a complete cardiac cellular electrophysiology is still ongoing with the support
of advanced experimental technique. The pioneer model of action potential was introduced by
Hodgkin and Huxley (1952). This model of the electric properties of squid nerve was the first
to describe the physiology of cell excitability by comparing to an electrical circuit. The model
has raised computational modelling of physiological function to a new level. The model itself
had established an unrealistic expectation for the rapid implementation of a similar approach to
other cardiac cells. The model was successfully model the AP neuron by incorporating only three
ionic currents: a Na+ current, a K+ current and a leak current to describe the remaining unknown
current. However, the model was unsuitable to be used for the human cardiac cell as the AP could
only last for a short duration (1-5 ms), as the average human ventricular AP may last for 400 ms.
The Hodgkin-Huxley model was a major ground-breaking development in the computational
modelling of electrophysiology had paved the way for model development. Following their
success, there was substantial work done to apply their modelling approach to various different
cell types, including cardiac cells. To date, there are hundreds of cardiac electrophysiology model
for various species. Among the many other cardiac ionic models, we mention several cardiac
action potential models of Purkinje fibre, atrial and ventricular cells that we believe to have a
significant impact on the later model. For further, more detailed review of the development of
cardiac electrophysiology model, the reader is advised to refer to the original paper and to these
published review articles: Kohl et al. (2001), Niederer et al. (2009), Noble (2011), Wilhelms et al.
(2013) and Noble et al. (2012).
2.5.1 Purkinje fibre models
In 1962, Noble proposed the first model of cardiac action potential for Purkinje fibre cells. The
model framework was adapted from Hodgkin-Huxley type, expressed in terms of ionic currents
and conductances. The model used three ionic currents, known as an inward sodium current, an
outward potassium current and a chloride leak current. The potassium current was further refined
so that the model could produce more prolonged AP of cardiac cell. Also, the Noble model
(Noble 1962) incorporated two different types of potassium conductances, identified as IK and
IK1. While the Noble model succeeds in reproducing the Purkinje fibre action potential with a
Hodgkin-Huxley style model, the underlying physiology is inaccurate, mainly because the model
was developed before data on the ionic currents were available. Particularly, the inward sodium
current was given the dual role of generating the upstroke and maintaining the plateau. The
calcium current was also not included in the model as it was not discovered until 1967 (Reuter
1967).
Following the finding of calcium current and recent experimental evidence, McAllister et al.
(1975) introduced an improved model for the action potential of Purkinje fibres. The description
of the kinetics of the currents was still based on the Hodgkin-Huxley formulation, but with
more detailed individual ionic fluxes (the previous three ionic currents of the Noble model were
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now replaced with nine). In the model, there are two inward currents (INa and Isi), three time-
dependent outward potassium currents (IK2, Ix1 and Ix2), a time-dependent outward current ICl
carried by chloride ions and several background (leak) currents. Nevertheless, the IK2 mechanism
in the model could not correctly describe the process of ion accumulation and depletion in the
extracellular space. In consequence, Di Francesco and Noble (1985) introduced a better model of
Purkinje fibre by taking into account the intracellular and extracellular ion concentration changes
and the influence of ionic pumps. Recent studies of ion channels, based on experiments using
assembled ion channels in highly regulated expression systems, have allowed the development
of more sophisticated models of the kinetics of ion channels that are expressed in Purkinje fibre
cells. These ionic models are ideally suited for studying ion channel disruptions and membrane
currents in disease and treatment, e.g. changes caused by drug block (Sampson et al. 2010).
The most recent Purkinje model was developed by Trovato et al. (2020). This model in-
corporates detailed Purkinje-specific ionic currents and calcium handling, and was developed,
calibrated and validated using human experimental data acquired at multiple frequencies, both in
control conditions and following drug application. Multiscale investigations were performed in
a Purkinje cell, in fibre and using an experimentally-calibrated population of Purkinje cells to
evaluate biological variability.
2.5.2 Atrial models
One of the earliest models of action potential behaviour for atrial cells is due to Courtemanche
et al. (1998) and Nygren et al. (1998). Both models are based largely on similar experimental
human data. In the absence of human data, both models rely in part on data from other mammals
and have slightly different formulations of ionic currents, pumps, exchangers, ion concentrations,
resulting in divergent responses (AP morphology and APD restitution curve), as reviewed before
by Nygren et al. (1998). The Courtemanche model exhibits a spike-and-dome morphology,
whereas that of Nygren et al. shows a more triangular shape. Although these two models have
been extensively used in consecutive studies of atrial fibrillation (Tsujimae et al. 2008, Zhang
et al. 2005), very little has been made to improve the physiological accuracy of the models, until
recently.
In 2008, a re-implementation of the Nygren model was published by Maleckar et al. (2008),
to provide a more accurate reconstruction of the repolarisation of the atrial action potential at
a number of different steady-state frequencies of stimulation. Koivumaki et al. (2011) further
extended the Nygren and Maleckar models by developing a human atrial model that incorpo-
rated the heterogeneity of intracellular calcium dynamics emerging from a structurally detailed
sarcoplasmic reticulum (SR). Additionally, Grandi et al. (2011) have proposed a novel model
using recent experimental evidence to explain intracellular calcium handling and incorporated
cellular function β -adrenergic and cholinergic regulation into the human atrial model system.
Using the atrial model by Grandi et al. (2011) as the general framework, an extensive model was
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then created by Voigt et al. (2014) to study arrhythmogenic mechanisms in paroxysmal atrial
fibrillation. The model includes IK,ACh current and modifications to IK1 and its dependence on
the external potassium concentration.
2.5.3 Ventricular models
While the development of AP Purkinje fibre and atrial model was still being explored, a new focus
had shifted to the modelling of AP ventricular myocytes. Beeler and Reuter (1977) proposed
the first widely used AP model for mammalian ventricular myocyte. The model equations
were based on the formulation Hodgkin-Huxley model and the model assumed that sodium and
potassium intracellular concentrations ([Na+]i, [K+]i) remain constant during the generation of
the action potential. Though, in cardiac myocytes entry of Ca2+ through the L-type calcium
channel, ICaL creates a significant change in the intracellular calcium concentration ([Ca2+]i),
largely by triggering Ca2+ release from the sarcoplasmic reticulum (SR) via the calcium-induced
calcium-release (CICR) process. Four distinct ionic currents were included in the model where
the main emphasis was on the role of the calcium current. The current was shown to play a
significant part in the creation of the AP plateau.
Also, variations in [Na+]i and [K+]i may also affect the action potential waveform when
cells are paced at a fast rate. The first model including detailed information regarding [Na+]i
and [K+]i dynamic concentration changes was the Di Francesco and Noble (1985) model of the
Purkinje fibres. In cardiac ventricular model, the first attempt to take into account the dynamic
changes in intracellular ion concentrations (Na+, K+, Ca2+) was introduced in the Luo-Rudy
model (Luo and Rudy 1994a;b). These models were founding members in a new class of second-
generation models that account for dynamic ion concentration changes. The key components
in the Luo-Rudy model were further adapted into other AP models of various cell types and
species (see, e.g. Courtemanche et al. (1998), Fox et al. (2002), Mahajan et al. (2008), Priebe
and Beuckelmann (1998), Shannon et al. (2004)). It is so inspiring to see that the models were
kept updated and expanded in order to incorporate any new findings in cardiac electrophysiology,
such as newly discovered ion currents and modifications of ion current responses as well as more
intricate intracellular calcium handling.
Recently, Tomek et al. (2019) proposed the human ventricular ToR-OTd model of cellular
electrophysiology and excitation-contraction coupling. This model was constructed based on
the overall structure of the human ventricular model by O’Hara et al. (2011), but with some
reformulations in the L-type calcium, hERG and chloride currents to improve the agreement with
experimental data in terms of action potential waveform and response to channel block. The
development of the ToR-ORd model also involved the use of independent experimental datasets
for calibration and validation. The intracellular chloride in the model was then further refined by
Tomek et al. (2020) to increase the stability properties of the model over very long simulations.
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2.5.4 Reduced ionic models
On the other hand, the second type of action potential model is a simplification of the biophysically
detailed ionic model; the objective is not to reproduce the experimental data but to understand
the role of action potentials in cardiac circuits qualitatively at a minimal computational cost.
Typically, these models are often based on the elegant Fitzhugh-Nagumo two-variable reduction
of the Hodgkin-Huxley system or truncated from a detailed model. There are now many simplified
models, for examples, FitzHugh (1961), Mitchell and Schaeffer (2003), Barkley (1991), Aliev and
Panfilov (1996), Rogers and McCulloch (1994) and Fenton and Karma (1998). The unknowns of
these models are a normalised transmembrane potential v and a gating variable u, following the
general kinetics,
dv
dt
= f (v,u).
du
dt
= g(v,u).
(2.15)
The kinetic terms in some models are defined as follows,
• Fitzhugh-Nagumo model:
f (v,u) =−kv(v−a)(v−1)−u, g(v,u) = ε(v− γu); (2.16)
• Roger-McCulloch model:
f (v,u) =−kv(v−a)(v−1)−uv, g(v,u) = ε(v− γu); (2.17)
• Aliev-Panfilov model:
f (v,u) =−kv(v−a)(v−1)−u, g(v,u) = ε(γv(v−1−a)+u); (2.18)
• Mitchell-Schaeffer model:
f (v,u) =− u
τin
v2(v−1)− v
τout
, g(v,u) =
{
1−u
τopen
v≤ vgate
−u
τclose
v > vgate.
(2.19)
Here a, k, ε, γ, τin, τout , τopen, τclose, vgate are given constants. These models, however, do not
preserve the important characteristics of an action potential (Biktashev et al. 2008). Bueno-
Orovio et al. (2008) then introduced a minimal ventricular human model that is designated to
reproduce important tissue-level characteristics of epicardial, endocardial and midmyocardial
cells, including AP amplitudes and morphologies, upstroke velocities, steady-state action potential
duration and conduction velocity restitution curves.
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In general, the advantages of using the simplified models is that they 1) are computationally
cheap and tractable (Clayton et al. 2011); 2) allow for further analytical works such as deriving
explicit formula of APD restitution curve and asymptotic expressions for the conduction velocity
restitution in cardiac tissues (Mitchell and Schaeffer 2003, Simitev and Biktashev 2011, Tolka-
cheva et al. 2002); 3) reproduce experimental measurement (Guo et al. 2013) 4) can be used for
patient-specific simulation (Corrado and Niederer 2016); 5) can be used for 2-dimensional (2D)
wave propagation (Bueno-Orovio et al. 2008, Fenton and Karma 1998, Kogan et al. 1991) and
even intensive 3-dimensional (3D) computations of the whole heart (Aliev and Panfilov 1996).
Ideally, models should be as simple as needed to describe the phenomena of interest - but no
simpler.
In this thesis, the characteristics and behaviour of both detailed and simplified action potential
models are examined. Particularly, these models are used to investigate the underlying effects of
AP variability on cardiac drugs, to study mechanisms of cardiac alternans and to develop efficient
numerical method for solving such models.
2.6 Some applications of cardiac electrophysiology models
Modern cardiac research has become increasingly aware that suitable models and simulation can
help interpret a wide range of experimental data and dissect crucial hypothesis (Clayton et al.
2011). The hypothesis can be translated into predictions of observable events. To date, cardiac
electrophysiology models are undeniably important for many clinical applications, including
functional imaging and mapping, drug safety evaluation, disease diagnosis, patient-specific
clinical predictions, and therapy optimisation (Pathmanathan and Gray 2018). Indeed, overall
long term goal of the research community is to make a fully-integrated electro-mechanical model
of the human heart that is fast-enough and fine-tuned enough to enable general clinical use at the
molecular, cell, tissue and organ level simultaneously.
In this section, we outline some applications of cardiac AP models as a quantitative tool to
look into various cardiac-related problems. A complete account of these is outside the scope
of this thesis; only some examples will be discussed here. Some reviews can be found in Wei
(2005), Potse (2012) and Trayanova and Chang (2016).
2.6.1 Drug safety evaluation
Cardiac drug safety is of utmost importance in the growth of drug development due to the possibly
destructive nature of unforeseen ‘off-target’ drug-related cardiovascular complications. Reports
have shown that the potential of several drugs to cause cardiac toxicity, such as inducing Torsades
de Pointes (TdP) in the context of existing long QT syndrome (LQTS) or the development of
‘acquired’ (drug-induced) LQTS. In consequence, it resulted in the removal of several drugs from
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the market, for example, terodiline in 1993 (Shah 2007), terfenadine in 1997 (Anonymous 1997)
and cisapride in 2000 (Henney 2000). Hence, a thorough evaluation of drug safety is vital in
order to understand the responses and toxicity of any drugs before they are released for public
use.
Traditionally, drugs are commonly tested on animals to detect any possible risks and side
effects before commencing trials on humans. It is undeniable that animal testing has been
the most precise and reliable way of examining new drugs. However, this method costs an
enormous amount of money, time-consuming protocols and indeed highly controversial for some
as countless animals need to be killed (Festing and Wilkinson 2007, Knight 2013). Hence, various
approaches have been suggested to minimise the use of animals in drug and chemical testing
(Doke and Dhawale 2015), for instance, in vitro cell cultures and mathematical models.
In modelling, mathematical techniques are used to represent a real-world situation by taking
into account key variables and constraints so as to determine an optimal solution that is feasible
and achieves certain objectives. Simulation, on the other hand, evaluates multiple different scenar-
ios in an attempt to understand how a real-life system would work. In cardiac electrophysiology,
computer simulation via a mathematical model of action potential is used to gain insight into how
the electrical excitation in the heart performs under different scenarios. This method is cheap,
less time-consuming and require less human resources. Passini et al. (2017) demonstrated that
computational models are likely to produce higher accuracy than animal models in predicting the
cardiac drug effect like arrhythmias. It indicates that a mathematical model can potentially be a
robust tool and advantageous way for improving the drug safety evaluation, hence reducing the
use of animal experiments in the early stage of drug testing.
One of the most significant challenges encountered by the pharmaceutical industry is to
develop a new drug that works on everyone without contributing to serious side effects. Further-
more, no two individuals are identical, and they may respond to the same drug differently. Due to
this variability at the physiological level, it is neither practical nor desirable to examine a new
drug on the entire population to ensure it is safe and effective. With the support of computational
models and new population-based approach, we can now study the effect of drug application on a
population of subject both faster and at lower cost. For example, Britton et al. (2013) have used a
model of Purkinje fibre to investigate how the differences in the underlying ionic properties of
rabbit Purkinje cells from different individual rabbits could affect their action potential response
to potassium channel blocker dofetilide. Other studies have used an ionic mathematical model
to study the effect of sodium channel blockade (Class I anti-arrhythmic drug) in terminating
fibrillation in cardiac tissue (Kneller et al. 2005, Moreno et al. 2011, Qu and Weiss 2005). In a
nutshell, we believe that in-silico modelling could soon become a mainstream and robust method
for drug testing development.
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2.6.2 Alternans
Cardiac alternans refers to a condition in which there is a periodic beat-to-beat oscillation in
electrical activity and the strength of cardiac muscle contraction at a constant heart rate. In this
context, electrical alternans might be interpreted as a marker that the system of cardiac electrical
activation is approaching its chaotic pattern, characterised by the induction of reentrant rhythm
disturbances such as ventricular tachycardia and fibrillation. The initiation of alternans usually
happen due to instabilities involving the transmembrane voltage, but it can also be driven by
intracellular calcium cycling dynamics where the amplitude alternates small and large magnitude
(Edwards and Blatter 2014). Hence, knowing the factors that lead to the onset of alternans are
critically important, so that, it helps us to build up targeted strategies to control and prevent
alternans.
Numerous simulation and experimental studies have made outstanding contributions to
understand the mechanism of alternans and even the dynamics of ventricular fibrillation (Bayer
et al. 2016, Fox et al. 2002, Karma 1994, Ten Tusscher et al. 2007). To date, the primary
method for exploring alternans behaviour is by studying responses of action potentials to periodic
stimulation and constructing a restitution curve of cardiac cells. Restitution curve describes the
dynamics of an action potential when the cell is stimulating at a various basic cycle length (BCL).
The mathematical equation can be written as,
APDn+1 = f (DIn) (2.20)
where DIn is the diastolic interval of the current action potential and APDn+1 is the subsequent
APD where BCL is kept constant, such that BCL = APDn +DIn. Therefore, the restitution curve
is always assumed that the APD is a function of its previous DI. The membrane recovers its
resting properties during the diastolic interval until the next excitation. Typically, a DI that is
sufficiently long for the membrane to have fully recovered will be followed by a long APD that is
independent of the DI. In contrast, a short DI that only allows partial recovery will be followed
by a short APD. There is a minimum DI for which the ionic currents are activated (and hence
refractory) to the extent that it is not possible to elicit another action potential. Furthermore, APD
restitution slope is an important indicator of wave stability and a linear stability study by Guevara
et al. (1984) has shown that the steady-state solution of this function could become unstable when
the slope of f is larger than one in magnitude, hence resulting in a period-doubling bifurcation. A
steep gradient (greater than unity) of the restitution curve has been observed as one of the major
cause to the onset of alternans and later leading to the transition of ventricular fibrillation (Karma
1994). Following the hypothesis, Garfinkel et al. (2000) showed that flattening the restitution
curve may prevent the alternans from occurring and thus inhibit fibrillation. Moreover, it can
convert existing fibrillation either to a periodic state or to quiescent healthy tissue. However,
other experimental and simulation studies have shown the slope of the restitution curve might
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not be a sufficiently good indicator to the onset of APD alternans, as the behaviour can still be
seen even at gradient value less than unity (Banville et al. 2004, Goldhaber et al. 2005). The
finding provides a clue that there might be some other properties inherent in the restitution curve
that determine the onset of alternans, for instance, the spatial heterogeneity of restitution slopes
(Keldermann et al. 2008, Nash et al. 2006). In general, the onset of alternans is not due to a single
cause but many factors, for example, cardiac memory (Gilmour et al. 1997, Tolkacheva et al.
2003), intracellular calcium dynamics (Goldhaber et al. 2005), and mechano-electric feedback
(Kohl et al. 2006).
2.7 Experimental techniques
The ability to record the electrical activity of cardiac cells and tissues brought about an immense
increase in understanding of the basis for normal and abnormal cardiac behaviours. In this
section, we now discuss several experimental techniques that have been applied widely in cardiac
cellular electrophysiology studies and that are also been used to develop cardiac cell model. The
advantages and limitations of each method are discussed.
2.7.1 Micro-electrode recording method
Micro-electrode method is the gold-standard method for measuring the transmembrane potential
of cardiac cells. The technique requires tiny (sharp) electrodes to be inserted into an isolated
cardiac cell. Typically, one electrode will be placed into the cell in order to send sufficient
(constant) stimulus current that will onset the action potential, while the other electrode is used
to measure the cell’s membrane potential and thus record the trace of the action potential. This
method authorises the experimentalists to control the magnitude of the stimulus current as well
as pacing rate, which then allow steady pacing at various rates. As a consequence, the cell’s
responses to different pacing rate (restitution curve) can be studied.
The first transmembrane action potential in cardiac tissue recorded using the micro-electrode
method was done by Draper and Weidmann (1951). These experiments managed to reveal
the accurate voltage-time course of an action potential. In addition, the exact magnitude of
the resting potential and upstroke of an action potential were also discovered. Since then, the
micro-electrode method was further developed and improved, and it was used to investigate many
types of cardiac tissues to understand the electrophysiological basis of the particular cell (West
1955) or arrhythmic condition (Hoffman and Cranefield 1964).
2.7.2 Voltage and patch-clamp methods
A significant advance made possible by the use of the micro-electrode was the development of
voltage and patch-clamp techniques. Unlike the previous method which can only measure the
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Figure 2.4: Sketch of patch clamp set up in experiment. A glass micropipette is attached to the
cell membrane to allow recording of current across a single ion channel. Figure is adapted from
Wikipedia (https://en.wikipedia.org/wiki/Electrophysiology).
transmembrane potential, these methods are widely used to record the current flows through ion
channels. In voltage-clamp technique, the cell potential is ‘clamped’ at the desired (‘command’)
value, and the ionic current that crosses a cell’s membrane at the given voltage is measured. The
step is essential as many ion channels in the membrane are voltage-gated ion channels, in the
sense that the ion channel will only open when the membrane voltage reaches a particular value.
In 1952, Hodgkin and Huxley applied this method to describe how ionic currents give rise to the
action potential in squid giant axon, which then eventually lead to the development of the first
action potential model.
The patch-clamp technique was introduced by Neher and Sakmann (1976) to refine the voltage
clamp method by permitting the measurement of current through individual ion channels. The
method uses a glass micropipette, and it is brought into contact with the membrane of the isolated
cell. Gentle suction is applied with the glass tip to create a high resistance ‘seal’ with the cell
membrane, as seen in Figure 2.4. Nevertheless, forming and maintaining a perfect seal between
the cell membrane and the tip of micropipette can be quite challenging as the micropipette has to
stay still during the entire recording process. A slight movement may cause leakage or rupture the
entire cell. Several configurations of patch-clamp have been introduced since then, for instance,
whole-cell recording, inside-out patch and outside-out patch, but the goal remains similar, which
is to measure the individual ionic currents (see Sakmann and Neher (1984) for a detailed review).
However, due to the complex and time-consuming protocols, the above methods are restricted
to measuring a small number of cells (∼ 5-10 cells) per individual heart. This reduces the
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experimental yield and hampers the study of cellular variability within large populations of
cardiomyocytes. Moreover, the use of sharp micro-electrodes in clamp methods may also
damage the cell membrane and lead to cell death (Fendyur and Spira 2012). Alternatively, many
laboratories begin to use voltage- or calcium-sensitive dyes in order to track the changes in
membrane voltage and calcium transient of contracting muscle cells (Herron et al. 2012).
2.7.3 Optical mapping technique
The problems of achieving multiple micro-electrode impalements in whole tissue for measurement
of action potential can be overcome by the technique of optical mapping with voltage-sensitive
dyes. The first optical recording of the membrane potential of nerve fibre was first conducted in
1968 by Cohen et al. (1968), with a poor signal-to-noise ratio (SNR). Since then, more than 1,000
fluorescent dyes have been screened as possible membrane potentials probes in search of better
signals (Cohen and Salzberg 1978). The method was first applied to the cardiac application by
Kamino et al. (1981), where they successfully measured the pacemaker activity in embryonic heart
preparations. Although optical mapping of the heart was initially restricted to a few laboratories,
this procedure became more common in the 1990s.
The optical mapping system aims to produce high SNR and high temporal and spatial
resolution optical signals while reducing the possibility of side effects, such as photobleaching.
Most cardiac optical mapping studies involve heart staining with voltage-sensitive and/or calcium
dye, and then use imaging devices to monitor heart surface electrical activity and calcium
transients. Voltage-sensitive dyes carry molecules that bind to cell membranes when supplied
through coronary perfusion to the whole heart, cardiac tissue, or myocytes. In experimental
studies of cardiac electrophysiology, styryl dyes, for example, di-4-ANEPPS, are commonly used
due to their characteristics; produce large SNR, short excitation wavelengths and the ability to
exclude the scattered and reflected light and the filtering away of the background autofluorescence
(Wuskell et al. 2006). However, an important limitation of the optical mapping technique is signal
distortion due to scattering of fluorescent photons from excited tissue. Such distortion could
compromise experimental data analysis and interpretation as well as the use of optical recordings
to validate computer simulations of electrical activity (Bishop et al. 2007).
The recording of membrane voltage in isolated cardiac cells presented in the thesis (Chapter 3)
was measured using voltage-sensitive dye FluoVolt (Thermo Fisher Scientific). The method uses
optical fluorescence techniques and automated image and electric signal analysis to characterise
the electrical and mechanical response within large populations of cardio-myocytes ranging
between 100 to 500 cells per individual hearts (Lachaud 2019). The recording is then monitored
using the CellOPTIQ program designed by our collaborator Dr Francis Burton. The software is
used to collect fluorescent measurements from isolated cardiomyocytes loaded with fluorescent
dyes. With such a technique, it is now possible to quantitatively measure the cellular and regional
heterogeneity across the population cells, including under the effect of an intervention like drug
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application. Compared to other fluorescence-based technique, this method yields better signal
output and resolution, allow for larger sampling and coincidentally reduce animal usage.
In general, optical mapping techniques offer a unique opportunity for investigating ventricular
arrhythmias in the whole heart. Rapid technological developments will allow the study of
ventricular fibrillation in complex settings in normal and diseased human heart. A complete
review of this method can be found in Attin and Clusin (2009).
2.8 How close are animal and human hearts?
Animal experimentations have contributed to a number of important cardiac medical break-
throughs. Developments such as the cardiac pacemaker, the cardioverter defibrillator, the heart-
and-lung machine, and numerous drug and gene therapies were made possible because of the
knowledge gained from animal research (Sigg 2010). Hence, alongside with the advanced experi-
mental techniques to record the APs, the appropriate animal model must be chosen so that the
results produce the most transferable information to humans.
The most common small animal models for cardiac investigations are the rat, guinea pig
and mouse (Kaese et al. 2013). These animals are affordable, highly available, and serve as
efficient models for understanding electrophysiological mechanisms of cardiac arrhythmias seen
in humans (Janse et al. 1998, Kaese et al. 2013). Nevertheless, murine and rodent cardiac
electrophysiology investigations are mostly limited to changes in ECG patterns and incidences
of electrophysiological changes (Janse et al. 1998) because of their order of magnitude faster
heart rate (HR), significantly different AP morphologies and substantially smaller heart sizes. In
addition, guinea pig, rat and mouse hearts are lacking of particular potassium channels, which
are important in humans for regulating cardiac excitability (Nerbonne and Kass 2005). Large
animal models such as the pig, sheep, goat and canine have hearts that are more anatomically and
physiologically same to that of the human, making them a better option for studying atrial and
ventricular arrhythmia in comparison to those smaller species (Kaese et al. 2013).
Indeed, larger mammals also exhibit HRs, cardiac ion channel expressions, and ECG and
AP waveforms identical to humans (Kaese et al. 2013). Due to these factors, such models are
more relevant for translational pre-clinical validation studies that examine the safety and efficacy
of putative cardiovascular therapies. Unfortunately, usage of larger animal models in testing
laboratories is costly, possess complex procedures and highly controversial, which then limit their
widespread use in important basic and translational research endeavours (Towbin and Bowles
2001). Moreover, not all large mammalian hearts have similar physiology with the human heart.
For instance, the pig heart tends to have a highly penetrating transmural Purkinje fibre network,
an inconsistent size of the aortic valve cusps and a higher ratio of wall thicknesses between the
left and right ventricle than the human heart which limits its clinical use for some disease models
(Lelovas et al. 2014).
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Interestingly, among the many options for animal models, the rabbit shows the optimal
selection for investigating cardiac electrophysiology, specifically those involving myocardial
repolarisation. The rabbit cardiac electrophysiology properties exhibits many similarities with
the human heart (Bers 2002, Kang et al. 2016, Odening et al. 2020) and is the most used model
for human heart physiology and pathophysiology (Lou et al. 2011). This is because the rabbit has
significantly lower cost compared to other large mammals, similar AP morphology to human,
and possess both rapid and slow activating delayed rectifying potassium channels (Kaese et al.
2013). Furthermore, compared to pigs and dogs, the effective size of the rabbit heart is closest to
the effective size of the human heart, making the rabbit heart the superior experimental model in
the studying of human arrhythmias (Panfilov 2006).
2.9 Action potential variability in cardiac cells
The motivation for this study is that variation between individuals modulates cardiac electrophysi-
ological activity, requiring the incorporation of experimental data and computational modelling to
resolve the nature of a biological system that varies from individual to individual. In this section,
we provide evidence for variability in cellular cardiac electrophysiology between individuals of
the same species.
In cardiac electrophysiology, there are significant differences in the electrical activity of
cardiac tissues from a similar region of the heart (Gemmell et al. 2016, Muszkiewicz et al. 2016,
Ni et al. 2018, Walmsley et al. 2015, Zhu et al. 2016). The electrophysiological variability is
even more pronounced in isolated cardiac cells, leading to differences in the morphology and
duration of the action potential (see Chapter 3). A likely source of this behavioural variability
is differences in the levels of ion channels, pumps, and transporters, which arise as the cellular
expression system interacts with stochastic effects, genetic factors and environmental effects (e.g.
drugs and circadian rhythm). The physiology of the cell can therefore be thought as a complicated
input-output function, where the behavioural outputs (features of action potential and calcium
waveform) result from the cardiomyocyte system’s integration of the activity levels of functional
expression of ion channels, pumps and transporters.
Evidence for variation in the properties of ionic currents in the cell membrane of cardiac cells
arises from various reasons and mechanisms. We focus on factors that include stochastic effects;
pathological processes; circadian rhythm effects; spatial location of the cell within the heart; and
inter-species effects.
Several studies have found that stochastic behaviour of any of the ion channels could be
involved in APD variability (Heijman et al. 2013, Pueyo et al. 2008, Walmsley et al. 2015,
Zaniboni et al. 2000). Zaniboni et al. (2000) demonstrated that variations in late sodium current
could account for beat-to-beat variations in APD observed in guinea pig ventricular cells. Also,
calcium ions release by the SR is a stochastic process (Lopez-Lopez et al. 1994) and these
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ions modulate several sarcolemmal currents, including L-type calcium and sodium-exchanger
currents. Hence, beat-to-beat variations in subsarcolemmal calcium ions might be expected to
influence sarcolemmal channels and electrogenic transporters, hence promoting beat-to-beat APD.
Nevertheless, beat-to-beat variability of repolarisation induced by stochasticity in ion channel
gating is dramatically reduced when cells are electronically coupled in tissue.
Numerous types of heart disease and rhythm disruptions may result to ion channel and trans-
porter changes. Heart failure (HF) itself leads to various remodelling processes including changes
in ion channel composition and function. To date, numerous investigations have highlighted
the influence of potassium current (IKs, IK1 and Ito) downregulation in HF myocytes (Akar and
Rosenbaum 2003, Beuckelmann et al. 1993, Tsuji et al. 2000). The changes in these channels have
resulted in the prolongation of the action potential repolarisation which is a common feature of
ventricular myocardium from patients/animals with severe HF (Hegyi et al. 2018, McIntosh et al.
2000). Furthermore, channelopathies (inherited genetic disorders with mutations) may also alter
ion channel genes. Depending on the respective ion channel mutation, function and/or expression
level of the respective ionic current will change with effect on the cardiac action potential. Unlike
natural variability, ion channel remodelling processes in HF and in channelopathies are often
pathological in general. Although individuals who possess these mutations are not considered to
be part of the healthy normal population in terms of their heart function, and these mutations are
uncommon and only happen in a small fraction of the population.
Circadian rhythm is also another source of variation in channel protein expression. A
circadian rhythm is a natural, internal process that governs the period of sleep-wake, and repeats
approximately every 24 hours. In a study on mice, Yamashita et al. (2003) demonstrated that
the expression of cardiac ion channels indeed fluctuated during the course of a day. Their main
finding showed that among 14 cardiac potassium channel genes, the expression of Kv1.5 and
Kv4.2 exhibited significant circadian variations that were the reverse of each other, whereas that of
the other 12 potassium channels was maintained stable. As a consequence, this could contribute
to the fluctuating alterations of cardiac electrophysiological characteristics and subsequent
arrhythmogenesis. In another study on mice, Jeyaraj et al. (2012) demonstrated that circadian
clock may regulate rhythmic variation in repolarisation and alter susceptibility to arrhythmias
through Klf15 expression. Gene expression microarrays in hearts of mice revealed that Klf15
altered expression of the KCh1P2 gene, the regulatory β -subunit for the repolarising transient
outward potassium current (Ito) is responsible for electrophysiology variation in the heart.
The configuration of cardiomyocyte AP arising from different layers of the ventricular wall
in mammalian myocardium is well known to exhibit variations (Antzelevitch and Fish 2001,
Antzelevitch et al. 1991, Kimura et al. 1986, Weissenburger et al. 2000). In general, these
variations are due to the asymmetric distribution of different potassium currents such as Ito, IKr,
IKs and IK1 (Liu et al. 1993). The transmural heterogeneity in AP morphology is probably most
prominent in ventricular myocytes of canine, where endocardial APs show a prominent plateau,
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Figure 2.5: AP morphology and profile of ionic currents of ventricular model from various
animals. Reproduced from Edwards and Louch (2017).
while epicardial APs exhibit a spike-and-dome appearance. A probable reason is due to the
difference in the magnitude of Ito current, in which, large Ito measured in epicardial cells is
responsible for the prominent spike-and-dome configuration and small AP duration (Litovsky and
Antzelevitch 1988). Also, it is now well established that the transmural differences in the profile
of ICaL could contribute to differences in AP configuration of endo- and epi- canine ventricular
myocytes, where epicardial cells exhibited a higher net charge of ICaL (Banyasz et al. 2003).
Source of variability in cardiac electrophysiology encompass multiple spatial and temporal
scales, including inter-species. The molecular constituents of ionic currents are thought to be
relatively consistent across species. Nevertheless, many studies have shown that these ion current
expressions are species dependent, which in turn, influencing the AP variability (see Figure 2.5).
For example, sodium-calcium exchanger current varies significantly in rat, guinea-pig, hamster
and human, which the density of the current was highest in hamster and lowest in rat myocytes
(Sham et al. 1995). In addition, peak ICaL is slightly reduced in rats compared with larger
mammals (Su et al. 2003) and in part, this is because of lower channel expression, specifically
compared with guinea-pig (Bers 1993). The ensemble of potassium currents contributing to
repolarisation is relatively large, and varying expression of the different potassium currents is the
primary explanation for major species differences in cardiac electrophysiology (Edwards and
Louch 2017). Like humans, rabbits rely more heavily on IKr in modulating the AP repolarisation.
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In the context of brief APs of mouse and rat myocytes, repolarisation excites so rapidly due to
high expression of both Ito and IKur which then dominates other inward currents in these cells
(Figure 2.5).
From the above discussion, we can see that many factors may lead to action potential
variability that could be present simultaneously in a cardiac cell. Such variation should not be
ignored as it can have a significant impact on cardiomyocyte behaviour and on the chances of
promoting arrhythmias in the heart.
2.10 Anti-arrhythmic drugs
Other than studying variability in action potential, our objective is also to investigate the effects
of cardiac anti-arrhythmic drugs on cardiac cellular electrophysiology. As part of the introductory
material, we discuss several type of cardiac drugs used in pharmaceutical nowadays.
Anti-arrhythmic drugs have been used widely to reduce and eliminate various lethal arrhyth-
mias, such as atrial fibrillation, atrial flutter, ventricular tachycardia, and ventricular fibrillation. In
particular, these drugs are used to decrease the conduction velocity of cardiac action potential, al-
ter the excitability of cardiac cells by changing the effective refractory period (ERP) and suppress
abnormal rhythms. All anti-arrhythmic drugs directly alter membrane ion conductances, which
lead to changes in the physical characteristics of the action potential. In general, these drugs are
classified into five main classes according to the Vaughan-Williams classification system. The
system categories the medications based on the primary mechanism of action (although some of
the drugs retain properties from several classes). The five main classes are,
• Class I : fast sodium channel blockers
• Class II : beta blockers
• Class III : potassium channel blockers
• Class IV : calcium channel blockers
• Class V : other or unknown mechanisms
Each of these agents has different mechanisms, and they are used for a particular type of
arrhythmia. However, all these cardiac drugs have important efficacy and safety limitations which
require further development in parallel with a better understanding of complex mechanisms
involved in the arrhythmia. For the purpose of this thesis, we will only discuss on Class III and
IV agents, and we suggest the readers read the review article by Dan et al. (2018) and Tamargo
et al. (2004) for further discussion.
The class III drugs are the potassium channel blockers. In the human heart, potassium
channels, including voltage-gated channels, for example, IKr, IKs, IK1, IKur and Ito, are responsible
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for modulating the shape and duration of the cardiac action potential and the frequency of
pacemaker cells. Blocking the expression of these potassium channels can cause a marked
prolongation of the action potential duration (increase the effective refractory period), without
affecting intracardiac conduction velocity. Examples of class III agents are amiodarone, sotalol,
ibutilide and dofetilide. These agents are very effective in the treatment of atrial fibrillation
(Anderson and Prystowsky 1999, Jaiswal and Goldbarg 2014), except for amiodarone which
has been approved by FDA for the treatment of ventricular tachycardia. Nevertheless, in certain
conditions, these drugs may be proarrhythmic. It has been shown in many experimental (Guo
et al. 2011, Lu et al. 2001, Nalos et al. 2012) and computational (Cooper et al. 2016, Costabal
et al. 2018, O’Hara and Rudy 2012) studies that blocking potassium channels may also lead to
arrhythmic effects such as long QT syndrome and arrhythmogenic early afterdepolarisations
(EADs).
The class IV agent is the calcium channel blockers. In particular, these drugs block the L-type
calcium channels. This channel is a voltage-dependent calcium channel, which is important for
the excitation-contraction coupling of cardiac muscles. L-type calcium current, ICaL is responsible
for maintaining the plateau region of an action potential, by opposing the repolarising outward
potassium currents. Inhibition of this current may result in action potential shortening as ICaL is
no longer providing resistance to IKr and IKs currents, which then leads the membrane potential
to restore to its resting membrane quickly. Examples of ICaL blocker are nifedipine, verapamil
and diltiazem. Nifedipine is usually used to treat hypertension and chest pain but sometimes,
may also cause tachycardia (fast heart rate) for some people (Castaneda et al. 2005). Hence,
understanding the drug mechanisms and effects are extremely important, and the study is our
main focus in the next part (Chapter 3 and 4).
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Part II
Applications of detailed models of the
cardiac action potential
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We have experimental data via collaborators (lead by Prof. Godfrey Smith) in the Institute of
Cardiovascular and Medical Sciences, University of Glasgow, that shows significant variability in
AP biomarkers between single cells and between cells from various regions in the heart. In this
part, we perform complementary mathematical modelling and analysis in order to understand
the origins of this variability and quantify it. Data presented in the next chapter can be found in
Lachaud (2019).
As discussed in the previous chapter, transmembrane potential morphology and time course
can vary considerably between different regions of the heart muscle. In the past, technical
limitations prevented experimentalists to obtain high enough throughput (>30) within one heart.
For instance, a low-throughput method like patch-clamp recording is limited to small numbers of
cells due to its time-consuming protocols. This hampers our ability to study the action potential
variability present in the cell population, as well as variability within individual hearts. To
overcome the problem, a medium/high throughput method was implemented in order to study
electrophysiological variation and excitation-contraction (E-C) coupling in large cell populations.
Furthermore, quantification of heterogeneity between cell populations sampled from discrete
regions of the myocardium could therefore can also provide valuable information about the
underlying electrical phenotypes within the myocardium.
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Chapter 3
Experimental database of rabbit
ventricular myocytes
This chapter describes the general features of the experimental data and how the experiments were
performed by our collaborators (Dr Quentin Lachaud and Dr Francis Burton). Using this dataset,
action potential biomarker values for each of the available control conditions experiments were
measured and the distributions of these biomarkers were then quantified in order to understand the
variability in AP behaviour present in these measurements. Also, the calibration ranges of each AP
biomarker were extracted, which will be used to construct experimentally calibrated population
of models in the next chapter. Lastly, the effects of two different cardiac anti-arrhythmic drugs on
the electrophysiological heterogeneity of rabbit ventricular cells were examined. We will use
what we learn in this chapter from the experiments with drug to application to design a study
using the population on investigating how inter-subject variability affects the susceptibility of
cardiomyocytes to developing drug-induced repolarisation abnormalities.
3.1 Dataset features and method
In this section, a database of experimentally measured biomarker values characterising the
features of the transmembrane action potentials of cardiac myocytes are analysed. All the
experiments were conducted by our collaborator Dr Quentin Lachaud. The complete dataset
contains recordings of the action potential under control conditions and under a wide array of
different drug applications. The experimental dataset contains data from 6 adult rabbits. The
measurements that have been analysed were obtained from the sub-epicardial (base and apex
regions) and sub-endocardial layers of the left ventricle (LV) of healthy rabbit hearts.
The cells from the specified region were isolated, loaded with the fluorescent, voltage-sensitive
dye FluoVolt (1:6000), and plated on to 35 mm glass-bottomed plates (Krebs solution at 37C;
1.8 mM CaCl2). Cells were then continually paced at a cycle length of 500 ms (2Hz) using field
stimulation (2x20 mm graphite electrodes; 40V, 2 ms pulse width). The pacing was maintained
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Figure 3.1: Action potential recorded biomarkers. APDx values are the time intervals between
the beginning of an AP and x% repolarisation from maximum voltage (Vpeak). Tpeak is the time
at Vpeak. TUx refers to the time relative to the start of the AP and x% of Vpeak. Trise is measured
from 10% depolarised to 90% depolarisation of Vpeak i.e. Trise = TU90 - TU10. Triangulation
index is calculated using TRI = (APD90 - APD30)/APD90. All measured biomarkers are in
milliseconds (ms).
for 5 minutes, and a train of action potentials of 2.5s was recorded for each cell. Measurements
were only performed on cells with normal electrical behaviour while excluding cells with EADs
or alternans properties. The voltage signal is then passed through an analogue-to-digital converter
and shown on the monitor using the CellOPTIQ program (proprietary software from Clyde
Biosciences Ltd.) which was designed by our collaborator Dr. Francis Burton. CellOPTIQ
was also used to analyse fluorescent traces acquired for each cell, by averaging the last 5 action
potential trains. Several AP biomarkers such as APD90, APD50, APD30, Triangulation index
and Trise were measured for further analysis. Figure 3.1 depicts the action potential recorded
biomarkers.
After recording all the measurements of cells in the control condition, the drug was applied to
the medium. The effect of cardiac anti-arrhythmic drugs of Class III and IV that blocking hERG
and L-type calcium channels, respectively, was investigated. In this study, the drugs chosen to
represent these classes were: dofetilide (hERG block) and nifedipine (L-type calcium block). All
drugs applied were prepared in 100% dimethyl sulfoxide (DMSO); DMSO was used to dissolve
the drugs as they sometimes were insoluble or partially soluble in the saline solution that the cells
were kept in. The final concentration of DMSO was 0.05% when dofetilide and nifedipine were
applied. At low concentration, DMSO do not give any significant effect to the electrophysiology
of the cells (Ogura et al. 1995). This can also be seen in Figure 3.4 and 3.7 where the mean
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effect of DMSO on individual cells was negligible (Mean±S.D.: approximately 0±20.5 ms). A
concentration of 30nM of dofetilide and 1µM of nifedipine were used throughout. The pacing
was restored for 10–15 mins and action potential trains were again recorded from the same cells.
Finally, the AP biomarkers (Figure 3.1) of each cell under the drug condition were measured.
3.2 Data analysis
3.2.1 Statistical tools
In most cases, the data is presented as mean ± standard deviation, unless otherwise mentioned.
Statistical analyses were computed using MATLAB R2017b. Standard paired sample t-test (using
MATLAB function ‘ttest’) was used to compare the means of two distributions. It is often used
in hypothesis testing to determine whether a process or treatment actually has an effect on the
population of interest, or whether two groups are different from one another. All tests with
p-value lower than 0.05 are considered as statistically significant.
3.2.2 APD variation in left ventricle myocytes
Cardiac action potentials differ significantly in different regions of the heart. Indeed, isolated
myocytes with different action potential waveforms have been seen in the epicardial and endocar-
dial regions (transmural heterogeneity) due to differences in ion-channel expression. Numerous
studies in isolated cardiac cells in several animal species have found differences in APD across
the ventricular wall, highlighting a transmural dispersion with shorter APD exhibited in epi-
cardial cells compared to endocardial cells (Antzelevitch and Fish 2001, Kimura et al. 1986,
Weissenburger et al. 2000). Their results are consistent with this finding, as shown in Figure
3.2a. Cells in epicardium of rabbit ventricular exhibited shorter APD90 than the endocardial cells
(Epi: 245.4±25.6 vs Endo: 265.0±23.3 ms), and APD90 difference is 19.6 ms. The distributions
of APD90 from these two regions have an identical range with an IQR of approximately 30
ms. A major advantage of the experimental technique used by our collaborators is that it allows
measurements of a large number of single-cells recordings from the same heart, which cannot be
achieved using low-throughput method. This allows us to assess accurately the variation present
within each heart. From Figure 3.3a, mean APD90 of endocardial cells in 4 out of 5 hearts
was generally greater than epicardial cells by on average ∆21.9 ms. The value is comparable to
APD90 difference in intra-heart (19.6 ms).
Figure 3.2b shows the distribution of action potential duration in a population of cells in
epicardial basal and apical regions from LV of a single heart. The two subregions exhibited
extensive overlap between the two cell populations, with a comparable level of heterogeneity
(IQR of both regions was approximately 54 ms). The mean APD90 for cells in the base of
epicardium was slightly less (241.8±52.1 ms) than the apex of the epicardium (270.7±51.0
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(a) Epicardium vs Endocardium (b) Basal vs apical epicardium
Figure 3.2: Cell-to-cell variability in action potential duration in the left ventricle of rabbit
hearst. (a) Measurements of APD90 in the epicardial (n = 273) and endocardial (n = 216) cells
from LV of a single heart. (b) Measurements of APD90 in the region of apical (n = 561) and basal
(n = 576) of epicardium from LV of a single heart. The inverted triangle (5) indicates the mean
value of the respective distributions. Dotted line is the respective Gaussian fit generated using
mean and standard deviation of each cell population. Overlay panels were taken from Lachaud
(2019) and they show the position of (a) epicardial and endocardial regions and (b) epicardial
basal region and apical region in the LV.
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Figure 3.3: Inter-animal variation. (a) Comparison of mean endocardial and epicardial APD90
in 5 animals. (b) Comparison of mean APD90 values from cells isolated from basal and apical
epicardium in 6 animals.
ms). The mean APD90 difference between the two regions was 28.9 ms. Also, cells isolated from
the apical epicardial region had a larger mean APD90 than cells from the basal epicardial region
in all of 6 animals, as shown in Figure 3.3b. The average APD90 difference was approximately
29.4 ms and this is comparable to result in intra-heart. Franzone et al. (2014) reported that
the difference was probably due to IKr and IKs currents being smaller in apical than in basal
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myocytes, with IKr the largest in apical cells and IKs the largest in basal cells. The shorter basal
APD causes ventricular repolarisation to proceed from the basal toward the apical region. Overall,
the relatively large range of cell-to-cell differences compared to difference in mean APD90 values
between regions means that most of the cells isolated from different parts of the LV free wall
have overlapping electrophysiological properties. Also, this study is the first to demonstrate
cell-to-cell variation in APD90 may be at least as large as that seen in a population of hearts,
highlighting that there is exist significant variations in the expression level of ion channels and
pump exchangers in between cells that are genetically similar.
It is important to emphasise that the apparent variation in APD discussed above are most
readily shown in isolated myocytes, and are least evident in the intact heart. The mostly likely
explanation for this phenomenon is that the intrinsic differences in APD in cells from different
regions (epi- vs endocardial region and base vs apex region) are reduced in the intact heart due to
electronic interactions between cells, mediated by gap-junctions (Burton and Cobbe 2001). The
electrotonic coupling acts to attenuate and spatially average the differences between individual
cells. In a study by Zaniboni et al. (2000), they showed that cell-to-cell coupling could suppress
the variability and induce an asymmetric response in which APD90 shortening of intrinsically
long action potentials was more pronounced than APD90 prolongation of short action potentials.
The suppression is very important, which not only to attenuate the variability between cells
but may essentially protect the heart from sub-populations of myocytes that would provoke
arrhythmias in healthy hearts.
3.2.3 Calculation of calibration ranges
Our next goal is to use the recording of AP biomarkers in the cell population to generate the
biomarker ranges that could be used to construct a population of models in Chapter 4. The
calibration criteria usually differ from study to study, depending on the experimental data
available. In the majority of cardiomyocyte studies, only AP characteristics were used to develop
the population of models (Britton et al. 2017a; 2013; 2014, Romero et al. 2009, Sarkar and Sobie
2011), while a few used addition information from the calcium transient (Passini et al. 2016).
Since the experimental data was limited to recordings of APs, a single calibration criterion based
on the range of AP biomarkers will be used. Technically, there are several ways to determine the
calibration range. Perhaps the simplest way is by calculating the minimum and maximum values
(while excluding all the extreme outliers) obtained from experimental measurements (Gemmell
et al. 2014). Others used limits of 2 standard deviations from the mean of AP biomarker
distributions (Prinz et al. 2004). We used the first of these alternatives in this work.
In order to determine the calibration ranges from the experimental data, we treat the inde-
pendent measurement of 6 rabbit hearts as a collective measurement and only use the dataset
of epicardial basal region, since the difference with epicardial apex was negligible. Several AP
biomarkers under the control conditions were selected. The biomarkers were APD90, APD50,
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Biomarker (Dofetilide) APD90 APD50 APD30 TRise
Min range (ms) 90.9 75.5 46.1 1.0
Max range (ms) 376.5 323.2 263.5 5.5
Biomarker (Nifedipine) APD90 APD50 APD30 TRise
Min range (ms) 30.6 20.3 14.1 1.3
Max range (ms) 333.2 273.3 229.9 5.5
Table 3.1: Experimental ranges of selected biomarkers used in the calibration of two sets of
model populations, for the drugs dofetilide and nifedipine.
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Figure 3.4: Effect of DMSO and 30 nM dofetilide on electrophysiology of the cells in (a)
epicardial basal and (b) epicardial apical region.
APD30 and Trise, and their calibration ranges are shown in Table 3.1. Two set of model popula-
tions will be constructed as the two drugs were applied to two different cell populations.
3.2.4 Response to hERG block
hERG block was introduced by administration of a dose of 30 nM of the drug dofetilide. Many
clinical (Guo et al. 2011, Lu et al. 2001, Nalos et al. 2012) and modelling (Cooper et al. 2016,
Costabal et al. 2018, O’Hara and Rudy 2012) studies have shown that blocking the rapid delayed
rectifier potassium current, IKr (Class III agent) prolongs the duration of action potential and
increase the effective refractory period of the cell. Their results regarding the APD prolongation
are completely consistent with this experimental dataset, as depicted in Figure 3.4. Both regions
of epicardial cells exhibited a significant increase in the mean APD90 after the application of
dofetilide. The mean values of APD90 difference (APD90 after drug treatment - baseline APD90)
for epicardial basal and apical cells are 30.9±39.4 ms and 21.4±29.0 ms, respectively. These
values show that hERG block has comparable effects on the cells across the epicardium of the
heart in response to hERG block.
46
(a) (b)
Figure 3.5: Scatter plot net drug effect on APD90 of individual cells in epicardial basal of
5 animals. (a) Effect of dofetilide and (b) effect of nifedipine. The red region indicates the
maximum measurable ∆ when the cells were paced at 500 ms. A linear regression was fitted
to each cell population to determine the relationship between baseline APD and observed drug
effect (black line).
Figure 3.6: Examples of normal AP responder and hyper-responder. The upper row shows the
action potential traces before the drug treatment and the bottom row shows the AP responses.
(d) During hyper-response, the APD exhibits extreme prolongation beyond its stimulus cycle
length (500 ms). The red arrow indicates the applied of external stimuli. Figure is adapted from
Lachaud (2019).
A majority of the cells in basal epicardium (> 85% out of cell population) experienced APD
prolongation in response to hERG block. However, there was no reliable evidence to conclude
the correlation between baseline and recorded effect on APD, as shown in Figure 3.5a. The
APD-prolonging effect of dofetilide seems to be uniform across the cell population, as indicated
by the R2 value (R2 = 0.04, P = 0.005; paired t-test). The negative ∆APD seen in some of the AP
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Figure 3.7: Effect of DMSO and nifedipine on epicardial cells in (a) base and (b) apex region.
measurements in Figure 3.5a (14.1% out of cell population) was resulted due to effect of DMSO.
The DMSO is the chemical (commonly referred to as ‘vehicle’) that the drug had to be dissolved
into, so that the drug could dissolve into the cells. Hence, the effect that our collaborators have
seen in the measurements is due to the effect of the drug and DMSO. Nevertheless, DMSO has a
negligible effect on APD (Ogura et al. 1995) with mean ∆APD is close to 0ms, as depicted in
Figure 3.4 and 3.7.
Interestingly, a small proportion of cells (about 12% in basal cells and 20% in apical cells)
showed extreme APD prolongation, which was characterised as ‘hyper-response’. An example
of hyper-responder is depicted in Figure 3.6. The hyper-response occurs when the cells do not
have sufficient time to recover to its resting potential before the arrival of the next stimulus. Such
extreme prolongation would then cause the next AP to decay. The mean of baseline APD90 in
these group of cells showed no significant difference from normal responders. (Base: 277±9 vs
282±4 ms; Apex: 299±5 vs 290±4 ms).
3.2.5 Response to L-type calcium block
In contrast to the effect of dofetilide, L-type calcium block by nifedipine resulted in APD
shortening, as depicted in Figure 3.7. The mean value of APD90 has reduced from 228.4±56.5
ms to 141.1±54.6 ms for epicardial basal cells. Similarly, to apical cells which decrease from
259.0±46.5 ms to 155.3±48.2 ms. In Figure 3.5b, one can observe that vast majority of the
cells in basal epicardium (> 90% out of cell population) experienced APD shortening following
L-type calcium block. The net APD90 effect of 1µM nifedipine showed a negative correlation
between baseline APD90 and drug effect. The correlation coefficient value is -0.41 (P<0.00001;
paired t-test). Figure 3.5b also shows that in general cells with relatively short baseline APD90
values exhibit minimal responses to nifedipine. Meanwhile, cells with longer APD90 values
show a wide range of responses to the same nifedipine concentration. A probable reason is that
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in cells with large APD have a larger calcium current which then contributed to a large ∆APD.
This requires further study to support the hypothesis, which will be addressed in the next chapter.
3.3 Conclusion
In this chapter, a database of medium/high throughput recordings from rabbit ventricular my-
ocytes, in control and under drug blocks was analysed. The experimental procedures to measure
the AP of a population of cells were also explained. Comparing to the lower-throughput method,
the experimental technique presented in this chapter has allowed large measurements of single-cell
recording from the same heart, hence, enabling us to have an accurate assessment of understand-
ing the variation present within each heart. Furthermore, the method has significantly reduced
the use of animals as large samples (100-500 cells) could be collected from a single heart.
Under the control condition, the cells exhibited a large amount of variability within a single
region of the myocardium (epicardium vs endocardium and epicardial basal vs epicardial apical).
The coefficients of variation, CV ((std. dev/mean)*100) in epicardium and endocardium regions
are approximately 10% and 9%, respectively. Similarly, CV in epicardial basal and apical regions
are roughly 22% and 19%, respectively. The results showed that both regions have extensive
overlap between the two cell populations. Interestingly, this study is the first to demonstrate
cell-to-cell variation in APD90 may be at least as large as that seen in a population of hearts. The
mean APD90 difference between epicardial basal and apical regions is approximately 28.9 ms
and this is comparable to result in intra-heart (29.4 ms). The finding highlights that there is exist
significant variations in the expression level of ion channels and pump exchangers in between
cells that are genetically similar.
The vast heterogeneity present in isolated cells is always ignored as the variation is naturally
reduced in electrically coupled tissue (Walmsley et al. 2015, Zaniboni et al. 2000). Nevertheless,
the results showed that the heterogeneity of the cellular population has a significant impact on
the intervention of drug application. In the hERG block by dofetilide, the cells experienced a
various degree of APD prolonging effect, as depicted in Figure 3.5a. No correlation was observed
between the baseline APD of the cells and the drug net effect following hERG block. Also, a
group of cells exhibited extreme APD prolongation (hyper-response). In the most recent study by
Britton et al. (2017a), they reported that AP recordings from stimulated ex vivo human ventricular
trabeculae showed APD prolongation beyond the cycle length (2 Hz) when 0.1µM dofetilide
was applied to the cells. However, the ionic mechanism is not known. We will discuss the AP
behaviour further in the next chapter. In contrast, ICaL reduction by nifedipine which shortens
the APD showed a negative linear correlation between baseline APD and the APD of post-drug
treatment (Figure 3.5b). However, the root cause of such responses is not fully understood as the
experimental data was only comprised of AP measurements. A likely hypothesis is that in cells
with a more significant degree of ∆APD have higher calcium transient amplitude, which directly
49
translates to increased fractional shortening.
On top of that, it is important to know that the variability in cardiac electrophysiology cannot
be studied using experimental measurements alone due to limitation in experiment protocols to
gather information. Even-though the experimental procedures used the study have allowed us to
quantify the transmembrane action potential for a large population of cells; this method is still
limited in the sense that it cannot measure the individual ionic currents, ion concentrations and
other components in the cells. The AP alone does not carry sufficient information to pinpoint all
ionic current properties of each cell, which could hamper our ability to understand the physiology
behind AP responses toward drug blocks. Hence, with the aid of computational modelling which
is designed to encapsulate physiological understanding and to provide quantitative predictions
of such knowledge, we are capable of gathering more insightful information and use them to
determine the distributions of ion channel conductance values that capture the electrophysiological
heterogeneity measured in the cells. Based on the data we have analysed and the calibration
ranges we have generated in this chapter, we will construct a population of rabbit ventricular cell
models. We allow this population to cover a wide range of different possible cell models by letting
parameter values to vary widely. The model population are then used to investigate the drug
blocking hERG and L-type calcium channels. We also want to investigate which ionic current
are responsible for determining susceptibility to drug-induced repolarization abnormalities like
hyper-response and EADs.
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Chapter 4
Action potential variability and drug
pharmacodynamics
4.1 Motivation
The action potential (AP) of cardiac cells has many features important to excitation-contraction
coupling, the time-course and magnitude of the 4 phases of the AP reflects the orchestrated
activity of various ion channels and electrogenic transporters. In many studies, including both
experimental and computational modelling, have shown that there is significant inter-individual
variability in the combinations of molecular-input parameters that can generate very similar
integrated outputs (Britton et al. 2013; 2017b, Romero et al. 2009, Sobie 2009). The electro-
physiological variability is very pronounced in isolated cardiac cells, leading to differences in
the morphology and duration of the action potential (see Chapter 3). The implications of AP
variability are important, for example in drug cardio-toxicity screening or heart disease treatment,
but it has traditionally been ignored in experimental and theoretical studies that have sought to
understand generic drug pharmacodynamics. Such investigations normally focus on a typical
response within a particular population rather than quantitatively examining variability.
In a traditional cardiac cell modelling approach, the AP models are constructed to represent
the mean response of a cardiac cell of the studied tissue type or species. However, the model
would lose its ability to explain the underlying variability and cannot be used for studies of inter-
subject variability. Modellers have considered two main approaches to include the variability
effects into an existing modelling framework. The methodologies are sensitivity analysis based
methods and use of a model populations. In sensitivity analysis based method, one or more
parameters in the model are perturbed within its baseline values for a certain amount. The model’s
output in correspondence to such perturbation is then measured and the difference is analysed. In
most of the variability studies, this approach has been widely used.
In a study by Romero et al. (2009), a single parameter sensitivity analysis was implemented
on a human ventricular cell model to investigate the impact of ionic current variability on action
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potential properties, calcium and sodium dynamics, and their rate dependence. They varied
several sets of ionic conductances and time constants in the model, one at a time for ±15% and
±30%. Their studies were able to provide quantitative insights into the sensitivity of preclinical
biomarkers of arrhythmic risk to variations in ionic current properties in humans. Another
series of studies was performed bySarkar and Sobie (2010; 2011), Sobie (2009). Instead of
using a single-cell model, they used a population of models based approach generated from
log-normal distribution to study the impact of variability, but without calibrating the population
to experimental data. In the absence of experimental calibration, this approach can be thought of
as an extension of the sensitivity analysis framework, which then allowed the parameters to be
varied simultaneously (Muszkiewicz et al. 2016).
Recently, Britton et al. (2013; 2014) have proposed a new methodology to study AP variability,
by calibrating the population of models to a set of experimental measurements. Several models
parameters, mostly ion conductances, were randomly varied using a sampling technique to
generate a large number of parameter sets. The models outputs were then measured and calibrated
to experimental ranges of Purkinje fibres. The model population was further used to investigate
the effects of variability to four concentration of potassium blocks. Their results showed a good
agreement with experimental data. Nevertheless, their results are limited to small sample size (12
different Purkinje fibres) which could mask the level of variation seen in the experiments. Hence,
using large sample sizes from several animals could potentially improve estimates of variation.
4.2 Objectives of the chapter
The current generation of cardiac electrophysiology models usually incorporates parameters that
describe numerous interacting ion current and calcium handling processes, the diversity of which
depends on the experimental data available to their authors at the time of constructing the model.
The data is also measured from different laboratories under different conditions. In consequence,
this may lead to inconsistency in model output and predictions when the model is used to data
other than the data on which their parameter values have been fitted, even between models which
we assume to represent similar cell types or region (Gemmell et al. 2014, Ten Tusscher et al.
2006, Wilhelms et al. 2013). It explains why it has become difficult for us to rely on model
output alone without recourse to experimental data. The dissimilarities between model responses
also highlight the importance of careful model selection and appropriate use for computational
studies, which will be the focus of our studies.
In this chapter, the objectives are,
• to determine the distributions of ion channel conductance values that capture the electro-
physiological heterogeneity measured in large populations of rabbit ventricular cardiomy-
ocytes
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• to investigate the effects of action potential heterogeneity on the application of drug
blocking of hERG and L-type calcium channels.
• to understand the ionic mechanisms of hyper-responders observed in the experimental
measurement (Chapter 3).
• to understand the ionic mechanisms of any drug-induced repolarisation abnormalities.
• to study the capability of cell models in predicting the drug effects.
In this chapter, we tightly combine experimental measurements and computational modelling
to construct and calibrate a population of action potential cell models based on experimental
ranges in the previous chapter. Three different action potential models of cardiac ventricular are
used for this study, which will allow us to make quantitative comparisons between each model
outputs. For model calibration, we follow the established methodology by Britton et al. (2013).
The model population is constructed by matching the model output to both experimental ranges
and distribution. These cell models are used to represent the variability exhibited in particular
experimental measurements of rabbit ventricular cardiomyocytes. We then demonstrate the
capacity of the model population to predict variability in response to drug blocking of hERG and
L-type calcium channels. Quantitative comparison of effects of hERG and L-type calcium blocks
between the three models and experimental measurements are carried out.
We begin the chapter with a brief discussion on the action potential model used in our
work. We then provide the essential mathematical/statistical tools that are needed to create a
population of models and analyse the simulation results. In the following section, the calibration
methodology and simulation of drug action are explained. Finally, we show and discuss the effect
of hERG and L-type calcium blocks on three model populations.
4.3 Materials and methods
4.3.1 Baseline models and software
Three different ventricular AP models are selected and used as the baseline model in our com-
putational studies. The models are; 1) a rabbit ventricular model by Shannon et al. (2004); 2)
a human ventricular model by Ten Tusscher et al. (2004) and 3) a human ventricular model by
O’Hara et al. (2011). Next, we will briefly discuss the background of each model.
Shannon model (2004) The model is a detailed model for rabbit ventricular myocytes and it
incorporates 15 different ionic currents as listed in Table 4.1. The model was modified from
Puglisi and Bers (2001) model with some updates on calcium mechanisms. Specifically, the model
was reformulated to include; 1) a subsarcolemmal compartment; 2) use of realistic cytosolic Ca
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Shannon Tentusscher Ohara Description
IKr IKr IKr rapid delayed rectifier potassium current
IKs IKs IKs slow delayed rectifier potassium current
ICaL ICaL ICaL L-type calcium current
IK1 IK1 IK1 inward rectifying potassium
INaK INaK INaK sodium-potassium pump current
INaCa INaCa INaCa sodium-calcium exchanger current
Itos
Itof Ito Ito
slow transient outward potassium current
fast transient outward potassium current
IClb - - background chloride current
ICap ICap ICap sarcolemmal calcium pump current
INa INa INa fast sodium current
INab INab INab background sodium current
IClCa - - chloride-calcium pump current
ICab ICab ICab background calcium current
IKp IKp - plateau potassium current
- - INaL late sodium current
- - ICaK calcium-potassium pump current
- - IKb background potassium current
Table 4.1: List of ionic currents and pumps in the Shannon, TenTusscher and Ohara model. Ionic
currents/pumps in red colour were varied to construct populations of models.
buffering; 3) a reversible sarcoplasmic reticulum (SR) Ca pump; 4) a scheme for Na-Ca exchange
transport that is [Na]i dependent and allosterically controlled by [Ca]i and; 5) a practical model of
SR Ca release including both inactivation/adaptation and SR Ca load dependence.
A drawback of this model is that it fails to exhibit calcium transient alternans during rapid
stimulation rates. The deficiency was then resolved in the latter model by Mahajan et al. (2008).
However, since we do not particularly look into alternans behaviour in this work, the Shannon
model should be sufficient. Furthermore, L-type calcium current expression in the Mahajan model
was developed using Markov formulation. A known drawback of the Markov formulation is the
increasing complexity of the model and eventually increases the computational cost of the model.
From our analysis, we find that the Shannon model runs more quickly than the Mahajan model.
For instance, to run a simulation of 500 action potentials pacing at 2Hz in the Mahajan model
required about 60 mins. In contrast, in the Shannon model, the simulation could be completed in
approximately 2 mins. The models were both executed using MATLAB v2017b with 64-bit Intel
processor. To avoid such a long simulation time when constructing the model population, we
chose the Shannon model as our baseline model. Extensive model comparison between these two
models can be obtained in Gemmell et al. (2014).
TenTusscher model (2004) The TenTusscher model is a model for human ventricular myocytes,
and it includes 12 ionic currents (Table 4.1). The model can reproduce three different regions of
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Figure 4.1: Action potential and calcium transient morphologies in the Shannon (solid line),
TenTusscher (dash dotted line) and Ohara models (dashed line).
cardiac ventricular (epi-, endo- and mid-myocardial) with different characteristic action potential
morphologies. In contrast to the experimental data which was recorded from rabbit ventricular
cells, the model was constructed using data from human ventricular myocytes.
Ohara model (2011) Experimental data for the human heart is very difficult to obtain, and
some of the ionic currents in the model (for example Priebe and Beuckelmann (1998) model)
were constructed based on animal data (rodent or other mammalian). Even the TenTusscher
model used guinea-pig data to compare the conduction velocity restitution (CVR) curve because
no experimental data on human CVR were available at that time. The Ohara model, however, was
developed based on recent human data, which is critically important for the correct formulation of
mathematical models of simulation for human electrophysiology. The model can also reproduce
important arrhythmogenic behaviours such as early after-depolarizations and alternans, which
is crucial for studying the mechanisms of cardiac arrhythmias in human and simulate clinical
interventions like drugs.
Both the Shannon and TenTusscher models were downloaded from CellML model repos-
itory (https://models.physiomeproject.org/cellml) and were executed using
MATLAB v2017b with a 64-bit Intel processor. The model equations were solved using the
MATLAB function ode15s with relative and absolute tolerances at 10−6, respectively. MATLAB
function ode15s is used for solving stiff differential equations using variable order method. On
the other hand, the Ohara model was downloaded from Rudy laboratory model repository (http:
//rudylab.wustl.edu/research/cell/code/AllCodes.html). The simulation
was executed in MATLAB v2017b using a similar setting as the other two models.
Ionic currents and action potentials in rabbit and human models In this work, the numeri-
cal simulations were undertaken using both rabbit and human AP ventricular models. In contrast
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Figure 4.2: Comparison of profile of several common ionic currents found in the Shannon model
(solid line), TenTusscher model (dash dotted line) and Ohara model (dashed line).
to rodents, the cardiac electrophysiology properties present in rabbit heart are very similar to
those in human heart (Bers 2002, Kang et al. 2016, Odening et al. 2020, Panfilov 2006). Key
electrical features show pronounced similarities in the two species, such as the shape of action
potential and the biophysical properties of the underlying cardiac ion channels/currents. These
rabbit models have been instrumental in increasing our understanding of mechanisms initiating
and sustaining ventricular arrhythmias as seen in humans (Brunner et al. 2008, Lang et al. 2016).
Hence, both human AP models mentioned earlier are still appropriate for this work (refer
Section 2.8 for an extensive discussion). In the Shannon and TenTusscher models, the ionic
currents are generally reconstructed using mathematical formulation as in Luo and Rudy (1994a;b)
with variations in and additions to individual equations and parameters. Hence, it is expected
that the ionic currents shape in these two models are identical (Figure 4.2). On the other hand,
the Ohara model uses their novel mathematical formulation to describe the ionic currents in the
model, which then validated to various experimental data obtained from their experiment and
literature. However, the general waveform of the ionic currents are almost similar to the other
two models.
Distinct differences exist in action potentials and ionic currents between rabbit and human
models, as shown in Figure 4.1 and 4.2. From Figure 4.1, we can see that the Shannon model
generates action potential with significantly larger amplitude (Phase 0 peak) and more prominent
Phase 1 compared to other two models. Action potential in the Ohara model resembles the AP
from the TenTusscher model exhibiting deep notch at the onset of the plateau. AP rabbit model,
however, does not produce the notch. Unlike Shannon and TenTusscher models, the Ohara model
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lacks a well defined plateau phase during repolarisation and produces faster repolarisation phase.
Overall, both Shannon and TenTusscher models exhibit a good overlap between each other, with
minimal discrepancy at the Phase 1 of the action potential. The differences in AP waveform
between cell models are likely because the data used to generate the model were from different
laboratories with different experimental setting and conditions. The type of ionic currents/pump
exchanger included in each model is also different, as listed in Table 4.1, which might influence
the generation of AP waveform. For example, chloride current can only be found in the Shannon
model, whereas sodium late current is included in the Ohara model only.
From Figure 4.2, we can also observe that each model produces different magnitude and
morphology of ionic currents. It is well known that AP repolarisation is largely controlled
by the inward calcium current and the various outward potassium currents. Despite of these
differences, all models produce a comparable APD90 as plotted in Figure 4.1. This is because
the AP repolarisation difference mostly depends on the counterbalance of ionic currents between
each other. Furthermore, larger AP amplitude shown in the Shannon model is probably caused by
the large IK1 current in this model.
4.3.2 Parameter sensitivity analysis
Sensitivity analysis is typically used to evaluate the uncertainty in the output of the mathematical
model or system to various changes of the input parameter. Modellers may implement sensitivity
analyses for many purposes, for instance, to determine
• which parameters need further research for strengthening the knowledge base, hence
minimising output uncertainty
• which parameters are less important and can be removed from the final system
• which parameter inputs are the most sensitive and contribute the most to model output
uncertainty
• which parameters have larger correlation with the output and increase the understanding of
the relationship between input and output variables.
In general, there are many different methods of conducting parameter sensitivity analysis such
as differential sensitivity analysis, the sensitivity index, the relative deviation method and others
(see Hamby (1994) for a complete review on parameter sensitivity analysis). For this thesis,
we focus on a local sensitivity test known as ‘one-at-a-time sensitivity measures’ described in
Snowden et al. (2017). Conceptually, this is one of the simplest methods of parameter sensitivity
analysis by repeatedly varying one parameter with respect to small perturbation at a time while
keeping the other parameters fixed and then quantify the change in model output. The sensitivity
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Figure 4.3: Sensitivity of transmembrane voltage potential to variation of ionic conductances
in Shannon model. Several biomarkers extracted from functions ∂V/∂ p j are plotted. Each
parameter was perturbed by ±20% and the changes on AP biomarkers were recorded.
function is expressed as following,
zi j(t) =
∂xi(t,p)
∂ p j
≈
xi(p j +∆p j, t)− xi(p j, t)
∆p j
(4.1)
where xi is the i-th component of the vector of state variables in the model. p is a parameter vector
in the model and ∆p j is the amount of perturbation of j-th parameter. These partial derivatives
approximate the relative point-wise difference between the original and perturbed outputs when
parameter j-th is changed, while the other parameters are held constant.
We carried out a parameter sensitivity test on some parameters in Shannon model (as listed
in Table 4.1). Each parameter was perturbed by ±20%, while the other parameters were held
constant. Figure 4.3 shows the result of the test on all the ionic conductances in the model. From
the figure, we can observe that each parameter has different level of sensitivity. Some are very
sensitive to small perturbation and some do not alter the AP waveform. More importantly, each
parameter has particular effects on the AP morphology, highlighting its role in modulating the
specific phase of an AP. For instance, the amplitude of action potential is governed by gNa and
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gK1; meanwhile, the action potential duration is influenced by gCaL, gNaCa, gtos, gKr and
several others. The results of this test were used to select the parameters needed for constructing
the population of models. In particular, we only chose the parameters that have most significant
influence on the action potential duration. The parameters were gNaK, gKr, gKs, gK1, gtos,
gNaCa, gCaL, gClb.
4.3.3 Sampling method
Building a model population needs the generation of a large parameter sets with various combina-
tions, sampled from a high-dimensional parameter space. There are various sampling methods
which can be used to vary the parameters randomly, for instance, parameter sweeping (Peachey
et al. 2008), Monte Carlo sampling and Latin hypercube sampling (LHS).
Monte-Carlo methods include any techniques that draw samples from a probability distribution
function in order to produce various parameter combinations. This includes the use of log-normal
distribution centred around the baseline parameter values and within specific standard deviation
that controls the limit to which parameters varied. Using this distribution also ensured that the
non-physiological conditions due to negative conductance are never included in the parameter
sets. Such approach has been used in several studies to construct the model population (Ballouz
et al. 2019, Lawson et al. 2018, Sobie 2009, Varshneya et al. 2018). In this method, parameters
are chosen randomly from the probability distribution to generate as many parameters as needed.
Another sampling method is Latin hypercube sampling. LHS was first introduced by McKay
et al. (1979). This sampling method is very efficient in creating a random sample of parameter
values from a multidimensional distribution without bias. The LHS method begins by specifying
an upper and lower bound on the range of values of every parameter with the aim to spread the
sample points more evenly across all possible values. For M parameter sets, the method divides
each interval into M intervals of equal probability. One sample is randomly chosen from every
interval but with the condition that each parameter set can only contain parameter values from
intervals that have not been used in any other parameter set. This allows us to generate large
parameter sets with various and unbiased combinations. This makes the method suitable for
sampling high-dimensional parameter spaces where the relative significance of every parameter
in determining model output is not yet understood. In our work, we use the LHS to create
the parameter samples for the initial model population. The method is implemented using the
MATLAB built-up function ‘lhsdesign’.
4.3.4 Partial correlation coefficient
We use the partial correlation coefficient for characterising the properties of subsets of the
population further below in Section 4.5.1, 4.5.3 and 4.5.4.5, i.e. to look for correlations between
conductances in the control population and subset of drug population. PCC measures the strength
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and relationship between two random variables while considering the changes of one or more
other additional variables. However, before choosing any particular partial correlation, it is
important that we know the type of distribution of our data. We use Spearman’s partial correlation
coefficient since most of our variables have non-normal distribution. To find the PCC between
variables x and y, given a set of m controlling variables p = {p1, p2, ..., pm}, we first measure the
linear regression of x with pi y with pi:
x̂ = c0 +
m
∑
i=1
ci pi, and ŷ = b0 +
m
∑
i=1
bi pi. (4.2)
PCC between x and y can be found by calculating the correlation coefficient between the residuals
ex = x− x̂ and ey = y− ŷ and it is defined as following,
PCC(x,y, pi) =
cov(ex,ey)
var(ex)var(ey)
. (4.3)
PCC takes on a value in the range between [−1, 1] where 1 indicates a strong positive correlation
and -1 indicates a strong negative correlation. In MATLAB routine, PCC is defined in a built-up
function called ‘partialcorr’.
4.4 Experimentally-calibrated population of models
In this section, we describe the calibration methodologies used to construct the model population
in the control condition, as well as the model population under the action of drugs.
4.4.1 Constructing the control population
To create the control population, we generated an initial population between 10,000 - 30,000
rabbit/human ventricular action potential models by independently varying the value of ion
channel conductances in each model. These chosen parameters were based on the parameter
sensitivity analysis, as discussed earlier, by looking at the parameters that largely influenced
the action potential repolarisation. Technically, the parameters control the level of ionic current
magnitudes. The list of selected ionic currents are as shown in Table 4.1 and the expression for
each ionic currents in the model was replaced by,
Ix = αxgxF (V,y,w,p, ...), (4.4)
where αx is the multiplicative factor that relatively determines the maximal amplitude of the
respective current. gx and F (V,y,w,p, ...) are the ionic conductance of the different currents and
the function that describe the ionic current, respectively.
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Figure 4.4: Diagrammatic representation of model calibration.
Selecting ranges for parameter variation. The multiplicative factors were varied between
the range of 0.1 and 2 times the baseline value in the original model. The range allows substantial
level of channel expressions, so that the output distributions could cover the entire experimental
ranges.
APs quality control. Beat-to-beat repolarisation variability could be a major source to AP
variation in isolated cells due to stochastic behaviour of ion channels (Zaniboni et al. 2000) and
period of stimulation. In order to minimise the effect of beat-to-beat variability and ensure that
each model in the population reached its steady state, the model was numerically solved by
stimulation a train of 1000 action potentials at pacing rate 2Hz (500 ms). The last two APs of the
simulation were saved for further analysis. Then, the model AP biomarkers (APD90, APD50,
APD30, Trise) were computed for each model. As part of our quality control, a model variant
was eliminated from the initial sample populations if it failed to depolarise above 0 mV or had a
resting membrane potential larger than -65 mV. We also removed the model if it showed APD90
differences between the final two action potentials larger than 5 ms and this is similar to quality
control used experimentally. These filters were implemented to ensure that the accepted models
had viable APs.
Calibration criteria. A two step protocol was used to calibrate the model population to
experimental measurements, an approach similar to that of Lawson et al. (2018). Illustration of
our calibration steps can be seen in Figure 4.4. We first calibrated the initial model population
(constructed using the LHS) with the experimental ranges in Table 3.1. In most of the previous
works, calibration of a population of models has been achieved almost exclusively by eliminating
all the models that produced AP biomarkers falling outside the experimental ranges (Britton et al.
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2013, Gemmell et al. 2016, Sanchez et al. 2014). This is overdetermined as the accepted models
may not necessarily produce a good correspondence with the biomarker distribution shown in
the experimental data. One of the reason is that the baseline model was not constructed using
similar experimental measurements and the outputs produced by the model may not accurately
capture the response seen in the experimental data due to differences in experimental technique
and setting.
Therefore, to improve the model response relative to the experiment, the biomarker distribu-
tions were also fitted by randomly sub-sampled a model population around experimental mean.
This model subpopulation was randomly picked from the model population that fall within the
calibration ranges, as illustrated in Figure 4.4. In order to do that, we chose APD90 as the main
biomarker, considered that APD90 is the most affected biomarker when studying Class III and
IV channel blocks. Our goal was to fit the APD90 distribution alone and we expected the other
biomarker distribution would follow. To demonstrate our method, the range of APD90 values
was split into 11 equal sized bins and random model variants were removed from each bin until
the relative histograms of the model population and the experimental data were identical. Both
calibration criteria are critically important in order to ensure that the inferences from in-silico
modelling more physiologically relevant. The entire processes were repeated for all three cell
models, and the results were analysed.
4.4.2 Constructing the drug population
We simulated the administration of 30nM of dofetilide and 1 µM of nifedipine, by modelling
the action of the drug as a single-pore IKr and ICaL block, respectively (Brennan et al. 2009). A
dose of 30 nM of dofetilide is known to induce 30% inhibition of IKr channel. On the other hand,
a dose of 1 µM of nifedipine is known to induce 60% inhibition of ICaL channel. Each IKr/ICaL
in the model of the control population was reduced by this amount, and each model was paced
again to a new steady-state (1000 action potentials) at 2Hz pacing rate. The last two APs were
kept for further analysis.
The most common approach that has been used by others (Britton et al. 2017a; 2013; 2014)
to determine the degree of channel block is by using the Hill equation (Hill 1910) as formulated
below,
Fraction of blocked site, Y = Kn/(IC50+Kn), (4.5)
where n is the Hill coefficient and K is the drug concentration. IC50 is the drug concentration
that blocks 50% of the respective current. Nevertheless, there is no standardisation of IC50
measurement at present, which favours the existence of a high variability of the IC50 values
reported in the literature and databases (Crumb et al. 2016). There is experimental evidence of
the IC50 dependency on the experimental conditions, such as voltage protocol and temperature
(Kirsch et al. 2004, Yao et al. 2005). This makes the process of determining the accurate degree
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Figure 4.5: (a) Selected action potentials for cell models accepted in the control population (black
lines) when the conductances scaling factor were randomly varied in the range 0.1–2. The red
lines show the trace of action potentials when conductances scaling factor was varied across a
range of 0.9–1.1. (b) Variation of range of APD90 as a function of the parameter range. Dashed
lines indicate the experimental range used to calibrate the population of models.
of channel block a little bit difficult and challenging.
Hence, we used a pragmatic approach in our work to determine the degree of ion channel
block. For the given concentration of dofetilide, the range of inhibition of IKr channel is
approximately between 25–35%. We varied the amount of IKr block and ended up with 30% such
that the AP responses could match the experimental observation (Table 4.2 and Figure 4.12b).
Similar procedure was used for the second drug.
4.5 Results and discussion
In this section, we present and discuss the results obtained from our computational studies using
three different AP ventricular models. Results obtained with the Shannon model are presented
in the greatest detail because the model produced the most significant results compared to the
experimental measurements.
4.5.1 Development of the populations of models in control conditions
Parameter variation. Figure 4.5a shows the corresponding relationship between model action
potential to the level of parameter variation. We initially considered smaller parameter ranges
(±10%,±30% and±50%), attaining results that implied such variation levels were insufficient to
explain the experimental data. As we can see from Figure 4.5b, for a smaller range of parameter
variation, the range of model output (in this case the APD90) is small and not sufficient to
capture the variation level showed in the experimental data, suggesting further variation in these
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cell model properties was needed. Although at ±50% parameter variation the model output is
relatively close to experimental range, the population of models is not able to capture the effects
of drug block, as shown in the supplementary Figure A.1. Addition of ion channel blocking drugs
(dofetilide) exhibited a small range of effects within models, which is far from the experimental
observation. The results presented here demonstrate the importance of choosing the appropriate
level of ion channel expressions when constructing a population of models.
Biomarker distributions in each model population. Figure 4.6 shows distributions of se-
lected AP biomarkers in populations of models in comparison to experimental dataset. When
experimental ranges were the only calibration criteria used to construct the experimentally-
calibrated model population, we can see that both Shannon and Ohara model produce a right-
skewed distribution (green distribution in Figure 4.6(a) and 4.6(c)) compared to the experimental
measurements (blue distribution). An obvious reason is that the data used to construct the model
was from different laboratories with different experimental conditions. In consequence, randomly
varying the parameters from the baseline value would only produce a distribution within the
baseline value of the model. Only the TenTusscher model (Figure 4.6(b)) managed to give nearly
identical distribution to the experimental data and this is, of course, because the baseline model is
close enough to the mean value of the experimental recordings.
Hence, to improve the outcome of the biomarker distributions, we fitted the distribution of
the models to the experimental data, as discussed earlier in Section 4.4.1. Using this approach,
3425 Shannon models (11.4%), 7036 TenTusscher models (35.2%) and 2337 Ohara models
(23.4%) were accepted into the control population. We realised that the method presented here
was simplistic but sufficient enough to meet our objective, i.e., to fit the distribution. Lawson
et al. (2018) has demonstrated a more efficient approach (using a combination of Monte Carlo
sampling and simulated annealing-type algorithm) to address the problem, but yet the method
still failed to fit all the biomarker distributions simultaneously. A probable reason is because the
parameters that explicitly controlled the AP shape were not modelled, hence inhibiting a good
correspondence with the biomarker’s distribution in the experimental data (Britton et al. 2017a).
Figure 4.6 shows the biomarker distributions (red distribution) for each model after fitting to
the experimental data. After the optimisation, we can observe that the AP biomarkers show a
good overlap with the experimental biomarker distribution. In Shannon model population, both
APD90 and APD50 produce a good correspondence with the experimental dataset. APD30 has
similar variability between models and experiments, but the distribution mean is shifted ∼−50
ms in the model distribution relative to experiments. This happens because Shannon model
has higher amplitude compared to the experimental signal (see Figure A.3(a)). Compared to
APD90 and APD50, APD30 is a very sensitive biomarker which can be influenced by the value
of AP amplitude as it determines the ‘cut-off’ value for each APD. Overall, the TenTusscher
model population produces a remarkable correspondence with experimental distributions (refer
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Figure 4.6: Distributions of AP biomarkers in populations of models in comparison to exper-
imental data. (a) Top row is for the Shannon model, (b) Middle row is for the Ten Tusscher
model and (c) Bottom row is for the Ohara model. The green line represents the distribution of
biomarkers in the baseline model that fall within the experimental ranges, the red line represents
the distribution of biomarkers after fitting to experimental distributions and the blue line is the
distribution of biomarkers in experimental data. The inverted ( ) indicates the mean value of the
respective distributions.
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to Figure 4.6(b)). All biomarkers show a perfect agreement with identical mean values. Also, the
Ohara model gives a similar level of variability for every biomarker distribution, but the mean
has shifted for approximately -20 ms (APD50 and APD30). Importantly, the %IQR coefficient
(IQR*100/mean) of the APD90 at 2 Hz for each model population was 24%, close to the average
reported experimentally (19%−25%).
The set of model populations reproduce the spread of AP waveform features in terms of the
gross timings of the AP event. Absolute levels of diastolic, peak and plateau voltages are not
available from the optical measurements and would normally be additional important biomarkers
available from sharp micro-electrode measurements. However, the refinement of the models based
on the AP waveform shape alone resulted in a narrow range of diastolic and peak potentials from
the AP models. In Shannon model population, the mean of diastolic potential and AP amplitude
are -85.5±1.1 mV and 134±3.9 mV, respectively. Similarly, mean of diastolic potential and AP
amplitude in the TenTusscher (diastolic = -85.7±1.9 mV, AP amplitude = 119.3±8.6 mV) and
the Ohara (diastolic = -87.8±0.7 mV, AP amplitude = 126.6±3.5 mV) model populations have a
good overlap with literature reports from isolated rabbit ventricular myocytes. The difference in
AP amplitude in each model population is probably due to difference in the strength of stimulus
current or sodium current which was not altered when constructing the model population.
In general, our findings show that each model exhibits a different level of heterogeneities
and distinct model outputs. In comparison to the experimental dataset, the TenTusscher model
produces the most significant agreement, followed by the Ohara and then Shannon models. This,
however, does not guarantee that the TenTusscher model would produce a better outcome for
drug blocks compared to the other two models as the underlying ionic properties in the respective
model may influence the responses. In the next section, we investigate the capability of each
model population to predict the AP responses following drug blocks of hERG and L-type calcium
channels.
Correlations between ion channel expressions. One question that arises from this result is
whether the accepted models in the control population has similar ionic properties with the
rejected models. To answer this, we measured and compared the partial coefficient correlation
(as defined in section 4.3.4) for a pair of ionic currents in the model population of Shannon.
Particularly, the correlation between a pair of ionic currents while including the effect of other
ionic currents were measured. Figure 4.7 depicts the PCC values between the initial model
population (calibrated models within experimental ranges) and the accepted models in the control
population (randomly subsampled around experimental mean). For simplicity, we refer to the
first model population as Pcalibrated and the latter as Pcontrol.
We can see that for the selected pair of ionic currents in Pcontrol have more pronounced and
stronger correlation than Pcalibrated. Importantly, four pairs (gCaL-gNaK, gCaL-gKr, gCaL-gNaCa
and gCaL-gClb) of ionic current show significant correlation with PCC greater than 0.5. The
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Figure 4.7: Partial correlation coefficient (PCC) for selected pairs of ionic currents in the models
within the experimental ranges, Pcalibrated and the models that have been accepted in the control
population, Pcontrol. All results have p-values <0.001 (paired t-test). Data presented here is for
Shannon model population only.
strong positive correlation showed between ICaL and IKr indicates that viable APs required
a balanced expression of these two ion channels. Also, in a recent study by Ballouz et al.
(2019), they observed that the most notable correlation in mRNA extracted from human induced
pluripotent stem cell-derived cardiomyocyte was between IKr and ICaL currents (r2 = 0.89).
This result is consistent with our own where the IKr and ICaL in the model population exhibits a
strong positive correlation (PCC = 0.52). Also, the negative correlation of ICaL and INaCa has
not been previously reported, the mechanistic basis for this is uncertain, but may be linked to the
maintenance of the plateau phase to which both ICaL and INaCa contribute.
Interestingly, there is a strong positive correlation shown between gCaL and the baseline
chloride conductance, IClb (PCC = 0.63). The role of chloride channels in the generation of
cardiac action potential is well known. Cardiac chloride channels have the unique ability to
generate both inward and outward currents and cause both depolarisation and repolarisation
during the action potential (Duan 2009). This feature may be the basis for the positive correlation
with gCaL.
4.5.2 Parameter distributions in the control population of each model
We observe and compare the differences in parameter distributions of the accepted model
population of each AP model. This is plotted in Figure 4.8. In the figure, most of the conductances
span the full sampled range (0.1–2 times the baseline value for that conductance), highlighting the
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Figure 4.8: Box-whisker plot of selected parameter distributions in the Shannon (red), TenTuss-
cher (blue) and Ohara (green) model population. Lower and upper box boundaries is the 25th
and 75th percentiles, respectively. Median is denoted by a line inside box, outliers are marked
with a plus sigh (+).
robustness of the rabbit AP against conductances variations. In the Shannon model population,
the median of most of the parameters is close to baseline value, with the two exceptions being
gCaL and gK1. The baseline Shannon model has APD90 approximately 188 ms and this value
is shorter than the mean APD90 of the experimental distribution (approximately 257 ms). A
high gCaL and small gK1 were needed to compensate the APD difference between the model
and experimental distributions. Similarly, the APD90 of baseline Ohara model is about 50 ms
shorter than the mean APD90 of the experimental data. A small gKr value (as shown in Figure
4.8) would prolong the APD and compensated the difference.
Furthermore, in the Ohara model, gKr confined the smallest range and median value, in
comparison to the other two models. 95% of the models in the control population of Ohara
model have gKr values clustered between 0.1 and 1.4. The TenTusscher model shows the most
significant median value of gKr (x1.2). gCaL values are equally spanned between 0.1 and 2 in all
the three models, with different in median values. 76% of the models in the Shannon population
have gCaL larger than 1, followed by the Ohara model (59%) and lastly by the TenTusscher model
(47%). This highlights the importance of gCaL to adjust the APD in the respective model so that
the APD mean in the model population could match the experimental mean. Also, the Shannon
model shows a restricted value of gK1, which only span between 0.1 and 1.5. gK1 in the other
two model population is uniformly distributed within the sampled range. For larger gK1, stronger
stimulus amplitude is needed to depolarise the action potential. In essence, it is impossible to
directly compare the parameter distribution between the model populations as the excitation of
AP depends on the counterbalance of ionic currents between each other. In other words, the
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Figure 4.9: (a) Bar graph of the Qnet in the archetypal model of Shannon, TenTusscher and Ohara
model. (b) Profiles of ICaL and IKr in the respective models.
same AP can be generated as long as the inward and outward currents are equivalent (Banyasz
et al. 2011) and there are many ways to achieve that. Hence, it is not surprising that each model
population exhibited different ion conductance distributions, although all the model populations
were calibrated to a similar experimental distribution. Overall, our results demonstrate that a
viable AP can be generated by a wide variety of different balances of ionic currents, although
these balances may have different responses to drug blocks.
In addition, it is crucial to realise that the baseline current magnitude differed between each
model and hence the conductance scaling factor plotted in Figure 4.8 did not provide a fair basis
for comparison between the Shannon, TenTusscher and Ohara models. To make the comparison,
we generated the ionic currents (ICaL, IKr, IKs, INaCa and IK1) in each model and then measured
the net charge transported by individual currents over the duration of one action potential Qnet,
Qnet =
∫ t1
t0
I j(t)dt, (4.6)
where t0 and t1 are the start and end of the simulated beat, respectively. I j is the current in the
respective model. The Qnet of each ionic current was computed using the trapezoidal integration
method. Instead of using the entire accepted model population, we constructed an archetypal
model for each of them by taking the median values of the conductances scaling factor (Figure
4.8). Figure 4.9a shows the Qnet of common ionic currents in each archetypal models. We can
see that most of the ionic currents in the Shannon model dominate the ionic currents in the other
two models. The Qnet of ICaL, INaCa, INaK and IK1 is the largest in the Shannon model. Ohara
has the smallest Qnet of ICaL but possesses the largest IKr. In the next section, we will show how
these differences in the Qnet may significantly affect the model’s responses to channel blocks.
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Figure 4.10: PCC values between selected biomarkers and parameters varied in the control
population of (a) Shannon model, (b) TenTusscher model and (c) Ohara model. PCC values are
displayed for coefficient values larger (or smaller) than 0.5 (-0.5). Positive value indicates strong
positive correlation and vice versa. Colour map is shown using a bar to the right in each panel.
All indicated PCCs have P<0.001 (paired t-test).
4.5.3 Partial correlation coefficient for model biomarkers
Ionic currents are well known to act together in a different region of the action potential, and
some are very sensitive to perturbation, which could alter the AP shape. We investigated whether
there were correlations between parameter values in the models of the control population and
the AP biomarkers. The parameters were initially varied randomly, and they were uncorrelated,
hence any correlations found are due to the calibration process. To measure the correlations, we
used the PCC which identifies correlations between variables while controlling for the effects
of the remaining parameters. PCC for selected AP biomarkers in each cell model is depicted in
Figure 4.10.
In the Shannon model, we can see that all model parameters have a strong correlation with
APD90, except for gK1 and gKs. gCaL has the strongest positive correlation with the APD90,
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followed by gNaCa. The results are as expected since the selected parameters to construct the
model population were based on their effect on AP repolarization, and this finding is consistent
with our parameter sensitivity test earlier (see Figure 4.3). A similar outcome can be observed in
the Ohara model, where almost all model parameters correlate strongly with APD90. Only gto,
gNaCa and gNaK have a small influence on APD90. Compared to the other two models, many
conductances in the TenTusscher model show a more insignificant effect on AP repolarization.
Only gKr, gCaL, gNaK exhibit strong correlation with APD90. For consistency, the same
parameters as those in the Shannon model were varied in the TenTusscher and Ohara models.
However, all selected conductances in all models influence APD, but not always strongly.
It is known that the inwardly rectifying potassium current (IK1) is responsible for forming the
initial depolarization, final repolarization, and resting phases of the action potential (Dhamoon
and Jalife 2005). In the Shannon and Ohara model, the conductance of this current has strong
correlations with the amplitude and resting membrane potential (RMP) of the action potential.
However, the correlation is weaker in the TenTusscher model. Also, gNaCa in the Shannon and
TenTusscher models has a strong positive correlation with RMP due to reactivation of INaCa
during this stage in order to restore the calcium concentration in the cell. Other than these two
ionic currents, INaK is also responsible for the generation of the resting membrane potential of the
action potential by transporting sodium ions out and potassium ions into the cell (Bueno-Orovio
et al. 2014). This is consistent with our result where gNaK in all cell models shows a strong
negative correlation with the RMP.
4.5.4 Response to hERG block by dofetilide
Following the calibration of the model population, we used the population of rabbit/human ven-
tricular myocytes to predict electrophysiological response to dofetilide. From our computational
modelling, we observed various AP responses when IKr was blocked as follows,
• (Normal response) AP with normal APD prolongation.
• (Hyper-response) AP with extreme APD prolongation, i.e, the AP slowly repolarizes, but
fails to reach the resting potential (> -65 mV) before the arrival of next stimulus.
• (EAD) AP with single or multiple early after-depolarisations, i.e, if EAD amplitude is
greater than 10% of action potential amplitude.
• (Alternans) APs with APD difference larger than 5 ms, i.e models that exhibit 2:1 or 2:2
responses.
Figure 4.11 depicts some examples of APs simulated for control condition (solid line) and the
effect of IKr block (dashed line) in the Shannon model. Our finding shows that these AP responses
are model-dependent, and not all responses were seen in every model, as shown in Table 4.2.
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Figure 4.11: Examples of simulated AP traces obtained in several models accepted in control
populations (solid line) and their responses to 30% IKr block (dashed line). Left panel shows
examples of normal responders, Middle panel shows examples of hyper-responders and Right
panel shows examples of EADs.
AP response Experiment (%) Shannon (%) TenTusscher (%) Ohara (%)
Normal response 87.4 89.2 99.4 99.93
Hyper-response 12.6 8.2 0.09 0.02
EADs - 2.6 - -
Alternans - - 0.45 -
Table 4.2: Size of sub-populations in the drug population of cell models and experiment.
4.5.4.1 Normal response
From Table 4.2, it can be seen that a majority of the cell models (approximately larger than 90%)
in the respective model experienced APD prolongation when IKr was blocked. The Shannon
model makes a good agreement with the experimental data. Meanwhile, the other two models
show a slightly higher proportion than the observed value with more than 99% of the models in
the two populations exhibited normal responses. Figure 4.12 shows the scatter plot of baseline
APD90 values of each accepted model at 2Hz against ∆APD90 attributable to IKr block, in
comparison to experimental data.
In general, the APD prolonging effect of IKr block seems to be uniform in all three models.
There is also no significant correlation between the baseline APD and the amount of APD
prolongation following block. The degree of ∆APD does not depend on its baseline APD. This is
because APD is a function of model parameters such that a given APD value can be produced
by infinitely many different sets of parameter values. These sets form a continuous contour
hypersurface in the parameter space (as illustrated in supplementary Figure A.2). In the Shannon
model, the distribution shows that the range of ∆APD is narrow (< 25 ms) at smaller AP, but
getting more pronounced as the baseline APD increases. A similar trend can be seen in the
TenTusscher and Ohara models. Ohara model has the smallest spread of APD prolongation across
the model population, and no model has ∆APD between 0–30 ms. Nevertheless, the mean value
of ∆APD is the largest in Ohara model, highlighting the model has the most significant response
to IKr channel block. This is predictable as Ohara model has the highest level of IKr magnitude
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Figure 4.12: Scatter plot of net effect of IKr block on APD90 against baseline APD90 by
individual cell models (paired), in comparison to experimental data (red squares). (a) is for
the Shannon model, (c) is for the TenTusscher model and (e) is for the Ohara model. (b, d, f)
Histograms of the distribution of ∆APD90 across the population of models (green), compared to
experimental distribution (red). Mean value of each distribution is marked as inverted triangle
( ). The mean and standard deviation of ∆APD90 in each population are 33.18± 20.26 ms
(Shannon), 24.18± 15.02 ms (TenTusscher), 40.29± 9.26 ms (Ohara) and 32.23± 34.46 ms
(experiment). Red triangle region in (a,c,e) is the maximum ∆APD90 allowed for the respective
baseline APD90.
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(Figure 4.9a) in comparison to the other two models; hence, more IKr current could be reduced.
The TenTusscher model has the smallest mean of APD prolonging effect with 76.5% out of
model population have ∆APD below the experimental mean, which makes the model prediction
slightly underachieving. The general spread, however, looks comparable to experimental distri-
butions with several models that could prolong as large as 200 ms. This did not happen in the
other two model populations. Statistically speaking, among the three models, the Shannon model
population shows the strongest correspondence with the experimental distribution, followed by
the TenTusscher model and finally the Ohara model.
In addition, notice that none of the model population exhibited AP with APD shortening when
IKr channel was reduced, in comparison to experimental data. Approximately 14.1% out of cell
population (5 hearts) produced APD shortening effect following application of dofetilide. This
is uncommon as class III antiarrhythmic agents like dofetilide are well-known to induce APD
prolonging effect and increase the effective refractory period of an action potential (Anderson
and Prystowsky 1999, Jaiswal and Goldbarg 2014, Tamargo et al. 2004). The negative ∆APD
was due the effect of DMSO (refer to Chapter 3.2.4). In section 4.5.6, we explore this further by
adding random noise.
4.5.4.2 Hyper-response
Following IKr block, some cells experienced extreme APD prolongation, which was beyond
the stimulation cycle length (500 ms). The AP failed to repolarise before the arrival of the next
stimulus current. We characterise this AP as hyper-response (see Figure 4.11). Since the amount
of APD prolongation of these cells cannot be determined (APD > CL), the minimum ∆APD is
measured as follows,
∆APD90min = CL (ms)−APD90baseline(ms) (4.7)
In computational studies, we observe that only the Shannon model exhibited hyper-response
across the model population, as stated in Table 4.2. The proportion of hyper-responders in the
other two models is negligible. Our result using the Ohara model is consistent with a recent
study by Britton et al. (2017a). In their study, they reported that the dofetilide simulations using
Ohara model did not exhibit such extreme APD prolongation, although their experimental data
did exhibit the behaviour. Later, we will use result obtained by the Shannon model in order to
understand the underlying cause of hyper-response. In addition, the mean baseline APD90 for
hyper-responders in the Shannon model population is not significantly different from the cell
population (302±28 ms vs 277±9 ms, respectively). The mean of minimum ∆APD is 197±28
ms in the population of models, compared to experimental data which is 224±44 ms.
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4.5.4.3 Early after-depolarizations (EADs)
As shown earlier that blocking IKr increases the APD and hence increases the effective refractory
period (ERP) of the cells. However, cells with higher ERP are vulnerable to EADs occurrence.
EADs are a pro-arrhythmic event and may precipitate Torsade de Pointes (TdP) and other types
of arrhythmias (Yap and Camm 2003). By definition, EADs can arise when there is an abnormal
depolarization (self-amplify) during phase 2 or 3 before normal repolarization is completed.
In our work, an AP is considered to generate EADs if EADs amplitude (after 100 ms of AP
excitation) is 10% higher than the AP amplitude. MATLAB function ‘findpeaks’ was used to
measure the EADs amplitude. In the experiment, the noisy signal of AP trace (see Figure 3.6)
could mask EADs generation if the EADs amplitude is too small. The criterion was also used in
order to distinguish the AP signal between hyper-responders and EADs.
Based on this detection criterion, only the Shannon model displayed EADs in response to IKr
block. No EADs was observed in the other two models and experimental data. EADs generation
in response to IKr block, however, is more common when cells are stimulated at slower pacing
rates. This has been reported in several clinical studies (Guo et al. 2011, Nalos et al. 2012) and
computational modelling (Cooper et al. 2016, Costabal et al. 2018, O’Hara and Rudy 2012).
Fast pacing rate (2Hz) used in our work should prevent EADs. In another study conducted by
Lu et al. (2001), they demonstrated that there are species differences in EAD occurrence with
rabbit cells constituted the most sensitive species. This is probably why the Shannon model
showed a slight tendency to exhibit EADs, compared to other two human AP models. Also, we
speculate that EAD generation in the Shannon model is highly linked to the level of INaCa and
ICaL magnitudes in this model. Compared to the Ohara and TenTusscher models, the Shannon
model possesses the largest degree of INaCa and ICaL currents (Figure 4.9a) which makes the
model prone to displaying EADs.
4.5.4.4 Parameter distributions for each AP response
To study the ionic current properties in each AP response, we only consider results obtained from
the Shannon model population as this is the only model that exhibited various AP responses
following IKr block. Distribution of parameters for the TenTusscher and Ohara models are
similar for both control population and normal responders, except for gKr as it was the only
parameter changed. Analysing the parameter distributions in three sub-populations of the Shannon
model show that IKr plays an important role in the prolongation of APD as depicted in Figure
4.13. In normal responders, most of the parameters have identical median values with the
control population (blue distribution), except for gKr. The discrepancy is because gKr was the
only channel blocked under drug condition. Indeed, more than 90% of the model population
experienced a normal AP response when IKr was reduced; hence we could expect that the
parameter values were not significantly distinct from the control population.
For hyper-responders, gNaK, gKr, gtos, gK1 have almost similar median values with the
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Figure 4.13: Distribution of values for the eight ionic conductances varied in the Shannon
population for models within all three classified responses in comparison to control population.
Blue solid line is for control population, green dashed line is for normal responders, red dotted
line is for hyper-responders, and black dashed-dotted line is for EADs. Inverted triangle symbol
( ) denotes the median value of each distribution.
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control population. Both median of gKs and gClb decreased by approximately 28% and 35%,
in comparison to their values in the control population, respectively. Median value of gCaL in
hyper-response shows a significant increase (31%) with most of the parameter values strictly
covered in the top region of the sampled value. gNaCa was drastically reduced with median value
approximately 0.5.
In contrast to the above, gNaCa increased dramatically in models with EADs and the allowed
values of this conductance of which were within a narrow subset of the sampled range (top half
of the sampled range). It is well known that Na/Ca exchange current is responsible for EADs
formation (Qu et al. 2013, Weiss et al. 2010). Other conductances such as gCaL, gKr and gNaK
showed a small reduction in the median values, whereas gtos was increased by about 10%.
In a recently published paper by Varshneya et al. (2018), they demonstrated that less arrhyth-
mic behaviour was observed in models with higher IKs level. Particularly, models with low IKs
are more susceptible to EADs when ICaL is elevated. Our model population with EADs strongly
support the finding as most of gKs conductance covered the bottom half of the parameter range.
In addition, INaK expression was also found to have a major role in generating EADs. In another
study by Britton et al. (2017b), the results showed that when EADs was generated, INaK was
smaller than its baseline values. This is in agreement with our finding where median of gNaK
was reduced slightly (approximately 13%) in comparison with the control population.
4.5.4.5 Correlation between ion conductances of sub-populations
Figure 4.14 shows the 2D density plots of the distributions of selected pairs of ionic conductances
in three sub-populations of Shannon model. These results show that normal responders span a
broader range of sampled values, compared to hyper-responders and EADs. In normal responders,
majority of parameters span almost the entire range (up to ±100% of their values from the
original parameter set of the baseline model), with the exception being for gCaL. gCaL spans
mostly the top half region of the sampled values.
Meanwhile, in hyper-responders and EADs classes, there is a more tightly concentrated
distribution of parameter values. This contrasts with the wide spread of parameter values in
normal responders. For instance, gCaL in hyper-responders are more often in the top region of
the parameter space (larger than x1.5), whereas for gNaCa are more often in the bottom half of
the range. In EADs, gCaL are uniformly distributed across the sampled values, whereas gNaCa
covers the top region of parameter range (larger than x1.1), highlighting the significant role of
INaCa to generate EADs. Our results also demonstrate that these AP behaviours could only occur
when current magnitudes are within a certain value.
To measure and compare the correlation between each pair of ionic conductances in the three
model subpopulations, we used the partial correlation coefficient as plotted in Figure 4.15. In
general, we can see that most of the ionic pairs have a strong correlation (PCC>0.5). Interestingly,
PCC in both hyper-responder and EADs are more pronounced and larger than normal responder.
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Figure 4.14: 2D density estimation plots showing the relationship between selected ion channel
pairs in normal responder, hyper-responder and EADs. Brighter orange is the region with the
most data points and black region is the region without the parameter values.
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The most noticeable change is shown by gKr-gKs pair, where the value increased by more than
double. In humans/rabbits, the AP repolarisation duration at baseline is mostly modulated by
IKr and slightly by IKs. However, following the IKr block, the role is taken by small IKs.
Models with low gKs (high gKr) increase the probability of hyper-response and EADs formation.
In models with EADs, PCC of gCaL-gKr has the highest value compared with the other two
responses. It tells us that coexpression between these two ionic currents plays a significant role in
the development of arrhythmias (EADs) in response to a drug that blocks IKr.
4.5.4.6 The ionic mechanisms of hyper-responders and EADs
In this section, we discuss the mechanisms and physiology of hyper-responders and EADs
by linking these responses to dynamic changes of ionic currents. In order to do this, we first
constructed two archetypal models to represent both responses in an attempt to understand the
underlying causes of the behaviours. These models were built by using the median values of ion
conductances across the model population (Figure 4.13). Parameter values are listed in Table 4.3.
Hyper-response Figure 4.16 depicts the action potential and selected ionic currents of the
archetypal model of hyper-response. Under normal condition, the formation of AP plateau region
is mainly influenced by inward current ICaL. At the end of this phase, ICaL slowly begins to
diminish as activation of time-dependent outward potassium current IKr and IKs will dominate
the other ionic currents, hence forcing the AP to repolarize. Nevertheless, during the application
of IKr blocker, IKr is not properly activated, and ICaL remains to dominate (Figure 4.16b). This
79
Parameter Normal-response Hyper-response EADs
gNaK 1.0 0.95 0.84
gKr 1.0 1.38 1.20
gKs 1.21 0.9 0.56
gCaL 1.29 1.7 1.22
gNaCa 1.25 0.52 1.72
gK1 0.73 0.77 0.67
gtos 0.91 0.9 1.15
gClb 1.11 0.72 0.73
Table 4.3: Parameter values used to construct the archetypal models. Values were extracted from
the median value of each conductance in the respective models subpopulation (Figure 4.13).
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Figure 4.16: Traces of (a) action potential and the corresponding (b) ionic currents in archetypal
model of hyper-response. Solid line shows the model outputs under control condition and the
dashed line shows the model outputs after the IKr block.
prevents the AP from repolarizing. Moreover, the long plateau is also contributed more or less by
continuous activation of outward potassium current IKr and chloride current, IClb.
EADs EADs generation normally occurs when outward currents are reduced, or inward cur-
rents are increased or both, such that the net outward current needed to repolarize the AP is
compromised, leading to increase in APD (Qu et al. 2013, Weiss et al. 2010). Under these
conditions, any mechanism which regeneratively increases net inward current can potentially
overcome and reverse repolarization. It is known that L-type calcium current and Na/Ca ex-
change current are responsible for EADs formation. When IKr is blocked, predomination of
ICaL over the time-dependent outward currents like IKr and IClb cause the AP repolarization
to be aborted and lead the membrane potential to self-amplify (Figure 4.17a). As membrane
potential depolarizes during the EAD, ICaL slowly inactivates, and time-dependent outward
currents are further activated ((Figure 4.17b)). If ICaL remains to predominate, repolarization
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Figure 4.17: Traces of (a) action potential and the corresponding (b) ionic currents in archetypal
model of EADs. Solid line shows the model outputs under control condition and the dashed line
shows the model outputs after the IKr block.
can be altogether aborted, producing a ICaL-mediated AP upstroke that can result in a triggered
beat, or a run of triggered beats.
The second primary current that facilitates EAD occurrence is INaCa (Luo and Rudy 1994b).
Na/Ca exchanger is responsible for exchanging three sodium ions for one calcium ion from
the cytoplasm, producing an inward current. If the intracellular calcium is still elevated during
repolarization, INaCa gets larger, thereby resisting repolarization (Figure 4.17a). Nevertheless,
INaCa cannot trigger the membrane potential to depolarize itself, unless if the intracellular
calcium increases further. Since during the initial phase of EADs, ICaL increases dramatically,
it would trigger additional calcium release from the sarcoplasmic reticulum. In consequence, it
leads to an increase in INaCa (Figure 4.17b), increasing the probability of EADs generation.
A crucial caveat is that ICaL and INaCa are such highly interacting currents that it is generally
fruitless to debate which one plays a more critical role to cause EADs. The correct viewpoint
is that these two currents act synergistically to generate EADs, with their relative contributions
varying under specific conditions. Thus, targeting either current alone may suffice to prevent
EADs by suppressing their synergy.
4.5.4.7 IKr and ICaL conductances are the main determinant of APD prolongation
Earlier works by Sarkar and Sobie (2011) and Britton et al. (2013) showed that the expression
level of IKr conductance plays a significant role on APD prolongation. In order to further support
this result, we isolated a group of models that have baseline APD90 between 250–280 ms. Two
sub-groups of small ∆APD90 (< 15 ms) and large ∆APD90 (> 60 ms) were then separated and
the differences between ion conductances values were identified. For simplicity, we denote the
first model subgroup as Dsmall and the second one as Dlarge. From Figure 4.18, we can observe
81
gNaK gKr gtos gK1 gNaCa gClb gCaL gKs
0
0.5
1
1.5
2
C
on
du
ct
an
ce
 
sc
al
in
g 
fa
ct
or
100 150 200 250 300 350 400
Baseline APD90 (ms)
0
50
100
150
AP
D
90
 (m
s)
100 150 200 250 300 350 400
Baseline APD90 (ms)
0
0.5
1
Ba
se
lin
e 
C
aT
a 
(m
M
) 10
-3
Figure 4.18: Small ∆APD90 vs Large ∆APD90. Top panel: Ion conductance differences in
Dlarge (red) and Dsmall (blue). Both sub-groups of models have similar baseline APD90 between
250–280 ms. Middle panel: Distribution of baseline APD90 and ∆APD90. Bottom panel: The
corresponding calcium transient amplitude (CaTa) against baseline APD90. Data presented in
this figure is for the Shannon model population only.
that models in Dlarge have larger gKr than Dsmall. Larger gKr may contribute to larger fractioning
of IKr reduction, hence, lead to a larger APD prolonging effect.
Nevertheless, this is not strictly accurate because higher IKr may not necessarily result in
more substantial APD prolongation. As observed in Figure 4.19, two sub-groups of models with
different baseline APD90 and similar value of ∆APD90 (< 20 ms) shows a different level of
IKr conductance. For simplicity, we denote the first sub-group (models with APD90 between
180–210 ms) as Asmall and the second sub-group (models with APD90 between 270–300 ms) as
Alarge. gKr in Asmall appear to be larger than the other sub-group. Our first expectation is that
models with a larger gKr would give a larger ∆APD90. However, the effect is almost similar to
the models with a smaller gKr, contradicting our earlier observation. This confirms that larger
gKr does not always result in a more marked effect when IKr is blocked. It is possible that other
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Figure 4.19: Small APD90 vs Large APD90. Top panel: Ion conductance differences in
Alarge (red) and Asmall (blue). Both models sub-groups have ∆APD90 < 20 ms. Middle panel:
Distribution of baseline APD90 and ∆APD90. Bottom panel: The corresponding Ca transient
amplitude against baseline APD90.
than IKr conductance, level of calcium transient in the model may influence the APD prolonging
effect.
From the bottom panel of Figure 4.18 and 4.19, we can see a strong correlation between
baseline APD90 and Ca transient amplitude. Models with larger Ca transient amplitude are more
likely to have a larger ∆APD90. We conclude that in order for a model to experience significant
∆APD90, both IKr conductance and Ca transient amplitude (modulated by ICaL expression)
must be sufficiently large. If one of these criteria is not satisfied, the APD prolonging effect
would be less significant. In extreme cases like hyper-responders, we can observe that both
IKr conductance and Ca transient amplitude are larger than normal responders (see Figure 4.13
and 4.20). This offers an explanation for why no hyper-responders were observed in the model
population of TenTusscher and Ohara. The TenTusscher model has sufficiently large ICaL current
but small IKr current, whereas the Ohara model has the opposite characteristics (refer Figure
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Figure 4.20: Distributions of calcium transient amplitude in normal responders (blue) and hyper-
responders (red) of Shannon model population. The mean value of the normal responders
distribution is 5.48± 1.31× 10−4 mM and the mean value of the hyper-responders is 7.68±
1.27×10−4 mM, and the mean value locations are denoted by a triangle ( ).
AP biomarker APA (mV) RMP (mV) APD90 (ms)
Control 134.88 ± 4.02 -85.47 ± 1.23 225.89 ± 56.10
ICaL block 132.90 ± 4.22 -85.86 ± 1.2 139.24 ± 38.96
CaT biomarker CaTa (mM) CaT90 (ms)
Control (4.88 ± 1.51) x 10−4 331.93 ± 3.71
ICaL block (2.53 ± 0.62) x 10−4 324.05 ± 5.80
Table 4.4: Effects of L-type calcium block on AP and CaT biomarkers in the model population of
Shannon. (Abbreviation : APA = AP amplitude, RMP = resting membrane potential, CaTa = CaT
amplitude).
4.9a).
4.5.5 Response to L-type calcium block by nifedipine
To simulate the action of 1µM nifedipine on ventricular cells, we blocked 60% of the L-type
calcium current and then observed the AP responses. Figure 4.21 shows some examples of
simulated AP and calcium transient (CaT) traces before and after blocking the ICaL. APD was
reduced, but there were no significant change in action potential amplitude and resting membrane
potential (see also Table 4.4). Similarly, for CaT, the amplitude was reduced dramatically, but
there was a small effect on calcium duration (CaT90). In all three AP models, the majority of the
cell models in the population showed shortening in APD, in agreement with the experimental
data and earlier clinical studies (Dangman and Hoffman 1980, Go et al. 2005).
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Figure 4.21: Two examples of simulated (a) AP and their corresponding (b) Ca transient traces
obtained in control populations (solid line) and after 60% L-type calcium block (dashed line).
Figure 4.22 shows the distribution of degree of APD shortening against the baseline APD
following ICaL block, for all three action potential models. From the figure, we can observe
that the Shannon model makes a good overlap with the experimental data, in comparison to the
TenTusscher and Ohara model. All models in the population experienced APD shortening when
ICaL was reduced. Importantly, the model population exhibits a strong correlation between the
baseline APD and ∆APD, highlighting the dependence of ∆APD on its starting AP. R2 value
is 0.53 in the Shannon model and 0.2 in the cell population. The degree of APD shortening
gets large for larger baseline APD. The mean values of ∆APD between the model population of
Shannon and experimental data have an excellent agreement.
On the other hand, the TenTusscher model looks to follow a similar pattern with experimental
data. From Figure 4.22c, we can see that 75% out of TenTusscher model population have ∆APD
from -75 to 0 ms. The drug effect is slightly underestimated compared to the mean response of
the experimental data. Also, if we look closely, the model population produces a small gap at the
centre of the distribution, where most of the cells concentrated at. The Ohara model, however,
gives the poorest fit with the experimental distribution. The Ohara model population appear to
have a uniform effect on APD, following the ICaL block (R2 value is 0.067). The amount of
APD shortening falls between -60 to 0 ms, with the mean of the distribution is shifted ∼+65 ms
in the model distribution relative to experiments. We suspect this was due to low ICaL current
magnitude (refer Figure 4.9a) in Ohara model, which prevented the models from exhibiting large
∆APD.
4.5.5.1 Larger calcium transient leads to larger drug effect
We have shown that blocking L-type calcium channels lead to APD shortening. A strong linear
correlation was also displayed between baseline AP and ∆APD. We can hypothesise that models
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Figure 4.22: Scatter plot of net effect of 60% ICaL block on APD90 against baseline APD90 by
individual cell models (paired), in comparison to experimental data ( ). (a) is for the Shannon
model, (c) is for the TenTusscher model and (e) is for the Ohara model (P<0.001; paired t-test). (b,
d, f) Histograms of the distribution of ∆APD90 across the population of models, with mean value
is marked as ( ). The mean and standard deviation of ∆APD90 in each model are −86.7±39.2
ms (Shannon),−56.8±52.8 ms (TenTusscher),−21.3±8.5 ms (Ohara), compared to experiment
−87.3±41.7 ms.
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Figure 4.23: (a) Distribution of calcium transient amplitude, CaTa against baseline APD90 across
the model population of Shannon. (b) Distribution of ∆APD90 against CaTa.
with small AP may have smaller calcium transients which then prohibited the AP from having a
significant degree of ∆APD. To test our hypothesis, we measured the calcium transient amplitude
across the model population of Shannon and compared them against voltage biomarkers. This is
plotted in Figure 4.23. From the figures, we can see clearly that both baseline APD and ∆APD
have a strong linear correlation with calcium transient amplitude. Models with small APD have
smaller Ca transient, which then leads to a small ∆APD.
4.5.6 Adding noise to simulation data
All measurements are subjects to experimental errors and the observations we make are never
precisely representative of the process we think we are observing. Mathematically speaking, this
is conceptualised as,
a = â± ε, (4.8)
where a is the measured value, â is the true value and ε is the experimental noise or error. The
noise is a combined measure of the inherent variation in the phenomenon we are observing and
the numerous factors that interfere with the measurement. In cellular biology, cells with identical
genetics, even within similar tissue samples, are often observed to have different expression levels
of proteins and structures. These apparently random differences could have significant biological
and medical consequences.
Recordings of the transmembrane potential of rabbit ventricular myocytes in the experiment
are modulated by the extrinsic noise, probably due to non-constant physical environment (tem-
perature, pressure, etc). Also, the effect of channel blocks on APD (Figure 3.5a and 3.5a) was
influenced slightly by the effect of DMSO. Mathematical models, however, are too deterministic
87
50 100 150 200 250 300 350 400
Baseline APD90 (ms)
-100
-50
0
50
100
150
200
AP
D
90
 (m
s)
(a) IKr block
0 50 100 150 200 250 300 350 400
Baseline APD90 (ms)
-300
-250
-200
-150
-100
-50
0
50
100
150
AP
D
90
 (m
s)
(b) ICaL block
Figure 4.24: Scatter plot showing net effect of IKr and ICaL blocks on APD in the model
population of Shannon after adding noise (grey), in comparison to experimental data (red).
and their outputs take no account of such noise. Hence, to replicate the noise seen in experimental
measurements, we added an ‘artificial’ noise to our data using the following equation,
APDexp ≈ APDpredict = APDmodel± ε. (4.9)
We assumed that noise arises from an independent and identically distributed Gaussian noise
(X ∼N (µ, σ2)) with mean zero and σ = 20 ms. The value was chosen to compensate for
similarly estimated errors in experimental measurements. The error was resulted due to the effect
of DMSO. The DMSO is the chemical (commonly referred to as ‘vehicle’) that the drug had
to be dissolved into, so that the drug could dissolve into the cells. Hence, the effect that we
have seen in the measurements is due to the effect of the drug and DMSO, although DMSO
mostly has a negligible effect on APD with mean value 0 ms. We only introduced the noise on
the measurements of APD before and after the IKr/ICaL reduction, rather than to the entire AP
trace. The ∆APD was then measured. For this purpose, we only applied the noise on the Shannon
model population.
Figure 4.24 shows the scatter net effect of IKr and ICaL blocks on APD after including the
noise. For IKr block, we can see that the degree of APD prolongation has increased with a few
models exhibited ∆APD as large as 150 ms. This could not be achieved in the original model
population (without the noise). Also, a sub-group of models experienced APD shortening (15.9%
in the model population and 14.1% in the cell population). There is no significant correlation
shown between baseline APD and APD difference. Mean value of ∆APD in the model population
remained consistent with the model population before the addition of artificial noise (33.65 ms
vs 33.18 ms), but the range has increased from σ = 20.26 ms to σ = 34.83 ms. This value is
comparable with ∆APD shown in experiment (32.23±34.46 ms).
For ICaL block, majority of the models experienced APD shortening, as seen in Figure 4.24b.
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3.4% of the models in the population exhibited APD prolongation between 0–50 ms. The finding
is in agreement with our cell populations which 2% of them experienced APD prolongation.
Mean and standard deviation of ∆APD in model population and experiment are −87.3±48.2 ms
and −87.3±41.7 ms, respectively.
4.6 Conclusion
In this study, we have investigated the underlying effects of action potential variability on
the hERG and L-type calcium blocks. We compared closely experimental measurements and
computational modelling of rabbit/human ventricular myocytes. Three different biophysically
detailed AP models were considered in this work. They were a rabbit AP model by Shannon
et al. (2004) and two human AP models by Ten Tusscher et al. (2004) and O’Hara et al. (2011).
Population of models from randomly generated parameter sets were constructed by varying
several ionic channel conductances in the respective model. The outcome of each model in
predicting the effect of channel blocks was compared to each other and experimental data.
When constructing a population of models without experimental evidence for the extent
of variability in parameters, the choice of level of parameter variation to sample is wide open.
Our data showed that a large parameter space (0.1–2x baseline value) was required to cover
the variability level shown in the experimental measurements. We initially considered smaller
parameter ranges (±30% and ±50%), but obtained results that implied such variation levels were
insufficient to explain the experimental data (Figure 4.5b and A.1). This suggested that a larger
variation in these cell properties was needed. Moreover, an important key point in our study also
demonstrated that variation in 8 ionic currents expression and the action potentials were sufficient
to explain the data we have seen experimentally without the need of adding other biomarkers, for
example, the biomarkers from calcium transient.
In addition, our results demonstrated that a viable AP can be generated by a wide variety
of different balances of ionic currents (Figure 4.8). In an earlier work by Banyasz et al. (2011),
they showed that there exists large variation in the magnitude of ionic currents between the
guinea pig ventricular cells, with the peak of ICaL and IKs exhibited coefficient of variation (std.
dev/mean*100) approximately 45% and 70%, respectively. This variation is considerably large
as number of cells used in the study was relatively small (5–6 cells). The finding is comparable
with our own which the Shannon model population showed large variation in gCaL (35%) and
gKs (50%).
In most previously published work, calibration of a population of models was typically
performed by making sure that all relevant models fall within the ranges of data (Britton et al.
2013). For a low and limited number of experimental samples, this approach is perfectly
reasonable, with the restriction that some information inherent in the data may not be fully
captured. Therefore, we have considered the data distribution as part of the calibration criterion
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to improve the outcome of model population. We believe the calibration procedure used here is
better and allowed us to estimate the underlying distribution of outputs represented by the data.
We understand the calibration technique we used to construct the control population is quite
simplistic compared to more advanced methods such as implemented by Lawson et al. (2018),
but it was able to match the AP biomarker distributions. Our results showed that not all models
could match the experimental distribution under control condition (Figure 4.6). The baseline
Shannon model exhibited shorter AP amplitude compared to the experimental recording which
then lead to disagreement in APD30. Both the TenTusscher and Ohara models showed a good
overlap with the experimental measurements of AP biomarkers. We then demonstrated the
capacity of these model populations to predict variability in the response to drug blocking of
hERG and L-type calcium channels. Among the three models, the Shannon model exhibited the
most reliable correspondence with the experimental data, highlighting the importance of careful
model selection in computational studies. The undesirability of relying on model output alone
without recourse to experimental data was also apparent.
Our finding showed that how different models may produce different responses to IKr and
ICaL blocks. For IKr block, the degree of APD prolongation was not homogenous across the
model population. There was no strong correlation shown between drug effect and the baseline
AP. A curious feature was the sub-group of models with extreme APD prolongation (hyper-
responder), despite having the same baseline as normal responders. The reason behind this
sub-population was that these models have both large IKr and ICaL expressions which could
lead to bigger fractioning of IKr reduction, hence increase the degree of ∆APD. During IKr
block, predomination of inward current by ICaL also prohibited the membrane potential from
repolarizing, which then lead to an extreme long plateau. In addition, EADs generation was
also seen in our computational model in response to IKr block. No EADs was observed in the
experimental measurements. The explanation for this observation probably lies in the stimulation
rate used in this study; EADs were more common when cells were stimulated at low frequency
(Guo et al. 2011, Nalos et al. 2012). Interestingly, we did not see hyper-response or EADs in the
TenTusscher and Ohara model following IKr block. We suspected that these behaviours could
only be seen in Shannon model due to high ICaL and INaCa presented in the model (Figure 4.9a).
It is well known that these two ionic currents are responsible for EADs generation (Qu et al. 2013,
Weiss et al. 2010).
Contrasting the above, blockade of L-type calcium channels produced a baseline dependent
AP shortening, and our computational models (except the Ohara model) displayed a linear
correlation between baseline AP and drug effect. Models with small AP showed the smallest
amount of APD shortening, compared to large AP. The cause was that these models have smaller
calcium transients amplitude (Figure 4.23), which directly reduced the fractional shortening. In
turn, cell models with larger calcium amplitude may exhibit wider range of ∆APD.
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Part III
Analysis of a simplified model of the
cardiac action potential
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In the previous chapter, we used several complex models of cardiac action potential to study the
AP variability and effects of ion channel blocks. This model, however, is extremely complicated
due to their large parameters and variables included in the model, which may lead to parameter
unidentifiability and dissimilarity in predictions (as shown in Chapter 4), even between models of
similar cell type (Wilhelms et al. 2013). This makes the process of understanding the relationship
between models output and model parameters more complicated, suggesting a need for a simple
and robust model of cardiac action potential. In the upcoming chapters, we move from studying
realistic models of action potential to studying a simpler conceptual model.
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Chapter 5
The caricature Noble model
In this chapter, we provide a brief introduction to a simplified model of action potential and
discuss the reason for choosing this model in our work. The model is the modified version of
the caricature Noble model. We then describe the model formulations and then solve the model
as initial and boundary value problem. The exact analytical solutions are derived and validated
with numerical solutions. Next, we present the asymptotic solutions of the model, including
both fast subsystem and slow subsystem. These asymptotic solutions will be further exploited to
develop an asymptotic-numerical method in Chapter 6 and investigate the mechanism of cardiac
alternans in Chapter 7. Finally, the phase portrait of the caricature Noble model and the criteria
needed for the AP excitation are discussed. The material included in this chapter mostly follows
results previously published in the literature for the caricature Noble model. These results are
cited as appropriate within the sections below and are then applied to the modified version of the
caricature Noble model.
5.1 Introduction
Caricature Noble model is a simplified model of the electrical potential of cardiac cell membranes,
and the model is an accurate approximation of the classical cardiac Purkinje fibres model by
Noble (1962). As mentioned in Chapter 2.5, Noble (1962) model is the first cardiac action
potential model which is used as the prototype for other modern voltage-gated cardiac models.
Biktashev et al. (2008) then used the model as the starting point, due to its simple functional
forms, to construct the caricature Noble model by using a set of verifiable simplification steps.
As a result, the caricature Noble model can be considered as a detailed ionic model because
the model preserves the generic properties of cardiac excitability, such as slow repolarization,
slow subthreshold response and fast accommodation (Biktashev et al. 2008). The model is also
amenable to analytical works which allow an exact solution. The small parameters embedded in
the model has allowed the system to be reduced asymptotically that can potentially be exploited
for various purposes, for instance, derivation of action potential restitution curves and conduction
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of velocity dispersion curves. Unlike most other simplified action potential models such as
Fitzhugh-Nagumo model, Mitchell and Schaeffer model, Rogers and McCulloch model, Barkley
model and Fenton and Karma model which fail to reproduce qualitative features of a cardiac
action potential, caricature Noble model is more realistic and preserve the fundamental structures
of an action potential.
The model itself has been further used to derive asymptotic expressions for the conduction
velocity restitution in cardiac tissues (Simitev and Biktashev 2011), to elucidate the conditions for
propagation and block of excitation in the atria (Simitev and Biktashev 2006), to understand the
formation of excitation waves (Bezekci et al. 2015) and to study cellular alternans (Asgari-Targhi
2017). In line with those compelling results, we want to extend the analysis of this model by
utilizing the model for various applications and analytical works.
5.2 Model formulation
The authentic caricature Noble model was formulated by Biktashev et al. (2008). The model
includes three state variables, the transmembrane voltage potential E(t), and the two gating
variables h(t) and n(t) describing the inactivation of the fast inward and slow outward currents,
respectively, coupled by the non-linear ordinary differential equations. The model equations are,
dE
dt
=− (INa + IK + Ileak) (5.1a)
dh
dt
=
1
ε1ε2
Fh ·
[
H(E†−E)−h
]
, (5.1b)
dn
dt
=Fn(E) ·
[
H(E−E†)−n
]
, (5.1c)
where H(.) is the Heaviside step function. h(t) and n(t) represent the closing and opening of the
respective ion channels and ranging between 0 and 1. The caricature Noble model incorporates
three different ionic currents which were formulated from Hodgkin-Huxley model. The ionic
currents are sodium current, potassium current and a leak current which are formulated as follows,
INa =−
1
ε1ε2
GNa · (ENa−E) ·H(E−E∗) ·h, (5.2a)
IK =−
g2(E) ·n4
ε2
, (5.2b)
Ileak =−
G(E)
ε2
. (5.2c)
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In the thesis (Chapter 5–7), we consider a modified version of caricature Noble model where the
fourth order of variable n in equation (5.2b) is replaced by linear term in n as follows,
n4→ n. (5.3)
The linearity is introduced in order to obtain a model with simpler analytical solutions. While the
replacement of n4 by n1 is an arbitrary step, we will demonstrate that for appropriately selected
parameter values the modified caricature Noble model behaves similarly to the original caricature
Noble model. The parameter values used in the model remain similar as listed in Table 5.1. The
other functions in the model are formulated as below,
g2(E) = g21 H(E†−E)+g22 H(E−E†),
E2 = (k1/k2 +1)E†−E1k1/k2,
E3 = (k2/k3 +1)E∗−E2k2/k3,
Fn(E) = fn
[
r H(E†−E)+H(E−E†)
]
,
(5.4)
G(E) =

k1(E1−E), E ∈ (−∞,E†),
k2(E−E2), E ∈ [E†,E∗),
k3(E3−E), E ∈ [E∗,+∞).
In addition, we provide a CellML code (is available on GitHub1) of the model which can be
readily employed within various simulation tools.
5.3 Exact solutions
5.3.1 Solution of the initial value problem
It is possible to find an exact analytical solution of the modified caricature Noble model following
the method of Biktashev et al. (2008) used for the original caricature Noble model. The equations
(5.1b) and (5.1c) in the model are separable and fairly simple to be solved. The solutions of these
two ordinary differential equations (ODEs) are then substituted into the voltage equation (5.1a)
and it becomes a first order linear ODE. Consider the following initial conditions for respective
variables,
E(0) = Estim > E∗, h(0) = h0, n(0) = n0, (5.5)
and natural continuity conditions at the ends of the three intervals separated by E† and E∗. The
exact analytical solutions of the system (5.1) can be formulated as follows,
1https://github.com/hifzhudin/CaricNobleModel
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Parameters Default
ε1 (dimensionless) 1.0
ε2 (dimensionless) 1.0
GNa (mS/µF) 100/3
ENa (mV) 40.0
E† (mV) -80.0
E∗ (mV) -15.0
k1 (dimensionless) 0.075
k2 (dimensionless) 0.04
k3 (dimensionless) 0.10
E1 (mV) -280/3
fn (dimensionless) 0.0037
Fh (dimensionless) 0.5
g21 (mS/µF) -2.0
g22 (mS/µF) -4.0
r (dimensionless) 1.0
Table 5.1: Parameter values used in the modified caricature Noble model.
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Figure 5.1: The exact analytical solutions (solid line) derived in (5.6) in comparison to numerical
solutions (dotted line) for t ∈ [0, 600]. For numerical solutions, the model was solved using
explicit Euler scheme with time step 0.005. The red, blue and green line correspond to variable
E, h and n, respectively. The initial conditions used were E(0) =−10, h(0) = 1 and n(0) = 0.
Parameter values used are as listed in Table 5.1.
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n(t) =

1
n(t) = 1− (1−n0)exp(− fnt), t ∈ [0, t†]
2
n(t) =
(
1− (1−n0)exp(− fnt†)
)
exp
(
fnr(t†− t)
)
, t ∈ [t†,∞]
(5.6a)
h(t) =

1
h(t) = h0 exp
(
−Fht/(ε1ε2)
)
, t ∈ [0, t†]
2
h(t) = 1− (exp(Fht†/(ε1ε2))−h0)exp(−Fht/(ε1ε2)), t ∈ [t†,∞]
(5.6b)
E(t) =

1
E(t) = exp
[
GNah0
Fh
exp
(
− Fh
ε1ε2
t
)
− k3
ε2
t
]
×
{
E0 exp
(
− GNah0
Fh
)
−(k3E3 +g22)u(ε1k3, t)+g22(1−n0)u(k3ε1− fnε1ε2, t)
−GNaENah0
ε1
u(ε1k3−Fh, t)
}
, t ∈ [0, t∗]
2
E(t) = w(t)+ [E∗−w(t∗)]exp
(
(t− t∗)k2ε2
)
, t ∈ [t∗, t†]
3
E(t) = v(t)+ [E†− v(t†)]exp
(
k1
ε2
(t†− t)
)
t ∈ [t†,∞]
(5.6c)
where
u(κ, t) =
ε1
Fh
(GNah0
Fh
)−κ/Fh[
Γ
(
− κ
Fh
,
GNah0
Fh
)
−Γ
(
− κ
Fh
,
GNah0
Fh
exp
(
− Fh
ε1ε2
t
))]
, (5.7a)
w(λ ) = E2−
g22
k2
+
g22(1−n0)
k2 + ε2 fn
exp(− fnλ ), (5.7b)
v(λ ) = E1 +
g21(1− (1−n0)exp(− fnt†))
k1− ε2 fnr
exp( fnr(t†−λ )), (5.7c)
and Γ(a,z) is the upper incomplete gamma function,
Γ(a,z) =
∫
∞
z
e−xxa−1dx, (5.8)
for Re(z) > 0 as defined in Abramowitz and Stegun (1965). The comparison between exact
analytical and numerical solutions are shown in Figure 5.1. From the Figure, we can see a
good overlap between analytical and numerical solutions, indicating the accuracy of the derived
analytical solutions. In comparison to the solutions of authentic caricature Noble model, the
solutions derived using the modified model is shorter. In particular, a few terms in the solution
of
1
E(t) are eliminated because of the linearity in the n variable. The solutions of h and n are
remained similar.
Similar approach can also be used to obtain the solutions for different AP responses i.e. for
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slow over-threshold and sub-threshold responses. The slow over-threshold response is the case
when the initial value of the voltage is larger than the threshold value of the slow-system (5.16)
but smaller than E∗ such that E2 < Estim < E∗. The AP evolution described using the slow-system
is without the fast upstroke as the sodium current modulated by h−gating is not activated. The
latter response is when the initial value of E is smaller than the threshold value of the slow-system
(5.16) i.e. Estim < E2. In this case, the voltage will just decays towards its global equilibrium.
The analytical solutions for these two responses using the original caricature Noble model can be
found in Asgari-Targhi (2017).
5.3.2 Solution of the boundary value problem
Next, we derive the solution of the boundary value problem (BVP) for the modified caricature
Noble model. The BVP is relevant in cases when we model periodic solutions excited by a
periodic stimulus train. This generates a continuous identical AP waveform when the model is
excited because the initial conditions for each variable are not changed throughout the stimulation
period. In this case, we set the boundary conditions as follows,
E(0) = E(t = B) = Estim > E∗, h(0) = h(t = B), n(0) = n(t = B), (5.9)
where B is the basic cycle length. Solutions of the BVP for the original caricature Noble model
are given in Asgari-Targhi (2017). Here we follow the same procedure to derive the corresponding
solutions for the modified model. By imposing the above boundary conditions (5.9), the particular
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Figure 5.2: The exact analytical solutions (solid line) derived in (5.10) in comparison to numerical
solutions (dotted line) for B = 700 ms. The red, blue and green line correspond to variable E, h
and n, respectively. Parameter values used are as listed in Table 5.1
solutions are as follows,
n(t) =

1
n(t) = 1−C1 exp(− fnt), t ∈ [0, t†]
2
n(t) =
(
1−C1 exp(− fnt†)
)
exp
(
fnr(t†− t)
)
, t ∈ [t†,∞]
(5.10a)
h(t) =

1
h(t) = D1 exp
(
−Fht/(ε1ε2)
)
, t ∈ [0, t†]
2
h(t) = 1−
(
exp(Fht†/(ε1ε2))−D1
)
exp(−Fht/(ε1ε2)), t ∈ [t†,∞]
(5.10b)
E(t) =

1
E(t) = exp
[
GNaD1
Fh
exp
(
− Fh
ε1ε2
t
)
− k3
ε2
t
]
×
{
E0 exp
(
− GNaD1
Fh
)
−(k3E3 +g22)u(ε1k3, t)+g22C1u(k3ε1− fnε1ε2, t)
−GNaENaD1
ε1
u(ε1k3−Fh, t)
}
, t ∈ [0, t∗]
2
E(t) = w(t)+ [E∗−w(t∗)]exp
(
(t− t∗)k2ε2
)
, t ∈ [t∗, t†]
3
E(t) = v(t)+ [E†− v(t†)]exp
(
k1
ε2
(t†− t)
)
t ∈ [t†,∞]
(5.10c)
where
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C1 =
(
1− exp
(
fnr(t†−B)
))
/
(
1− exp
(
(− fnt†)− fnr(B− t†)
))
, (5.11a)
D1 =
(
1− exp
(Fh(t†−B)
ε1ε2
))
/
(
1− exp
(−FhB
ε1ε2
))
, (5.11b)
u(κ, t)≡ ε1
Fh
(
GNaD1
Fh
) κ
Fh
[
Γ
(
− κ
Fh
,
GNaD1
Fh
)
−Γ
(
− κ
Fh
,
GNaD1
Fh
exp
(
− Fht
ε1ε2
))]
,
(5.11c)
w(λ ) = E2−
g22
k2
+
g22C1
k2 + ε2 fn
exp(− fnλ ), (5.11d)
v(λ ) = E1 +
g21(1−C1 exp(− fnt†))
k1− ε2 fnr
exp( fnr(t†−λ )). (5.11e)
We now have the exact solutions of the equations (5.1) as a function of B. The solutions are
plotted in Figure 5.2 for B = 700 ms and they are compared with numerical solutions. For the
numerical solutions, the modified caricature Noble model was solved using ‘dsolve’ command in
Maple 18 with the numeric option for the ODE system boundary value problem. Notice that the
gating variables reach its initial value after one basic cycle length. If another AP is excited, then
a similar AP waveform will be produced as the initial values of the gating variables are as same
as the previous one.
5.4 Asymptotic solutions
Taking the limit of ε1, ε2 → 0+, the modified caricature Noble model can be dissected into
asymptotically reduced systems, which then provide much insight into the dynamics of the full
model. The derivation of the asymptotic solutions of this model are explained in the following
subsections. The method used to derive the asymptotic solutions is similar as published in
Biktashev et al. (2008).
5.4.1 Superfast-time system
We assume that our original system has a multiple timescales and consider a ‘super-fast’ timescale
T which is T = t/(ε1ε2). The time t is stretched into super-fast timescale T as the ε1→ 0. From
the chain rule of differential equation, we have
d
dt
=
1
ε1 ε2
d
dT
. (5.12)
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Substitute the above expression into (5.1) and taking the limit of ε1→ 0, we obtain the essential
dynamical variables of E and h,
dE
dT
= GNa (ENa−E)H(E−E∗)h, (5.13a)
dh
dT
= Fh
(
H(E†−E)−h
)
. (5.13b)
n is reduced to dn/dT = 0. This system describes the fast upstroke of the action potential.
Solving the above system (5.13), we can derive the explicit asymptotic solutions for this stage
which are,
E = ENa− (ENa−E0)exp
(
GNa
Fh
(e−FhT −1)
)
, (5.14a)
h = exp−FhT , (5.14b)
where E0 = Estim is the initial condition for variable E. The maximal overshoot voltage, Emax is
obtained as the fast time T goes to infinity,
Emax = E∞ = lim
T→∞
E(T ) = ENa− (ENa−E0)exp
(
− GNa
Fh
)
. (5.15a)
Since exp(−GNa/Fh) ≈ 10−29, the maximal overshoot volage Emax is extremely close to ENa.
The h(T ) = 0 as T tends to infinity.
5.4.2 Slow-time system
The slow-time system is obtained by directly taking the limit of ε1→ 0 in (5.1). By doing this,
we have h(t) = H(E†−E). Substituting this into equation (5.1a) will eliminate the first term and
left us with a reduced system as following,
dE
dt
=
1
ε2
(
g2(E)n+G(E)
)
, (5.16a)
dn
dt
= Fn(E)
(
H(E−E†)−n
)
. (5.16b)
This system describes the post-overshoot drop, plateau and recovery stages of the action potential.
The slow-time system can be further asymptotically split into two systems discussed below.
5.4.2.1 Fast-slow-time subsystem
Consider the ‘fast-slow’ timescale t ∼ ε2, or equivalently τ ∼ (ε2)−1, which is τ = t/ε2. The
time t is stretched into fast-slow timescale τ as the ε2→ 0. Using the chain rule of differential
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equation as previous, we obtain,
d
dt
=
1
ε2
d
dτ
. (5.17)
We then substitute the expression into (5.16) and take the limit of ε2→ 0 to yield,
dE
dτ
= g2(E)n+G(E), (5.18a)
dn
dτ
= 0. (5.18b)
The system above describes the post-overshoot drop and the repolarisation stages of the action
potential.
5.4.2.2 Slow-slow-time subsystem
The slow-slow time subsystem is obtained directly from equations (5.16) by taking the limit of
ε2→ 0. The system is described below,
0 = g2(E)n+G(E), (5.19a)
dn
dt
= Fn(E)
(
H(E−E†)−n
)
. (5.19b)
This system describes the plateau and the recovery stages of the action potential. We will further
extend the results of these asymptotic structures to develop a robust asymptotic-numerical method
(Chapter 7) and to understand the mechanism of cardiac alternans (Chapter 8), respectively.
5.5 Phase plane analysis
Phase plane analysis is closely related to the asymptotic analysis we discussed above. It is a
graphical tool for visualising how the solutions of a given system of differential equations would
behave in the long run with respect to a set of initial conditions. The phase plane can help us to
provide several important pieces of information such as
• providing motion trajectories corresponding to various initial conditions,
• examining the qualitative features of the trajectories,
• checking the stability of the equilibrium points of the system.
In addition, one can also explore the behaviour of a nonlinear system from various initial
conditions without the need of solving the equations analytically. However, the phase plane
method is most easily applicable to the second-order system as for higher-order the graphical
representation can be computationally and geometrically complex.
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Figure 5.3: The phase portrait of the (a) fast-time subsystem and the (b) slow-time subsystem of
modified caricature Noble model. Blue dashed line is the nullcline of h(t) in (a) and n(t) in (b).
The solid red lines and the cross-hatched region in (a) and (b) are the nullclines of E(t). Dotted
black lines with attached arrows are the trajectories. Dotted green line is the corresponding action
potential. The black dot point in (b) is the equilibrium point of the slow subsystem. Abbreviation
: Edag = E†.
Consider a first order vector-matrix system, x′ = f(x(t)), x ∈ℜ2, for each initial condition,
x0 = (x0,y0) there corresponds a unique solution x(t) = (x(t),y(t)), represented a parametric
curve in xy-plane.The parametric curve is called a trajectory of the system. In order to understand
how the trajectories behave in a phase plane, we need to construct the nullclines. The nullcline
is a set of points in the phase plane such that dx/dt = 0. Algebraically, we find the nullcline by
solving f(x(t)) = 0 and the intersections between the nullclines on a xy-plane are the equilibrium
points. A point is called an equilibrium point of the system when the solutions are not changing
and they stay in their initial state forever.
5.5.1 Phase plane of modified caricature Noble model
To explain the phase plane of modified caricature Noble model, we follow the analysis published
in Biktashev et al. (2008) and Simitev and Biktashev (2011). We use the fast and slow-time
asymptotic presented in the previous section. We first find the nullclines of the fast-time system,
by setting the equations (5.13a) and (5.13b) to dE/dT = 0 and dh/dt = 0, respectively. Solving
the right hand side of these equations, we have the nullclines of the fast-time subsystem as below,
H(E−E∗) = 0, E = ENa, h = 0, and h = H(E†−E). (5.20)
These nullclines are plotted in Figure 5.3a. The cross hatched regions in the figure separates
the excitation threshold of the system. The excitation of the action potential depends on the
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threshold value of the system, where in our model is represented by the E∗. If Estim ≥ E∗, then
the super-fast subsystem is activated and generating the fast upstroke as shown in Figure 5.3a.
If the Estim is smaller than the threshold value, the action potential either follows the slow-time
subsystem (without upstroke) or decays back to its resting membrane potential. Note that the
fast-time subsystem only determines the steep upstroke, not the duration of APs.
The phase portrait of the slow subsystem (5.16) can be observed in Figure 5.3b. The nullclines
of the subsystem are obtained by following similar approach as explained before and we have,
E =
g22
k3
n+E3, E =−
g22
k2
n+E2, E =
g21
k1
n+E1, and n = H(E−E†). (5.21)
The E-nullclines can be divided into two parts; the ‘systolic’ and ‘diastolic’ branch. The ‘systolic’
branches are represented by the first two nullclines between E ∈ [E2,E3] and the ‘diastolic’
branch is described by the third nullcline of E when E ∈ (−∞,E1]. The equilibrium point of the
subsystem is the solution of the intersection between E and n nullclines. From our analysis, we
find that these two nullclines intersect at (E,n) = (E1,0). This is indicated by black dot in Figure
5.3b. From the figure, the super-slow gating variable n takes the maximal value at
n∗ = k2(E2−E∗)/g22, (5.22)
which is when E = E∗. This consideration determines the excitability properties of the slow-time
system (5.16). As shown in Figure 5.3b, if Estim is larger than E2, the trajectory will be repelled
by the lower systolic branch and attracted by the upper one, and thus making a large excursion.
The trajectory moves along the diastolic branch to the equilibrium point and stops there, unless
another external stimulus is applied, hence repeats the whole cycle. If Estim is smaller than E2,
the trajectory will just decay back to its equilibrium point and no AP is generated. In addition,
the generation of AP also depends on nthr and it can only be excited if it satisfies the following
threshold,
n(t = 0)< nthr =

0, Estim < E2,
k2(E2−Estim)
g22
= n∗
E2−Estim
E2−E∗ , Estim ∈ [E2,E∗),
n∗, Estim > E∗,
(5.23)
such that nthr ∈ [0, n∗). nthr in the second equation is obtained by replacing the equation with g22
in (5.22).
5.6 Conclusion
In this chapter, we have introduced a simplified model of cardiac action potential, the so-called
‘modified Caricature Noble model’ following closely the methods of Biktashev et al. (2008)
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and Simitev and Biktashev (2011). The original model was modified where the fourth order of
variable n in equation (5.2b) was replaced by linear term in n. The entire right hand side of the
voltage equation is now piecewise-linear and so easier to solve and analyse. The model has three
variables and includes two essential ionic currents which are sodium and potassium currents.
Due to its simplicity, the model could be solved analytically. We derived the exact analytical
solutions of the model, using both the initial value problem and boundary value problem. This is
practically impossible with detailed action potential model due to large parameters and variables
presented in the model.
Also, we derived the asymptotic solutions of the model based on its timescale. In Chapter
7 and 8, we will use the solutions to construct an efficient numerical method and study the
mechanisms of cardiac alternans, respectively. We ended the chapter by explaining the phase
portrait of the fast-time subsystem and slow time subsystem of the modified caricature Noble
model. The excitation threshold of an action potential was also discussed. From this chapter,
we can see that the model offers several advantages, in terms of theoretical perspective and
computational tractability. It can also replace other more complicated action potential models
due to its simplicity. In the next chapter, we aim to propose the model as a generic model of
action potential by fitting the model to several complex models.
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Chapter 6
Estimation of parameters in models of
single-cell cardiac action potential
6.1 Introduction
Advances in experimental techniques have driven to a proliferation of mathematical models of
single-cell cardiac electrophysiology. Models exist for various types of cardiac cells, for various
species as well as for cells in various stages of physiological remodelling. A number of excellent
review articles have been published to summarise state of the art in the field (Clayton 2001, Fenton
and Cherry 2008, Noble et al. 2012). Many of the models are available in curated electronic
form (CellML 1998) along with simulation tools (Clerx et al. 2016, McFarlane and Biktasheva
2008, Mirams et al. 2013) to mention but a few. However, detailed cardiac models have a set of
well-known drawbacks. The main one is uncertainty in model structure and parameter values
(non-uniqueness, redundancy), which means that very few models, if any at all, can be used
without adjustment on data other than the data on which their parameter values have been fitted.
The limitation is due to several factors, for instance, biological variability from preparation to
preparation, experiment/data-specific, non-reproducible and parameters estimated by fitting to
different species. Further disadvantages of those models include computationally expensive
(Clayton et al. 2011), difficult for conceptual understanding and causal inference.
It is, therefore, necessary to obtain simplified mathematical models which can aid conceptual
understanding and causal inference. Some of the properties of such model are sufficiently simple
mathematical form, consist a small number of parameters, can be easily fitted to reproduce a wide
range of experimental data and including patient-specific data, amenable to further mathematical
simplification and interpretation, and lastly, computationally inexpensive in both single-cell and
tissue configurations. A number of simplified models have been proposed to address this need
(Nickerson and Hunter 2010), and most have become very popular and frequently used, for
example, Aliev and Panfilov (1996) and Mitchell and Schaeffer (2003). Some bear no relation to
experimental data and actual cardiac electrophysiology (Barkley 1991, FitzHugh 1961, Tonnelier
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2002). Others have been formulated specifically with cardiac applications in mind (Fenton and
Karma 1998). These models also have drawbacks. For example, Fitzhugh-Nagumo model was
lacking important cardiac properties, including a realistic APD restitution curve and failed to
reproduce some qualitative features of an action potential. Meanwhile, Fenton-Karma model was
used to study arrhythmia, but it could not reproduce a proper action potential waveform.
With this motivation, we use the modified caricature Noble model with the aim of finding
estimates for the values of its parameters such that the model would replicate the behaviour of
state-of-the-art models of ventricular and atrial excitation. The modified caricature Noble model
is fitted to the following biophysically detailed models such as the authentic Noble (1962) model
of Purkinje fibres, the human ventricular model of Luo and Rudy (1991) and the human atrial
model of Courtemanche et al. (1998). We also fit the model to experimental measurements of
healthy and failing rabbit ventricular myocytes (McIntosh et al. 2000). The action potential
morphology and the action potential duration (APD) restitution curves are reproduced to capture
the important characteristics of the ionic model. Fitting qualitatively different models to a
common mathematical structure offers a number of advantages for their use and interpretation as
well essential differences can be identified.
The parameter estimation is done using robust ‘out-of-the-box’ tools widely available within
popular numerical libraries such as MATLAB, NAG, Numpy. We implement a simple parameter
estimation method, the so-called ‘Nelder-Mead simplex method’ (Nelder and Mead 1965) in our
fitting algorithm. In general, the study aims to demonstrate a simple out of the box parameter
estimation methods and propose a simple, intuitive model with analytical solutions. We begin
this chapter by introducing some mathematical tools which will be used in our work. Using
the modified caricature Noble model, we carry out a simple parameter sensitivity test on every
parameter in the model and observe their effects on action potential characteristics. Then, we
explain the method of parameter estimation and the fitting protocols used in this work. The fitting
results on various biophysically detailed action potential models and experimental AP recordings
are discussed in the following section. Finally, we end the chapter with a conclusion.
6.2 Methods
6.2.1 Parameter selection and sensitivity analysis
Optimisation process is computationally expensive and time-consuming as the process depends
on the number of parameters that we want to estimate in the model. Large parameter number
could increase the parameter space, which would then add complexity in fitting algorithm to
search the optimised values. Hence, to avoid this computational challenge, one needs to identify
which parameters require optimisation. In several of earlier works, model ionic conductances
were chosen as the main components due to a huge number of parameters existed in the model
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Figure 6.1: Sensitivity analysis test for every parameter in the modified caricature Noble model.
Each parameter was perturbed for ±20% from its baseline value and the model was paced at 600
ms. The solid red line is the action potential with parameter values given in Table 6.2, the dashed
blue line is the action potential with −20% perturbation and the dotted cyan line is the action
potential with +20% perturbation. Abbreviation : Edag = E†.
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(Groenendaal et al. 2015, Sarkar and Sobie 2010, Syed et al. 2005). Meanwhile, some have
included all parameters in the model that define membrane current amplitudes and kinetics in their
fitting algorithm (Cairns et al. 2017, Dokos and Lovell 2004, Guo et al. 2013). Technically, the
choice of fitting parameters is based on the importance of the particular parameter in influencing
the AP characteristics. Although this is less of a burden for a simplified model due to the small
parameter number present in the model.
Hence, to understand the influence of each parameter in the modified caricature Noble model
to AP morphology, we performed a simple parameter sensitivity test on every parameter in the
model. Each parameter was perturbed for ±20%, and any changes to action potential were
recorded. This is depicted in Figure 6.1. From the Figure, it shows that some parameters are very
sensitive to perturbation, and some have a small effect on the action potential morphology. We
summarise the parameter sensitivity analysis and the effect of parameter changes in Table 6.1.
From the table, we can see that particular parameter influences the specific region of AP feature.
For example, the maximal voltage is controlled by ENa and the resting membrane potential is
influenced by E1 only. Some of them even influence more than a single property of the action
potential. For instance, E∗, E†, g22 and fn control the action potential repolarisation, but E∗ and
E† also contribute to the AP plateau.
To understand the effect of parameter perturbation on action potential morphology, we discuss
and relate the change in parameter values with the phase portrait of the model (Figure 5.3). We
only discuss for several parameters. First and foremost, we begin with the ENa that modulates
the AP amplitude. In the system, increasing the value of ENa could shift the E-nullcline (5.20)
up (as shown by the top red line in Figure 5.3a), hence, increase the duration of the AP to reach
maximum excitation. E† controls the transition point between inactivation and activation of
super-fast h variable (refer to the blue dashed line in Figure 5.3a). When the value is decreased,
the transition point is also delayed. In consequence, the voltage stays on the E-nullcline (the left
red line in Figure 5.3a) a little bit longer before the transition begins, thus, prolonged the APD.
E1 is the equilibrium point of the system, which directly controls the resting membrane potential
of caricature Noble model. Changing the value will alter the steady-state of the model. Other
parameters like g22, k2 and k3 control the intersection point of two E-nullclines (two upper solid
red lines in Figure 5.3b) as these parameters directly govern the equations of E-nullcline (5.21).
This intersection point is the point where AP begins to shift from plateau to repolarisation state.
Altering any of the values will shift the intersection point to another point, which then affects
the action potential duration. In addition, ε1 and GNa control the steepness of the front which is
already very steep so not much effect is seen visually. ε2 controls the steepness of the front and
the back of the AP in the secondary slow-fast subsystem. While this effect is dominated by much
faster sodium current in the front, it is visible in the APD variation in the back.
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AP features Parameters
Upstroke ENa
Post-drop repolarisation k3
Plateau E∗,E†,E1,k2,k3
Repolarisation/APD ε2, fn,g22,k1,k2,E1,E∗,E†,r
Resting membrane potential E1
Table 6.1: Summary of parameter effects on the important AP features of modified caricature
Noble model.
6.2.2 Method of parameter estimation
One of the primary challenges of complex computational models is the large number of free
parameters that must be determined. How best to fit these parameters to the targeted data has
been the subject of numerous investigations (Dokos and Lovell 2004, Guo et al. 2013). To
date, there have been various parameter estimation methods applied for cardiac action potential
models including maximum-likelihood estimation (Milescu et al. 2005), principal-axis fitting
(Vandenberg and Bezanilla 1991), genetic algorithms (Kaur et al. 2014, Syed et al. 2005, Tomek
et al. 2019), and the widely used empirical ‘hand-tuning’ of free parameters (Baranauskas and
Martina 2006, Mickus et al. 1999), whereby parameters were tweaked incrementally to achieve a
qualitatively acceptable fit to the data, as defined by the modellers. The empirical adjustment
technique depends primarily on operator intuition, developed through analysis and interpretation
of many data sets. It is subjective, functionally slow, and does not satisfy the increasingly stringent
requirements for robustness and reproducibility.
In contrast to hand fitting, automatic parameter optimisation procedures can survey a much
larger parameter space, determine quantitatively best fits to multiple voltage-clamp datasets
simultaneously, are reproducible, relatively easy to implement, and if given the right constraints
on the optimisation criteria can achieve a physiologically relevant parameter set. For both
automatic and ‘manual’ optimisation, it is not always possible to definitively identify a unique
global minimum; multiple local minima may be identified that correspond to a parameter set that
‘fits’ the data with sufficiently meaningful precision. The parameter estimation method that has
been applied in our work is based on a standard MATLAB routine for unconstrained multivariable
function. The toolbox is an implementation of bounded Nelder-Mead simplex method of Lagarias
et al. (1998) that minimises the real-valued function f (x) where x ∈ R, without the need of
looking the derivative (Nelder and Mead 1965). In our optimisation process, we implemented
the modified MATLAB function ‘fminsearchbnd’. The MATLAB code can be downloaded from
the provided link1. Our preliminary finding using other parameter estimation methods such as
genetic algorithm and Bayesian optimization produced a large fitting error when the AP was
fitted, in comparison to the Nelder-Mead simplex method. We could not find the reason of this
1https://uk.mathworks.com/matlabcentral/fileexchange/
8277-fminsearchbnd-fminsearchcon
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discrepancy and this is a direction for further research.
The parameter estimation method implemented in this work is straightforward and relatively
robust, despite its several limitations. One of them is that it does not guarantee convergence
to a global minimum. The routine might stop at a particular local minimum which is far
from the optimised parameter values. If this happens, the initial guess needs to be changed.
Latin hypercube sampling method (as discussed in Chapter 4) can be used to generate many
random parameter combinations of initial guess and cover the specified region space uniformly.
Furthermore, we also find that this method has an acceptable runtime, even though it has been
reported earlier by Moreno et al. (2016) that this method is computationally expensive. In our
work, a single fitting of AP waveform (refer to the middle panel in Figure 6.2) in the Luo-Rudy
model took approximately 40-50 minutes. This simulation was carried out for six parameters,
and convergence tolerance set up to 10−4. From our experience, we find that the robustness and
computational cost of optimisation method may vary as it mainly depends on many factors like
the number of parameters used, the closeness of the initial guess with respect to a local minimum,
size of convergence tolerance, the complexity of the model and fitting protocols. Nevertheless,
the runtime is not our priority here, as the main objective is to fit the AP morphology. If that is
the case, one needs to consider the implementation of a more robust optimisation method, see
(Cairns et al. 2017, Kirkpatrick et al. 1983, Rios and Sahinidis 2013, Syed et al. 2005).
In conclusion, the toolbox and method applied here are reasonably simple and easy to
understand, and it is sufficiently accurate for other purposes. We also provide the MATLAB
codes of our fitting work in the appendix for the benefit of others.
6.2.3 Fitting protocols
6.2.3.1 Data used
To avoid a highly computational cost, a single AP fitting at particular pacing cycle length was
considered (Dokos and Lovell 2004, Guo et al. 2013, Syed et al. 2005). We fitted our model
to both experimental and model-generated data by considering the voltage output only. For
model-generated data, the AP was paced for 11 beats at basic cycle length 1500 ms to produce
the most stable AP waveform. The last AP then was extracted for fitting purpose. The voltage
transient was discretised in as a set of ordered pairs {(ti,Vi)} where i = 1...M. The trace was also
simulated with equally time points of 0.1 ms to ensure there was enough coverage in the region
where the signals exhibited high variance. All model codes were downloaded from the CellML
model repository, and the model equations were solved using the MATLAB function ode15s with
relative and absolute tolerances at 10−6, respectively.
For experimental data, we used the voltage data of rabbit ventricular myocytes from McIntosh
et al. (2000) for both healthy and heart failure conditions. The data was extracted from the
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published manuscript using the WebPlotDigitizer software2. To increase the resolution of the
voltage data, we interpolated the data (using MATLAB function interp1) by adding more points
over the entire AP duration with time step 0.05 ms.
6.2.3.2 Fitness function
In order to produce the optimal fitting result, we considered multiple fitness functions (Cairns
et al. 2017, Guo et al. 2013), giving priority to minimisation of the curve error and also the action
potential duration. In the optimisation routine, our main objective was to minimise the following
total error function,
Etotal = EAP +EAPD90. (6.1)
In particular, the functions error are defined as below,
EAP =
1
M
M
∑
i=1
|V simi −V
target
i |
|V targeti |
, (6.2)
and
EAPD90 =
|APDsim90 −APD
target
90 |
|APDtarget90 |
(6.3)
where V simi and V
target
i are the voltage values of our model and the target data respectively. APD
sim
90
and APDtarget90 are the APD90 of respective models. The second error function allows the fitting
algorithm to prioritise the APD90 when optimising the AP morphology.
6.2.3.3 Restitution curves
APD restitution curve plays an important role in describing the dynamics of an action potential
when the pacing rate is varied. In this work, we only consider the dynamic pacing method. The
protocol is started by pacing the myocyte at a steady-state pacing rate for 11 beats until the AP is
adequately equilibrated, then the action potential duration, APD90 of the last action potential is
measured. APD90 is measured approximately at 90% of the AP repolarisation. Next, the pacing
rate is shortened, and the procedure is repeated. However, since the aim of the study was only
fitting the AP shape at normal condition, the alternans behaviour was not considered. The APD
restitution curve is constructed by plotting the APD90 values against basic cycle lengths (BCL).
6.2.3.4 Simulation workflow
The simulation starts by optimising the AP morphology of the model with some values of initial
guess. The potential parameters to be estimated were chosen from the sensitivity analysis in
the previous section. Once the fitting routine was finished, we directly used the new estimated
2https://automeris.io/WebPlotDigitizer/
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Figure 6.2: The AP morphologies of the respective models after fitting process. Each model was
paced at basic cycle length of 1500 ms.
parameters to generate the APD restitution curves as described above. The relative mean error of
the APD restitution curves between the caricature and targeted models was then measured using
the following formula,
EAPDcurve =
1
W
W
∑
i=1
|APD90simi −APD90
target
i |
|APD90targeti |
, (6.4)
where the APD90simi and APD90
target
i are the APD90 of the respective models at a particular
BCL. BCLi was increased from BCL1 = 400 to BCLW = 2000 ms with an increment of 100 ms.
If the EAPDcurve was still large, the initial guess was changed and the entire process was repeated
until we found the most acceptable fitting results.
6.3 Fitting to action potential models
In this section, we show the results of the parameter estimation method that we have carried
out on several cardiac AP models. The models selected are ranging from various parts of the
heart which are Purkinje model by Noble (1962), atrial model by Courtemanche et al. (1998) and
ventricular model by Luo and Rudy (1991). We demonstrate that our modified caricature Noble
model is generic enough to reproduce the AP characteristics of various models.
6.3.1 Fitting to a single action potential
A single pacing period of 1500 ms was considered to fit the AP morphology using the fitting
protocols as described before. The new estimated parameter values obtained after parameter
estimation process are listed in Table 6.2. This is an optimisation problem in high-dimensional
parameter space, with presumably many local minima. Therefore, it is difficult to ascertain if a
given solution of the minimisation procedure is the best possible one. The results of the fitting
are shown in Figure 6.2. As one can see, the modified caricature Noble model is able to capture
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all the AP morphologies of various ionic models with reasonable error values. The mean relative
errors of AP morphology for the respective fitting results are listed in Table 6.3.
From the table and right panel of Figure 6.2, it shows that the fitting of modified caricature
Noble model to the Courtemanche model has the biggest discrepancy. The discrepancies can
be seen at the post overshoot drop and plateau regions. Our model fails to capture the deep
notch produced in the Courtemanche model. This suggests that either the fitting algorithm does
not settle into the part of parameter space that would reproduce the deep notch or that model
formulation itself is not flexible enough to match the feature. We suspect that it is the latter,
as the model lacks specific ionic currents that could create the notch phase which is produced
by the activation of transient outward K+ and Na+/Ca2+ exchanger currents (Santana et al.
2010). Penaranda et al. (2012) has shown that incorporating the fast transient outward current can
reproduce the characteristic notch in phase 1 of the AP. Meanwhile, for the Luo-Rudy model, the
modified caricature Noble model is not able to accurately fit the AP at repolarisation stage. The
membrane potential in our model drops faster and quicker than the Luo-Rudy model. However,
from the Figure and computed relative error, one can still conclude that the AP of our model
qualitatively gives an excellent agreement to the respective model.
6.3.2 Fitting to a restitution curve
Using the new estimated parameter values, we then generated the APD restitution curves of
modified caricature Noble model by following the dynamic pacing protocol. We compare the
results of the curves with the respective models, as shown in Figure 6.3. From the Figure, one can
see a good agreement between our model and the target models. This result demonstrates that
our modified caricature Noble model can preserve most of the important characteristics of AP
waveforms at various basic cycle lengths, ranging from 400 to 2000 ms. We did not decrease the
basic cycle length further as this might cause the model to exhibit alternans behaviour which is
beyond the scope of this study. For alternans problem, different approach of parameter estimation
method is needed as demonstrated in Cairns et al. (2017). In Chapter 8, we will reapply the
optimisation procedure designed in this chapter to study cardiac alternans.
6.3.3 Insights into models and the influence of parameters
Our experience in finding parameterisations to match various data sets have led us to new ways
of understanding the modified caricature Noble model and its parameters. Table 6.2 summarises
the new parameter sets needed to reproduce the AP characteristics of each targeted model. In
this section, we discuss briefly, the effect of the change of some of the key parameters to the AP
characteristics of various cardiac ionic models.
To begin with, we first look at the fast and stiff region of the action potential, which is
the upstroke or depolarisation. The depolarisation stage normally occurs due to the higher
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Figure 6.3: The restitution curves of modified caricature Noble model (dashed line) in comparison
to the target AP models. Blue line is the APD curve of Luo-Rudy model, the cyan line is the
APD curve of Courtemanche model and the green line is the APD curve of Noble model. BCL is
shortened from 2000 ms until 400 ms.
concentration of sodium ions outside of the cell membrane rush into the cell through its particular
channels, which latter increase the inward sodium current. The membrane potential then rises
extremely within a short period. The higher the sodium inward current, the larger the membrane
potential would rise. However, the peak value of this membrane potential differs in different
region of the cardiac. For instance, in ventricular, the value is about 40–45 mV (Hund and Rudy
2004, Luo and Rudy 1991, Mahajan et al. 2008), while the value is slightly lower in atrial which
is approximately 24–40 mV (Wilhelms et al. 2013). In the modified caricature Noble model,
the peak of the fast inward current is mainly controlled by parameter ENa. The higher the AP
amplitude, the higher the value of ENa. From Table 6.2, it is shown that the ENa is the highest in
the Luo-Rudy model, and the smallest is in the Courtemanche model.
After the upstroke, the post-overshoot drop begins to take over momentarily. During this
stage, the sodium ion gates start to close immediately and the potassium ion channels open, hence
allowing potassium ions to travel out of the cell. The gradient of the dropping voltage in each
model is not similar. The Noble model has the least steep gradient, followed by the Luo-Rudy
and Courtemanche model. In the modified caricature Noble model, k3 determines how steep the
dropping value of the voltage. Decreasing this parameter value will decrease the gradient of the
dropping voltage and also reduce the plateau region. The Noble model seems to have the lowest
value of k3 since it is the least steep among the other models. However, for the other two models,
we are not able to make any remark since k3 also controls the plateau of the action potential. The
difference in the plateau region has undoubtedly affected the estimated value.
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Parameters Default Noble Luo-Rudy Courtemanche
GNa 100/3 100/3 100/3 100/3
ENa 40.0 40.0 45.0 24.3
E† -80.0 -80.0 -75.0 -60.0
E∗ -15.0 -10.0 11.5 -9.0
k1 0.075 0.04932 0.03602 0.01702
k2 0.04 0.03033 0.00443 0.007173
k3 0.10 0.08007 0.33946 0.99977
E1 -93.333 -95.667 -84.333 -81.667
fn 0.0037 0.004471 0.003781 0.00353
Fh 0.5 0.5 0.5 0.5
g21 -1.0 -0.28325 -0.14359 -0.02303
g22 -9.0 -2.15744 -0.36512 -0.25370
r 1.0 0.7 1.8 2.8
Table 6.2: Comparison of the default value of the parameters in Biktashev et al. (2008) with the
value used in our modified caricature Noble model after parameter fitting.
Model Noble Luo-Rudy Courtemanche Exp. (Healthy) Exp. (Heart failure)
AP morphology 0.2629 0.4194 0.5774 0.231 0.1213
Table 6.3: The mean relative error of AP morphology between the modified caricature Noble
model and targeted models/data.
The membrane potential of Noble and Courtemanche model at plateau region is approximately
-10 mV and -9 mV, respectively. The Luo-Rudy model has the largest voltage value, which is
about 11 mV. In our model, E∗ is one of the parameters that modulate the voltage value at the
plateau region. The estimated value is consistent for each model, where E∗ in the Luo-Rudy
model is the biggest since it has the biggest value of voltage during the plateau phase. The Noble
model obtains the smallest E∗.
The next phase is the action potential duration. The APD of each model is not similar. From
Figure 6.3, it is clear that this value is varied in each model where the Luo-Rudy shows the largest
APD (∼ 365 ms), then followed by the Noble model (∼ 310 ms) and lastly the Courtemanche
model (∼ 285 ms). As shown in the sensitivity test, there are many parameters that explicitly
and implicitly control the action potential duration, for example, E∗, k2, fn, g22 and so on. It
is possible to obtain similar APD value for different parameter combinations. Hence, a direct
comparison between parameters in every model is difficult due to multiplicative roles of these
parameters.
The resting membrane potential (RMP) is the final stage of an action potential, where the
ionic balances inside the cell are restored for the next excitation. Our fitting results show different
RMP for each model, which the Noble model has the lowest value (-95 mV). RMP value in the
Luo-Rudy and Courtemanche model is roughly -84 mV and -81 mV, respectively. In the modified
caricature Noble model, the resting membrane potential is mainly influenced by parameter E1.
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This reduced the computational cost of our fitting process as we could manually adjust the value
without the need of including the parameter in our fitting algorithm. Our fitting results show an
excellent agreement between the estimated value and the RMP of each model, as listed in Table
6.2.
Briefly, we have provided some interpretations of the main parameters in our modified
caricature Noble model when fitted to various biophysically detailed action potential models.
However, full and direct comparisons for every parameter are difficult due to the complexity of
the parameter space. We hope that this analysis gives us some understanding and meaningful
insight into how the parameters in our model work.
6.3.4 Model performance
We analyse the efficiency of our model in comparison to the targeted model by calculating
the execution time of all the models. To do so, we measured the time taken of each model to
generate 1000 action potentials at a fixed basic cycle length of 1000 ms. Each model was solved
using the MATLAB function ode15s. Our finding shows that the modified caricature Noble
model took approximately about 180s to run the simulation. The Luo Rudy and Courtemanche
model required about 1246s and 1634s, respectively. From this result, we acknowledge that the
modified caricature Noble model is six times faster than the Luo-Rudy model and nine times
faster than the Courtemanche model. In complex tissue simulation, this could potentially reduce
the computational workload and runtime.
6.4 Fitting to experimental data
Prolongation of the action potential duration is a well-known feature of human ventricular
myocardium from patients with severe heart failure and have been recorded in many clinical
studies (Hegyi et al. 2018, Kaab et al. 1996, Li et al. 2004, McIntosh et al. 2000). Several
factors likely contribute to such APD prolongation, for instance, decrease in potassium currents
(Akar and Rosenbaum 2003, Beuckelmann et al. 1993, Tsuji et al. 2000) and increase in late
sodium currents (Valdivia et al. 2005). Hence, we use the modified caricature Noble model as
the toolbox to understand the ionic mechanism of AP differences in healthy and failing cardiac
cells. To do this, we fitted the model to experimental data of AP waveforms in McIntosh et al.
(2000). In the paper, they examined the changes of action potential and intracellular calcium
transient characteristics in isolated cardiac myocytes from sub-epicardial, mid-myocardial, and
sub-endocardial regions of the left ventricle of rabbits with heart failure. Their main finding
showed that in the heart failure group, APD90 and calcium transient duration (CaD50) were
prolonged in both sub-epicardial and mid-myocardial cells. These changes were significant at
lower stimulus frequencies but the relative effect diminished at higher frequencies (3 Hz). For
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Figure 6.4: (a) Action potential waveforms of both modified caricature Noble model and experi-
mental data at stimulation frequency of 0.3 Hz. The solid lines are the action potential from the
single cardiac myocytes isolated from the left ventricle of healthy and heart failure rabbit hearts
(•). The dashed and dotted line are the corresponding action potentials of modified caricature
Noble model. Small inset figure is the maximal magnitude of time-dependent potassium current
of the respective models. (b) The relationship between stimulus frequency and APD90. The
green and brown lines are the the restitution curve for healthy and heart failure cell, respectively.
The dashed and dotted lines are the corresponding restitution curves of modified caricature Noble
model.
Parameters Healthy Heart failure
GNa 100/3 100/3
ENa 41.5 41.5
E† -80.0 -78.0
E∗ 20.0 20.0
k1 0.0231 0.0173
k2 0.0057 0.0068
k3 0.0471 0.031
E1 -245/3 -245/3
fn 0.0043 0.0040
Fh 0.5 0.5
g21 0.0409 0.0405
g22 -1.097 -0.9461
r 0.4 0.6
Table 6.4: The parameters values of mod-
ified caricature Noble model after fitting
to the experimental data of healthy and
failing myocytes at 0.3 Hz pacing rate.
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Figure 6.5: Relative difference between the set
of parameters in healthy and HF groups.
our purpose, we only fitted our model to the AP morphology of mid myocardium cells (Mcells)
in both healthy and failing myocytes.
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6.4.1 Fitting to a single action potential
Similar to previous results, a single AP fitting was considered using the fitting protocols as
explained before. The modified caricature Noble model was fitted to isolated cardiac ventricular
cells at a pacing rate of 0.3 Hz (3333 ms) for both healthy and heart failure (HF) states. Figure 6.4a
shows the AP morphologies after the fitting process. As observed in the Figure, the discrepancy
largely occurs in the plateau phase. The modified caricature Noble model exhibits extended
plateau before the voltage begins to drop. We also measured the mean relative error of the
respective curves as listed in Table 6.3 and the error is relatively small. Table 6.4 shows the
estimated parameter values of our model after fitting to experimental data. In Figure 6.5, it also
shows that the most affected parameters in the model with HF are those related to potassium and
leak currents. The parameters are k1, k2, k3, r and g22. These parameters need to be adjusted in
order to compensate the large APD exhibited in the HF group. Other parameters like ENa and
E1 are similar in both states since the APs have identical action potential amplitude and resting
membrane potential.
As mentioned earlier, various factors are likely to contribute to the APD prolongation in failing
myocardium. To date, numerous investigations have highlighted the importance of potassium
current downregulation in HF myocytes (Akar and Rosenbaum 2003, Beuckelmann et al. 1993,
Tsuji et al. 2000). Our fitting results show that in failing myocyte, the maximal magnitude of
time-dependent potassium current is roughly 10% smaller than the healthy myocyte, as depicted
in Figure 6.4a, hence causing the APD prolongation.
6.4.2 Fitting to a restitution curve
Following the dynamic pacing protocol, we constructed the APD restitution curve using the new
estimated parameter values and we plotted the result in Figure 6.4b. For a given stimulation
frequency, failing myocytes exhibited larger APD90 than the healthy myocytes. At high stim-
ulation frequency, APD90 for both groups shows a less substantial difference. Our modified
caricature Noble model manages to reproduce accurate APD restitution curve for the HF myocyte,
compared to healthy myocyte. For healthy myocyte, the discrepancy occurs at several stimulation
frequencies, and it gets pronounced at stimulation frequency larger than 2 Hz, where the modified
caricature Noble model produced smaller APD90 than the experimental data of healthy myocytes.
The relative error between the two curves, however, is relatively minimal and acceptable, as
measured in Table 6.3.
6.5 Conclusion
In this chapter, we have demonstrated a simple parameter fitting protocol and presented the
modified caricature Noble model as a generic model of cardiac electrical activity. Using the
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Nelder-Mead simplex method, the model exhibited extensive flexibility by reproducing the action
potential waveforms of several detailed cardiac electrophysiology models and experimental
measurements of healthy and failing rabbit myocytes. The fitted AP morphology showed some
discrepancies at a particular region of AP phase. For example, when fitting to the Courtemanche
model, the AP deep notch in phase 1 was not accurately captured by our model. A probable
reason is that the modified caricature Noble model lacks of ionic currents that can reproduce
the specific AP feature, which in this case is transient outward potassium currents, Ito. Apart
from fitting the AP morphologies, we also successfully managed to fit the APD restitution curves
of the respective models and data, hence encapsulating the model’s AP dynamics at different
basic cycle lengths. Future work needs to include fitting the CV restitution properties of the
modified caricature Noble model to the targeted models in order to examine the AP propagation
in a spatially extended tissue simulation.
Unlike some other simplified action potential models, the parameters and variables in the
modified caricature Noble model could have the physiological meaning as the model was derived
from a genuine cell model (Biktashev et al. 2008, Noble 1962). Therefore, our results could be
translated into physiology. For instance, when fitting to healthy and failing rabbit cardiomyocytes,
we found that the maximal magnitude of time-dependent potassium current in the healthy model
was a bit larger than the heart failure model. This finding is in agreement with some earlier
experimental studies (Akar and Rosenbaum 2003, Beuckelmann et al. 1993, Tsuji et al. 2000).
The parameter estimation framework demonstrated in this chapter will be further used in Chapter
8 to study the mechanisms of cardiac alternans. Finally, parameter fitting of modified caricature
Noble model demonstrated in this chapter has shown that the model could potentially replace
other more complicated models for various analytical approaches, such as, looking for the
mechanisms of cardiac alternans and developing an efficient numerical method.
Also, the ability to connect a model representation of the Purkinje system with the com-
plex structure of the ventricles opened new opportunities to understand arrhythmogenesis, and
specifically, the contribution of Purkinje to the initiation and maintenance of reentry (Trayanova
and Winslow 2011). Berenfeld and Jalife (1998) made the very first attempt to incorporate the
Purkinje system in a whole-heart model. The 2-variable Fitzhugh-Nagumo model of cellular
kinetics was assigned to each system with different parameter sets. Other recent studies employed
two different AP models to couple the two systems (Purkinje and ventricular) and developed a
3D tissue model (Aslanidi et al. 2009b, Vigmond and Clements 2007). As part of our motivation,
future work should aim to utilise our finding in this chapter to be used for whole-heart modelling.
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Chapter 7
Efficient numerical method for the solution
of the modified caricature Noble model
7.1 Introduction
The nature of cardiac electrical activity requires very fine spatio-temporal resolutions and a
long period of simulation, which may render the process to be computationally expensive.
Typically, organ level simulations commonly involve millions of grid points and the solution
of the reaction-diffusion system has to be solved over thousands of time steps. Such enormous
computational demands can only be overcome with the aid of advanced numerical methods and
parallel computing approaches. Nevertheless, this is still time-consuming and the execution
process may take hours and days. For instance, a simulation of 1 min cardiac activity in a tissue
model with 4.3 million cells, using a rabbit ventricular model by Mahajan et al. (2008) took
more than 4.5 days (Plank et al. 2009). There have been numerous attempts to solve the cardiac
electrophysiology problem numerically, but yet it still remains an open question that demands a
powerful method and efficient algorithm.
In essence, the finite difference (FD) method has been widely used by a large number of
groups to solve the electrophysiology model (see, e.g. Barkley (1991), Ji and Fenton (2016),
Moghaderi and Dehghan (2017), Murillo and Cai (2004)). Compared to other available numerical
methods, FD method is the most common method used to solve this system due to its simplicity,
easy implementation and quite straightforward. However, the drawback of this method is that it
is difficult to describe smooth surfaces such as the surface of the heart without steps that might
cause some challenges to implementing boundary conditions (Clayton et al. 2011). For complex
modelling of action potential propagation in cardiac tissue geometry, finite element (FE) method
might be more suitable to be applied because the method allows us to have non-uniform size and
shape of small subdomains. The method is considerably robust and more efficient, especially for
simulations with anatomically complex geometry (Goktepe and Kuhl 2009, Hurtado et al. 2016,
Vigmond et al. 2002). Nevertheless, FE method requires one to give additional effort into both
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formulation and running the software, in comparison to FD method.
In addition, explicit, semi-implicit (also known as IMEX) and fully implicit methods have
been comprehensively implemented for solving the time and space dependence equations in the
cardiac electrophysiology model. The choice of the time-stepping scheme for the system plays a
vital role in their stability, accuracy, computational cost and as well as memory use. Typically, the
explicit time-stepping scheme is the most famous one (see, e.g. Dowle et al. (1997), Hanslien et al.
(2005), Ji and Fenton (2016)) due to its easy implementation. However, the explicit scheme is
always limited to a stability constraint in which the time step must be sufficiently small to ensure
the stability of the solution; otherwise, the action potential model cannot be solved. Therefore,
many extensive efforts to encounter the issue have moved to the application of a fully implicit
method which is more stable for large time step (Ji and Fenton 2016, Murillo and Cai 2004). The
implicit scheme also takes much less computational time compared to the explicit method but
require the solution of a nonlinear system of equations which demanding extra computation. A
good alternative between the two methods is the semi-implicit scheme. This method allows us to
rewrite the differential operator into two parts where the nonlinear term is solved explicitly and
the linear term is evaluated implicitly. Moreover, this method has a stronger stability condition
compared to the explicit method but weaker than the implicit scheme (Ethier and Bourgault
2008).
In general, numerous attempts have been made in order to develop robust and efficient
numerical schemes for solving the cardiac electrophysiology model from a single cell to the
complex geometry of whole heart simulation. Worth to mention here is like operator splitting
method (Qu and Garfinkel 1999, Strang 1968), parallel implementation (Epanchintsev et al. 2016,
Migliore et al. 2015), using lookup tables (Cooper et al. 2015) and adaptive numerical scheme
(Campos et al. 2011, Moghaderi and Dehghan 2017). These are among the common strategies
used to speed up the calculation time. Despite all these approaches, solving a biophysically
detailed ionic model is still too expensive, even with the aid of powerful computing facility. In
conclusion, it is a subjective matter to say which method is the most effective as they all have
limit and advantage over each other.
With this motivation, in this chapter, we use the asymptotic structure of modified caricature
Noble model as described earlier in Chapter 5 to develop an efficient asymptotic-numerical
method. In particular, we implement the heterogeneous multiscale method on this model by using
its fast and slow time subsystems. The method was initially proposed by Weinan and Engquist
(2003) and the idea was extended for solving a cardiac AP model. Prior to our knowledge, no
research in cardiac electrophysiology has applied this approach on an action potential which
becomes our primary motivation to explore the limitation of the method. The approach is then
compared with other numerical solvers to investigate its stability and efficiency.
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Figure 7.1: The general framework of HMM model.
7.2 Heterogeneous multiscale method
Weinan and Engquist (2003) introduced the heterogeneous multiscale model (HMM) as a general
methodology for the efficient numerical computation of multiscale problems. It provides a
framework for designing new methods for a large number of multiscale problems. The method is
widely used for solving a system with very different dynamics and time scale as many phenomena
in nature happen in multiple active scales like the combustion (Weinan et al. 2011), fluid dynamics
(Ren and Weinan 2005), cancer modelling (Deisboeck et al. 2011) and many others.
The framework starts with a predetermined form of the macroscopic model, F(y,D) where
y is the macroscopic variable and D is the missing component of the incomplete macroscopic
model. The component D can be measured using the microscopic model when the estimate data
is needed. On the other hand, we can define the microscopic model by f(x,d) such that d = d(y).
d is the constrain value provided by the macroscopic model to the microscopic model. Once the
microscopic model is solved, the missing part of the macroscopic model can be estimated. The
interaction between the macroscopic and microscopic model is illustrated as in Figure 7.1. In
order to outline the procedures of HMM framework, let us start with a simple fast-slow system of
the form,
dx
dt
=
1
ε
(−x+h(y))
dy
dt
= g(x,y)
(7.1)
x is the microscopic (fast) variable and y is the macroscopic (slow) variable. One can find the
attracting critical manifold and the asociated slow-flow of such system by taking the limit of ε
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goes to zero to obtain
C0 = {(x,y) ∈ℜ2|x = h(y)}. (7.2)
The macroscopic model is then defined as,
dy
dt
= g(h(y),y) =: G(y) (7.3)
and the microscopic model can be found by rescaling the normal time scale using the approxima-
tion τ = t/ε . Then, we have
dx
dτ
=−x+h(y). (7.4)
For simplicity, the steps of HMM model can be summarised as follows,
1. We begin the procedure from an initial point, yn provided by the macroscopic model. The
given point is used to reinitialise the microscopic model
xn,0 = yn (7.5)
where n represents the macroscopic time step.
2. Then, we perform a finite number of microtime steps by using the microsolver denoted as
Sδτ ,
xn,k+1 = Sδτ(xn,k,yn) (7.6)
where k = 0,1, ...K− 1 and δτ > 0. The value of K is choosen to be sufficiently large
enough, so that xn,K would reach a stationary point or value.
3. Finally, the macroscopic model is solved for the next macrotime step using the macrosolver,
S∆t ,
yn+1 = S∆t(xn,K,yn). (7.7)
4. Go to step 2.
Each time step of macroscopic model equals to several time steps of microscopic model. The
interaction between the macroscopic and microscopic time scales is depicted in Figure 7.2.
7.3 Implementation of heterogeneous multiscale method on
modified caricature Noble model
We implement the heterogeneous multiscale method (HMM) on the modified caricature Noble
model by considering the super-fast time system (5.13) and the slow time system (5.16) as
the microscopic and macroscopic solver, respectively. The procedures are similar as outlined
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Figure 7.2: Representation of the macroscopic and microscopic time scales in HMM.
previously. For simplicity, we choose the forward Euler scheme to be the macro and micro solver
of the two reduced systems. The algorithms for microscopic system are as follows,
Ei,k+1 = Ei,k +δτ [GNa(ENa−Ei,k)H(Ei,k−E∗)hi,k],
hi,k+1 = hi,k +δτ [Fh(H(E†−Ei,k)−hi,k)],
(7.8)
where k = 1...K−1 and δτ > 0 is the microtime step. K must be sufficiently large such that E
reaches the maximum voltage, ENa. If K is too small, E will not be able to reach its stationary
point which then will affect the trajectory of the macroscopic solver. This is because the initial
condition for the macroscopic solver is obtained from the microscopic solver. The algorithms for
macroscopic solver are
Ei+1,K = Ei,K +∆t
1
ε2
(g̃2(Ei,K)ni,K + G̃(Ei,K)),
ni+1,K = ni,K +∆t [Fn(Ei,K)(H(Ei,K−E†)−ni,K)].
(7.9)
Implementing the above algorithms, then we obtain the results as depicted in Figure 7.3. The
initial condition used to excite the action potential was E(0) =−10, h(0) = 1, and n(0) = 0. The
results show a very good agreement with exact analytical solution, except a negligible discrepancy
in the post over-shoot drop region. The discrepancy in the post overshoot-drop is because the
region is solved using the slow subsystem where the value of ε1 ≈ 0, meanwhile, in the full
system the value of ε1 = 1. However, the important AP biomarkers, for example, action potential
duration, maximum voltage, amplitude, resting membrane potential are still well preserved.
For further investigation on the stability and efficiency of this solver, we compare the result
with several other finite difference methods. The numerical methods are the explicit Euler,
implicit Euler, 4th order Runge-Kutta, 2nd order Adam Bashforth and Rush and Larsen (1978)
method. These solvers are very well-known and commonly used to solve the action potential
model. The algorithms for each solvers are as follows,
• Explicit Euler method
Explicit Euler method is a first order method and it is the most basic explicit method for
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Figure 7.3: The solution of E solved using HMM in comparison to the exact solution (solid red
line). Dotted blue and dashed green line are for ∆t = 0.01 and 1.0, respectively. The global mean
error for both solutions are 0.35 and 0.6. The small inset figure is the solution of E for t ∈ [0, 50].
numerical integration of ordinary differential equations. The solver is defined below,
yi+1 = yi +∆t F (yi, ti), (7.10)
where y = E,h,n and F is the local kinetics of each variables as defined in eqs. (5.1), (5.3)
and (5.4). For all the numerical solvers, h and n were solved first, then the results were
substituted in the E equation.
• Implicit Euler method
The scheme for this implicit method (or backward Euler method) is,
yi+1 = yi +∆t F (yi+1, ti+1). (7.11)
Due to linearity of F , the algorithms can be split into three respective intervals. They are,
If E ∈ [E∗, ∞),
Ei+1 =
Ei + ∆tε2
(
GNaENahi+1
ε1
+g22ni+1 + k3E3
)
1+ ∆t
ε2
(
GNahi+1
ε1
+ k3
) ,
hi+1 =
hi
1+∆t Fh
ε1ε2
,
ni+1 =
ni +∆t fn
1+∆t fn
.
(7.12)
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If E ∈ [E†, E∗),
Ei+1 =
Ei + ∆tε2 (g22ni+1− k2E2)
1− ∆t
ε2
k2
,
hi+1 =
hi
1+∆t Fh
ε1ε2
,
ni+1 =
ni +∆t fn
1+∆t fn
.
(7.13)
If E ∈ [−∞, E†),
Ei+1 =
Ei + ∆tε2 (g21ni+1 + k1E1)
1+ ∆t
ε2
k1
,
hi+1 =
hi +∆t
Fh
ε1ε2
1+∆t Fh
ε1ε2
,
ni+1 =
ni
1+∆t fnr
.
(7.14)
• 4th order Runge-Kutta (RK4) method
Runge-Kutta is a higher order method compared to Euler method, which requires the
method to take some intermediate steps before taking a second step. The scheme is
described below,
yi+1 = yi +
1
6
(k1 +2k2 +2k3 + k4),
k1 = ∆t F (yi, ti),
k2 = ∆t F (yi +
k1
2
, ti +
∆t
2
),
k3 = ∆t F (yi +
k2
2
, ti +
∆t
2
),
k4 = ∆t F (yi + k3, ti +∆t).
(7.15)
• 2nd order Adam-Bashforth (AB) method
Adam-Bashforth method is a linear multistep method. The method uses the information
from several previous points and derivative values in order to solve for the next time step.
The algorithm is as follows,
yi+2 = yi+1 +
3
2
∆t F (yi+1, ti+1)−
1
2
∆t F (yi, ti). (7.16)
• Rush-Larsen (RL) method
The gating variables h and n in (5.1) can be reformulated as
dz
dt
=
z∞− z
τz
, where, z∞ =
αz
αz +βz
, τz =
1
αz +βz
, (7.17)
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HMM Explicit Euler Implicit Euler
max ∆t 2.0 0.06 3.0
Rush-Larsen Runge-Kutta Adam-Bashforth
max ∆t 0.06 0.13 0.05
Table 7.1: Approximation of maximum time step allowed for each numerical solver to accurately
solve the modified caricature Noble model. The solution diverges if the value of the time step is
larger than the listed value.
and αz = αz(E) and βz = βz(E) for z = h,n. For this model, αz and βz are defined as below,
αh = H(E†−E)
Fh
ε1ε2
, βh =
Fh
ε1ε2
(1−H(E†−E)),
αn = H(E−E†)Fn(E), βn = Fn(E)(1−H(E−E†)).
(7.18)
The RL method assumes that the transmembrane voltage E is constant over each time step
and allowing (7.17) to be treated as linear ODE with an exact solution given by,
zi+1 = z∞ +(zi− z∞)exp(−∆t/τz). (7.19)
For other non-gating variables, one can solve using any available numerical method. For
simplicity and the sake of comparison, we use explicit Euler method for solving E.
These solvers are used to solve the modified caricature Noble model by varying the time step
from the smallest possible value until the method no longer converges where the action potential
is no longer produced.
7.4 The efficiency of the method
We then compare the results from all these solvers with HMM in order to investigate the stability
limit and execution time. For the stability limit, we solved the modified caricature Noble model
using various time steps for every solver. The AP global mean error between numerical and exact
solutions was measured by using the following equation,
ε =
1
M
M
∑
i=1
|Enumi −Eexacti | (7.20)
where Enumi and E
exact
i are the computed voltage, E with numerical solver and exact solution
(5.6), respectively. To measure the execution time of each solver, we calculated the time needed
for the particular solver to solve for 100 action potentials at a basic cycle length of 1000 ms.
Each simulation was executed using MATLAB v2017b with a 64-bit Intel processor. The results
for both global mean error and CPU time are shown in Figure 7.4. As what we expected, the
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Figure 7.4: The CPU time and global mean error for various numerical methods used to solve
the modified caricature Noble model. The solid lines and dotted lines are the CPU time and
global mean error for every used methods, respectively. The CPU time for Rush-Larsen method
is overlapped by the CPU time of Euler method. Red is for HMM, blue is for Runge-Kutta, green
is for explicit Euler, black is for implicit Euler, cyan is for Adam-Bashforth and magenta is for
Rush-Larsen method.
CPU time decreases as the size of the time-step increases. This is because the solver needs to
take fewer time steps to solve the model when the time step is increased. From the Figure, we
can also observe that HMM has the fastest computational time compared to other numerical
solvers. Explicit Euler and implicit Euler methods are slightly slower than HMM and these two
methods seem to be comparable between each other, but it is only valid for very small time-step
(∆t approximately less than 0.06). The explicit Euler method breaks after the solver reaches the
maximum time step. Runge-Kutta is the slowest solver because the solver needs to solve large
algorithms at every time step. Adam-Bashforth and Rush-Larsen exhibit comparable CPU time.
Other than faster computational time, the stability and the accuracy of the method are also
important. The primary goal is to construct a numerical scheme that not only has a faster
execution time but can also preserve the accuracy of the solutions. In comparison to other
numerical methods, HMM and the implicit Euler method are the most stable, although HMM
accumulates larger global mean error than all other methods (Figure 7.4). The large value
exhibited in HMM is mainly due to the difference in the post-overshoot drop, as shown in Figure
7.3. Nevertheless, from our viewpoint, the error level here is still acceptable since the important
action potential biomarkers are still well preserved. In addition, the implicit Euler maintains
a small global mean error, despite increasing in time step. Also, from Table 7.1, we can see
that the implicit Euler method has the biggest time step before the method breaks. From our
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Figure 7.5: The log-log plot of method efficiency, β . The black solid line at β = 1 indicates the
efficiency of HMM in comparison to other numerical methods. The green line is for the explicit
Euler method, the blue line is for the implicit Euler method, the cyan line is for AB method, the
blue line is for RK4 method and the magenta line is for the RL method.
study, we find that the second most stable method is shown by HMM, followed by Runge-Kutta
method and the least stable method is Adam-Bashforth method. Explicit Euler, Rush-Larsen and
Adam-Bashforth methods have almost similar stability limit and are the least stable.
The efficiency of each numerical method is evaluated based on its ability to solve the model
with less computational time but at the same time preserves the accuracy of the solution. To
quantify the efficiency of every solver, we use the following equation,
Method efficiency, β =
ε of method X for CPU time α
ε of HMM for CPU time α
. (7.21)
The global mean error of a particular method is compared with HMM at similar CPU time. At a
given CPU time, if HMM has lower global mean error than the other solver, then it shows that
HMM has a better resolution and accuracy level. Thus, suggesting that HMM is more efficient
than the other solver. In particular, if the value of β is greater than 1, then it indicates that HMM
is more efficient than the compared method. The result for the method efficiency between HMM
and other numerical methods is shown in Figure 7.5. From the Figure, we can observe that
at CPU time larger than 0.5 seconds (time step below than ∼ 0.04), the HMM is less efficient
than the other schemes. This is because HMM produces a considerably large global mean error,
although this method has faster computational time than most of the other schemes. As the time
step gets larger (CPU time reduces), the HMM becomes more efficient than the other solvers,
with the exception being for the implicit Euler method. At large time step, the other methods
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reach their stability limit and eventually they diverge, making HMM more efficient. The implicit
Euler scheme remains with the most excellent accuracy, despite increasing in time step.
In conclusion, from our analysis, we show that the implicit Euler scheme is the most efficient
numerical solver for this model. The next most efficient method is HMM, then followed by the
explicit Euler method and Runge-Kutta. The Rush-Larsen and Adam Bashforth method have
almost equal efficiency level. Note that although the implicit Euler method seems the best, it is
only possible to apply the method on this model because the model is linear and so equation (5.1)
can be solved to give (7.12), (7.13) and (7.14). For a general nonlinear AP model, the equation
that describes the process of action potential excitation cannot be inverted and so the implicit
Euler is not easily implemented. But the HMM can be applied and it has similar efficiency. Also,
the choice of a numerical method to be used to solve the model may depend on the goal of the
particular work. If the accuracy of the solution is the only priority, then all of the above methods
are suitable to be implemented, regardless of their computational speed.
7.5 Error analysis for heterogeneous multiscale method
This error analysis for heterogenous multiscale method was discussed in Kuehn (2015). In order
to illustrate the error analysis, we consider a simple system of ODEs as defined in (7.1). For
simplicity, we apply the forward Euler method on our both HMM microsolver and macrosolver.
For HMM macrosolver we have,
yn+1 = yn +∆t g̃(yn) (7.22)
such that g̃(yn) = g(xn,k,yn). Meanwhile, for HMM microsolver, we have
xn,k+1 = xn,k +∆τ (xn,k−h(yn)) (7.23)
where ∆τ = ∆t/ε and k = 0,1, ...,M. k must be sufficiently large so that xn,M will approach N
(stationary value). Next, we consider the global error between the HMM macrosolver and the
true slow flow (exact solution) defined as follows,
En = yn−Y (tn) (7.24)
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where tn = n∆t. From the definition of global error, we have,
En+1−En
∆t
=
yn+1−Y n+1− yn +Y n
∆t
,
=
yn +∆t g̃(yn)− yn− [Y n+1−Y n]
∆t
,
=
∆t g̃(yn)− [Y n+1−Y n]+∆t G(Y n)−∆t G(Y n)
∆t
,
= g̃(yn)−G(Y n)−
[Y n+1−Y n
∆t
+G(Y n)
]
,
= g̃(yn)−G(Y n)−G(yn)+G(yn)−T n,
(7.25)
such that T n is the local truncation error. We then rearrange the equation and take the norms, to
get
|En+1|= |En +∆t (G(yn)−G(Y n))|+ |∆t (g̃(yn)−G(yn))|−∆t|T n|. (7.26)
Note that by Lipschitz condition, we have,
|G(yn)−G(Y n)| ≤ LG|yn−Y n|= LG|En|, (7.27)
where LG is the Lipschitz constant and plucking the above equation into (7.26), yields
|En+1| ≤ (1+∆t LG)|En|+∆t|T n|+∆t |g̃(yn)−G(yn)|. (7.28)
for n = 0,1, ...,N−1. If we look at closely, the first two terms on the right hand side appear in
the common global error analysis for the forward Euler method on the macroscale. The last term
contains the error on the microscale. Taking the inequality, we can show by induction such that
|En| ≤
[
max
0≤n≤N−1
|T n|+ max
0≤n≤N−1
|g̃(yn)−G(yn)|
]
((1+∆t LG)n−1),
= [Emac,N +Emic,N ]((1+∆t LG)n−1),
≤ [Emac,N +Emic,N ](exp(LGn∆t)−1),
(7.29)
for n = 0,1, ...,N. This inequality shows that the error analysis techniques for the macroscale
solver for HMM is not similar to the standard methods because of the extra error term in the
microsolver approximation. Next, we want to estimate the error for microscale solver, Emic,N . In
particular, we want to estimate |g̃(yn)−G(yn)|. Using the definition of Lipschitz condition, we
have,
|g̃(yn)−G(yn)|= |g(xn,M,yn)−g(h(yn),yn)|,
≤ Lg|xn,M−h(yn)|,
(7.30)
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such that Lg is the Lipschitz constant. We hold this for the moment and let us define
en,k = xn,k−h(yn), (7.31)
where en,k is the error between HMM microsolver and the true slow flow. From the HMM
microsolver, we have,
en,k = [xn,k+1 +∆τ (xn,k−h(yn))]−h(yn),
= [xn,k+1−h(yn)]+∆τ (xn,k−h(yn)),
= en,k+1 +∆τen,k.
(7.32)
Rearrange the equation, we get,
en,k+1 = en,k(1−∆τ), (7.33)
for k = 0,1, ...,M. Iterating the equation leads to
en,M = en,0(1−∆τ)M. (7.34)
Using the result of the last argument in (7.30) and (7.31) yield
Lg|xn,M−h(yn)|= Lg|en,M|,
= Lg|en,0(1−∆τ)M|.
(7.35)
Therefore, from (7.30), we end with
|g̃(yn)−G(yn)| ≤ Lg|en,0(1−∆τ)M|. (7.36)
We can now define the error for HMM microsolver in (7.29). From the last inequality, we have
Emic,N = max
0≤n≤N−1
|g̃(yn)−G(yn)|,
≤ max
0≤n≤N−1
Lg|en,0(1−∆τ)M|,
= κ1|1−∆τ|M,
(7.37)
where κ1 = max
0≤n≤N−1
Lg|en,0| = Lg max
0≤n≤N−1
|xn,0− h(yn)|. Substituting the last argument into
(7.29), the global error for HMM with Euler micro and macrosolvers is defined as following,
|En| ≤ [κ0∆t +κ1|1−∆τ|M](exp(LGn∆t)−1). (7.38)
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The error |En| has one term for the macrosolver and it can be made small by choosing 0 <
∆t 1. Meanwhile, we can also minimize the microsolver error by using ∆τ < 1 and making
M sufficiently large. The decoupling approach in this method makes it possible to choose two
different step sizes, which then stabilizes the method.
7.6 Drawbacks of the heterogeneous multiscale method
In this section, we briefly discuss the limitation of HMM. First and foremost, the application
of HMM method is not straightforward and can only work if the model can be dissected into
microscopic and macroscopic systems. For a biophysically detailed model of cardiac electrophys-
iology, this might be extremely challenging and difficult due to a large number of state variables
present in the model. An ideal approach is to consider the reduction version of such a model
using a robust asymptotic reduction method (Biktasheva et al. 2006). Also, the implementation of
this method requires us to know the “speed” of each variable in the model, i.e., to identify which
variables have a fast, intermediate and slow timescale, before the model can be split up to fast
and slow-time systems. In order to distinguish the variables according to their speed, a speed
analysis (see Suckley (2004)) needs to be carried out beforehand.
The HMM can be applied to tissue simulation by including it as a component within an
operator splitting method (Qu and Garfinkel 1999, Strang 1968). This is a direction for further
research.
7.7 Conclusion
In this chapter, we have introduced an efficient asymptotic-numerical method for solving the
modified caricature Noble model by using the asymptotic structures of the model. We showed
that the method has better stability and more robust in comparison to other numerical solvers
(explicit Euler, Runge-Kutta, Adam Bashfoth, Rush-Larsen method), with the exception being
for implicit Euler method. The method also has the fastest execution time with an acceptable
global mean error. The large error was mainly due to discrepancy at the post-overshoot drop
(Figure 7.3). The method, however, still preserved the important action potential biomarkers.
Note that although the implicit Euler method exhibited the best efficiency, the method, however,
is only possible to apply on this model because the model is linear. For a more detailed AP
model, the method cannot be easily implemented as the equation that describes the process of
action potential excitation is nonlinear. At each time step, the solver needs to solve the algebraic
equation and this process increases the computational load. But the HMM can be applied on the
those models and it has comparable efficiency. In addition, the HMM also has several drawbacks
which require further investigation.
In the next chapter, we further extend the analysis and application of caricature Noble model
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to investigate the mechanisms of cardiac alternans. The slow-slow time system of the model will
be used again to derive the analytical formula of APD restitution curve and then to identify the
region of parameter values where alternans will appear.
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Chapter 8
Mechanisms of cardiac alternans
8.1 Introduction
Cardiac alternans is a condition wherein the heartbeat cyclically varies between weak and strong
despite a constant heart rate. It was described many years ago in experimental conditions and
clinically, in particular, in patients with heart disease like atrial fibrillation. It is a severe condition
which may lead to death. Hence, understanding the mechanisms and causes of cardiac alternans
is very important, especially for controlling, treating and terminating the onset of alternans.
Numerical simulation and experimental studies have made significant contributions to under-
stand the mechanisms of cardiac alternans (Bayer et al. 2016, Edwards and Blatter 2014, Fox
et al. 2002, Karma 1994, Ten Tusscher et al. 2007). To date, restitution properties of cardiac cells
have been utilised to explain the alternans behaviour, where it describes a functional relationship
between the duration of a cardiac action potential and the length of its previous diastolic interval.
However, the experimental protocols for measuring restitution encounter a number of difficulties,
including that of distinguishing the ultimate periodic regime from transient behaviour because of
the presence of cardiac memory (Gilmour et al. 1997, Tolkacheva et al. 2003).
Standard experimental protocols like dynamic restitution pacing method require the cell to
be periodically stimulated at a fixed interval of basic cycle length until it settles into a stable
periodic response. Several periodic responses have been recorded in experiments (Hall et al. 1999,
Visweswaran et al. 2013). For instance, every successful stimulus may excite an action potential
with an identical shape (1:1 response). However, under certain conditions, only every second
stimulus may excite an action potential and produce a 2:1 response. Under different conditions,
the action potential duration may alternate between long and short (alternans 2:2 response). It
is commonly assumed that the 1:1 response represents the healthy function of the cardiac cell;
meanwhile, the other two responses are viewed as “instabilities” of the normal response which
may potentially lead to cardiac arrhythmias (Cherry et al. 2012, Karma 1994). Hence, the action
potential duration (APD) restitution maps can be used to study such instabilities. On the other
hand, cardiac alternans can still occur due to other ion mechanisms, for example, fluctuation
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calcium handling dynamics which is caused by calcium currents (Tomek et al. 2018, Tse et al.
2016). However, in this study, we will only focus on the AP-driven alternans as the model does
not include the calcium current.
With this motivation, here in this chapter, we want to derive an explicit discrete restitution
map for caricature Noble model and study their equilibrium branches and bifurcations. We then
explore the regions in the parameter space of caricature Noble model where normal 1:1 response
and alternans 2:2 occur. The parameter space is validated with some numerical simulations (see
section 8.4). We also develop a framework formulated in terms of boundary value problems
for studying cardiac restitution. This framework can be used to derive analytically or compute
numerically different branches of the action potential duration restitution map from the full
excitable models. Our method is validated by comparing the asymptotic restitution map with
the boundary value problem formulated restitution curves. Note that this is a continuation of the
work by Asgari-Targhi (2017). Due to this, we use the original caricature Noble model (with
n4) as formulated in (5.1) and (5.2). The exact analytical and asymptotic solutions of this model
were derived in Appendix A.2. In this chapter, we improve and make minor corrections to earlier
works by Asgari-Targhi (2017); in particular, we
• validate and confirm the proofs of some lemmas and propositions.
• construct new figures of APD restitution curves using both IVP and BVP and compare
them with asymptotic restitution curve.
• fit the model to a canine ventricular model and validate the region in the parameter space
where normal 1:1 response and alternans occur.
8.2 APD restitution map from the slow-slow-time system
Action potential sequence is excited by the periodic pacing condition. The success of the
excitation of the next AP depends on the previous diastolic interval (DI), which is the rest period
between repolarisation and the next excitation. The relation between APD and DI was first
described by using a graphical method, relating them to APD restitution map (Nolasco and
Dahlen 1968). The APD restitution map relates the durations of subsequent APs and is usually
written in the following variants,
APDk+1 = ϕ(APDk)
= ϕ(B−DIk)
(8.1)
where B is the basic cycle length and it is kept constant for every stimulation. In this section,
our aim is to derive a simple APD restitution map using the slow-slow time system in caricature
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Noble model. The simplest APD restitution map of (5.1) and (5.2) is obtained in the limits
ε1,ε2→ 0+ as follows.
Lemma 8.2.1. For an AP sequence generated using slow-slow time system (A.15),
APDk = a(nk−1), a(x)≡ fn−1 log
(
(1− x)/(1−n∗)
)
, (8.2a)
Dk = d(nk), d(x)≡ (r fn)−1 log(n∗/x), (8.2b)
nk ≡ n(kB), k ∈ N.
such that nk = n(kB) represents the value of gating variable n at the beginning of the (k+1)-st
AP for k ∈ N. n∗ is the maximal value of super-slow gating variable n and the value is defined as
in (5.22) but with the power of 1/4.
Proof. The result can be obtained by integrating the equation (A.15b) along the systolic branch
as following,
APDk =
(k−1)B+APDk∫
(k−1)B
dt =
1
fn
n∗∫
n(k−1)B
dn
fn(1−n)
=− 1
fn
log(1−n)
∣∣∣n∗
n(k−1)B
=
1
fn
log
(1−nk−1
1−n∗
)
,
Dk =
kB∫
(k−1)B+APDk
dt =− 1
r fn
n(kB)∫
n∗
dn
n
=− 1
r fn
log(n)
∣∣∣n(kB)
n∗
=
1
r fn
log
(n∗
nk
)
.
(8.3)
Proposition 1. An APD restitution map relating APDk+1 to APDk is given by
APDk+1 = Φ(APDk),
Φ(APD) = F(ã,A) = F(a,B−A) = 1
fn
log
(
1−n∗ exp
(
− r fn(B−APD)
)
1−n∗
)
, (8.4)
where ã = [a,B]T = [r, fn,n∗,B]T is a vector of parameters.
Proof. From Lemma (8.2.1), we have
Dk =
1
r fn
log
(n∗
nk
)
(8.5)
and we know that Dk = B−APDk. Substituting this into the above equation yields,
B−APDk =
1
r fn
log
(n∗
nk
)
(8.6)
138
and from some algebraic rearrangements, we can express nk in terms of other parameters
nk = n∗ exp(−r fn(B−APDk)). (8.7)
The result is obtained by plucking nk in expression (8.2a) written for APDk−1 and it gives us,
APDk+1 =
1
fn
log
(
1−n∗ exp
(
− r fn(B−APDk)
)
1−n∗
)
. (8.8)
Lemma (8.2.1) describes the parametric representation of the action potential duration restitu-
tion map and Proposition (8.4) expresses an equivalent explicit representation. Next, we can begin
to find the fixed points of Φ and Φ2 which corresponds to 1:1 and 2:2 responses, respectively.
Proposition 2. The equation APD = Φ(APD) has a unique solution branch given in parametric
form by
APD = a(n), D = d(n), (8.9)
with a parameter n ∈ [0,nthr] which nthr ∈ [0, n∗).
Proof. To find the fixed point of Φ, we can either directly solve the transcendental equation
APD=Φ(APD) or use the parametric representation of Lemma (8.2.1). For simplicity, we choose
the later method as solving the transcendental equation might be analytically impossible. In a 1:1
response, we have APDk =APDk+1 and Dk =Dk+1. From Lemma (8.2.1), these are equivalent to
a(nk−1) = a(nk) and d(nk) = d(nk+1), respectively. By the bijectivity of the logarithmic function,
we have the following solutions nk−1 = nk ≡ n and nk = nk+1 ≡ n, respectively. From here, we
deduce that the in a 1:1 response, the action potentials begin from similar values of the n gate, n,
hence expressions (8.9) hold. The parameter n is a gating variable and must be in between 0 and
1. In addition, AP cannot be excited below the nthr, hence, n ∈ [0, nthr].
Proposition 3. The equation APD = Φ◦Φ(APD) has three solution branches: the first one is
identical to (8.9), and the other two are given in parametric form by
APDeven = a(αnb), Deven = d(nb), (8.10a)
APDodd = a(nb), Dodd = d(αnb), (8.10b)
nb =
(
α
1/r−1
)
/
(
α
(r+1)/r−1
)
, (8.10c)
with a parameter α ∈ (0,∞).
Proof. We use the equivalent parametric representation of Lemma (8.2.1) to find the fixed points
of Φ2, rather than solving the transcendental equation APD = Φ ◦Φ(APD) directly. For 2:2
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AP responses, we have these relations; APDk = APDk+2 and APDk+1 = APDk+3 as well as
Dk = Dk+2 and Dk+1 = Dk+3. By implementing equations (8.2), we obtain nk = nk+2 ≡ na and
nk+1 = nk+3 ≡ nb. Since the BCL, B is constant, we have,
B = APDk +Dk = APDk+1 +Dk+1⇔ a(na)+d(nb) = a(nb)+d(na). (8.11)
From expressions (8.2), then we get
1
fn
log
(1−na
1−n∗
)
+
1
r fn
log
(n∗
nb
)
=
1
fn
log
(1−nb
1−n∗
)
+
1
r fn
log
(n∗
na
)
log
[(1−na
1−n∗
)(n∗
nb
)1/r]
= log
[(1−nb
1−n∗
)(n∗
na
)1/r]
(1−na)r
(n∗
nb
)
= (1−nb)r
(n∗
na
)
(1−na
1−nb
)r
=
nb
na
.
(8.12)
Next, we set na = αnb where α is the ratio between na and nb. Replacing na with this expression
to obtain (1−αnb
1−nb
)r
=
nb
αnb
1−αnb
1−nb
=
1
α1/r
1−αnb =
1
α1/r
(1−nb)
−αnb +
1
α1/r
nb =
1
α1/r
−1
nb
( 1
α1/r
−α
)
=
1
α1/r
−1
nb =
α1/r−1
α1+1/r−1
(8.13)
Notice that (8.11) is invariant regardless of switiching na and nb, hence we set na ≥ nb. Since
both na and nb are always nonnegative, we then have na/nb = α ∈ [1, ∞).
Proposition 4. The equilibrium (8.9) of the APD restitution map (8.4) loses stability in a flip
(period-doubling) bifurcation at
nbif = 1/(1+ r) (8.14a)
or in terms of the BCL, alternatively at
Bbif =
1
fn
log
(
r n1/r∗ (1+ r)(1−r)/r
(1−n∗)
)
. (8.14b)
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Figure 8.1: Bifurcation set in the Estim-r-B parameter space. The blue surface S1 is defined
by (8.19) and indicates the threshold for existence of the 1:1 response. The transparent black
surface S2 given by (8.20a) is the threshold for existence of the 2:2 response. The red surface
S3 is defined by (8.14b) and illustrates the region where 2:2 response bifurcates from the 1:1
response. The green surface S4 with equation r = 1 separates region of alternans (r > 1) from
healthy response (r < 1).
Proof. The result can be obtained by differentiating (8.4) with respect to APD,
∂F
∂APD
∣∣∣∣
APD
=
∂
∂APD
[
1
fn
log
(
1−n∗ exp
(
− r fn(B−APD)
)
1−n∗
)]
APD
=− n∗r exp(−r fn(B−APD))
1−n∗ exp(−r fn(B−APD))
(8.15)
and then by setting ∂F
∂APD
∣∣∣∣
APD
= −1 (a condition where a fixed point is unstable and period
doubling bifurcation occurs), we have
− n∗r exp(−r fn(B−APD))
1−n∗ exp(−r fn(B−APD))
=−1,
n∗ exp(−r fn(B−APD))(r+1) = 1,
n∗ exp(−r fnD) =
1
r+1
.
(8.16)
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Figure 8.2: Cross-sections of the bifurcation set in Figure 8.1 at particular parameter values. The
red and green dots in (a) are the parameter sets that we choose to construct the restitution curves
in Figures 8.4a and 8.5a, respectively. The region between black line and red line is where the
alternans occur.
Using equation (8.2b), the equation yields
n∗ exp(−r fnd(n)) =
1
r+1
,
n∗ exp(− log(n∗/n)) =
1
r+1
,
n =
1
r+1
.
(8.17)
Evaluating (8.9) at n = 1/(r+1), we then get
APDbif = a(nbif) =
1
fn
log
(1/(1+ r)−1
n∗−1
)
Bbif = a(nbif)+d(nbif) =
1
fn
log
(rn1/r∗ (1+ r)(1−r)/r
1−n∗
)
.
(8.18)
Proposition 5. The threshold value of BCL for excitation of a 1:1 response is
APDthr = a(nthr) = fn−1 log
(
(1−nthr)/(1−n∗)
)
,
Dthr = d(nthr) = (r fn)−1 log(n∗/nthr), (8.19)
Bthr = APDthr +Dthr.
Proof. Recall that the k−th AP can only be excited by a super-threshold stimulus Esim > E2 for
which nk−1 < nthr where nthr is given by (5.23). The result then follows by evaluation of (8.2.1)
at n = nthr.
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Figure 8.3: (Top row) Examples of AP trace generated using full system of caricature Noble
model in the case of (a) r = 3.5 and (b) r = 0.9. ε2 = 0.05, Estim = −10 and B = 290 ms are
fixed in both cases. (Bottom row) Examples of AP trace in the case of (c) Estim = 10 mV and
(d) Estim =−35 mV. ε2 = 0.05, r = 2.5 and B = 280 ms are fixed in both cases. Solid line and
dashed line in each panel represent the action potential at 19-th and 20-th beat, respectively.
Proposition 6. The threshold value of BCL for excitation of a 2:2 response is
Bthr = a
(
nthr
)
+d
(
nthrα(nthr)
)
= a
(
nthrα(nthr)
)
+d
(
nthr
)
, (8.20a)
where α(nthr) is the solution of the transcendental equation
nthr =
(
α
1/r−1
)
/
(
α
(r+1)/r−1
)
. (8.20b)
Figure 8.1 shows the bifurcation set in the Estim-r-B parameter space which is plotted using
(8.19), (8.20a) and (8.14b). From the figure, we can see the region where alternans has appeared.
In particular, the alternans mostly occur when r > 1 and the response disappear when r < 1.
We plot examples of AP trace to demonstrate the parameter case in Figures 8.3a and 8.3a. The
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Figure 8.4: (a) The 1:1 and 2:2 restitution curves using analytical (solid line) and numerical
BVP (circle dot). The red, green, magenta and blue curves correspond to ε2 = 1,0.5,0.3,0.1,
respectively. The black curve is the restitution curve of asymptotic solution corresponding to
ε2 = 0. The inset figure shows the comparison of restitution curves between our approach (blue
line) and dynamic pacing method (red line). r and Estim are fixed at 2.5 and -10, respectively. (b)
The region between two curves is where stable alternans occur. The blue and red curves are the
data points for Bbif and Bthr, respectively.
existence of the 2:2 alternans occurs in a very tight region, and it also depends on the value
of Estim. When a sufficiently strong Estim is applied, the period of existence of 2:2 alternans
becomes more prominent, as observed in Figure 8.2a. Given a similar condition of r and B, the
model could exhibit 2:1 response when we paced the model using a weaker stimulus strength.
Examples of AP trace for these two conditions can be seen in Figures 8.3c and 8.3d. A likely
explanation for this behaviour is that the excitation threshold (5.23) gets affected by the value
of Estim. Although 2:1 response is not within the scope of our study, it is good to point out that
strength of the stimulus is also responsible for 2:2 response and can only be achieved at the
specific condition.
8.3 Constructing the APD restitution curves
APD restitution curve is used to exhibit the dynamical behaviour of action potentials when
stimulating at various pacing rates. It can be characterised into two different types which are the
normal 1:1 restitution curve and the alternans 2:2 restitution curves. The latter happens due to
rapid heart rate and then trigger the APs to alternate between long and short waveforms, which is
a common behaviour during arrhythmia. In this section, we want to construct the 1:1 and 2:2
restitution curves of caricature Noble model using the analytical formula in (8.9) and (8.10). We
then compare the results with the APD restitution curves generated using the analytical solutions
of boundary value problem.
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Figure 8.5: (a) The 1:1 and 2:2 restitution curves in the case of (unstable) alternans. The red,
cyan, magenta and blue curves correspond to ε2 = 1.0,0.7,0.3,0.1, respectively. The black curve
is the restitution curve of asymptotic solution corresponding to ε2 = 0. r and Estim are fixed at
0.9 and -30, respectively. (b) The region between two curves is where unstable alternans occur.
The blue and red curves are the data points for Bbif and Bthr, respectively.
8.3.1 1:1 restitution curves
To construct the 1:1 restitution curve, we pose the periodic boundary conditions as below,
E(0) = E(t = B) = E0 > E∗,
h(0) = h(t = B), n(0) = n(t = B). (8.21)
and impose them to the solutions of initial value problem in (A.5a), (A.5b) and (A.5c). We firstly
chose the value of n0 which was varied between 0 and nthr and then solved for t† such that (A.5a)
satisfied
1
n(t = t†) =
2
n(t = t†). When constructing the restitution curve, t† was used as the cut-off
value for APD90. After obtaining the t†, we then numerically solved for B such that
2
n(t = B) = n0
was satisfied. The equation was solved using Maple18 software with fsolve command. The
processes were repeated for different value of n0 within the specified interval. Value of t† and
its corresponding B were used to construct the restitution curve. Similar result can be obtained
using the formula in equations (A.8a), (A.8b) and (A.8c) because they are already satisfied the
boundary conditions. For the numerical solutions, the caricature Noble model was solved using
‘dsolve’ command in Maple18 with the numeric option for the ODE system boundary value
problem. The results were then compared with the analytical solutions.
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8.3.2 Alternans (2:2) restitution curves
To construct the alternans 2:2 restitution curve, the following periodic boundary conditions must
be satisfied,
Eeven(0) = Eodd(t = B) = E0 > E∗,
heven(0) = hodd(t = B), hodd(0) = heven(t = B), (8.22)
neven(0) = nodd(t = B), nodd(0) = neven(t = B).
From these conditions and analytical solutions in (A.5a) and (A.5b), we then have,
1
neven(0) =
2
nodd(B),
2
neven(B) =
1
nodd(0), (8.23)
1
heven(0) =
2
hodd(B),
2
heven(B) =
1
hodd(0),
These equations were solved simultaneously using the solutions of the initial value problem in
(A.5a), (A.5b) and (A.5c)). The processes are as similar explained previously.
Figure 8.4a shows the 1:1 and alternans (2:2) restitution curves constructed using both
analytical and numerical BVP approaches for r greater than one (stable alternans) and for
different values of ε2. From the figure, we can see that the analytical solutions make a good
overlap with the numerical solutions. We then compared the outcome with the restitution curve
from asymptotic solutions (8.9) and (8.10). In order to do that, the value of ε2 in the analytical
solutions of IVP and BVP need to be reduced as small as possible. This is because the explicit
analytical formula (8.9) was derived using slow-slow-time subsystem where ε1,2 goes to 0,
whereas the analytical solutions of IVP and BVP were formulated in the case of ε1,2 = 1. From
the Figure 8.4a, we can see that as the value of ε2 gets closer to 0, the restitution curve begins to
deviate closer (from red curve to blue curve) to the asymptotic solutions. Note that only ε2 was
reduced as ε1 does not have a significant effect on the AP repolarisation.
Similarly, Figure 8.5a shows the 1:1 and alternans (2:2) restitution curves of analytical BVP
methods in the case of r less than 1 (unstable alternans). The results were compared with the
restitution curve (solid black line) from the asymptotic solutions (8.9) and (8.10). For r > 1,
the bifurcation is supercritical as shown in Figure 8.4a, whereas the bifurcation is subcritical
when r < 1 (Figure 8.5a). Figure 8.4b and 8.5b depict the interval where the stable and unstable
alternans occur for various ε2, respectively. In the case of unstable alternans, the interval is very
tight and only gets more pronounced when ε2 is large enough.
In addition, we also compared our methodology with standard protocol in constructing the
restitution curve, which follow the dynamic pacing protocol as discussed in 6.2.3.3. From
the inset Figure in 8.4a, both methods show a good correspondence, with the exception that
bifurcation point (where 2:2 alternans begin to occur) is slightly delayed in our method.
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Figure 8.6: The action potential morphology of caricature Noble model (dotted line) after the
fitting process in comparison with CVM (solid line) for t ∈ [0, 600] ms. The parameter values
used to plot the caricature Noble model are as listed in the left column of Table 8.1
8.4 Numerical simulation: Fitting to a ventricular model
From the parameter space plotted in Figure 8.1, it has been shown that alternans appear when r is
greater than unity and disappear when r is less than that. To validate this theoretical result, we
fitted the caricature Noble model to a canine ventricular model (CVM) by Fox et al. (2002) and
demonstrated that alternans could be triggered when a particular parameter value is satisfied. As
reported in Fox et al. (2002), the alternans behaviours in CVM could be annihilated by adjusting
the peak magnitude of calcium or potassium currents in the model. For example, their result
showed that increasing maximal conductance of IKr by 62% did eliminate the alternans to the
normal response. The finding motivates us to choose CVM as our baseline model in order to
simulate the onset of alternans in caricature Noble model.
8.4.1 Action potential waveform
Following the similar parameter estimation method and fitting protocols as discussed in Chapter
6, we fitted our caricature Noble model to CVM model and the AP morphology is shown in
Figure 8.6. Our model failed to reproduce the AP deep notch during phase 1 but rather produced
a flat plateau. A probable reason is due to lack of ionic current in our model that produces the
specific AP feature, where in this case is transient outward potassium current, Ito (Santana et al.
2010). Moreover, it is known that models with the same restitution properties, but different
AP morphologies may give different onsets for alternans (Cherry and Fenton 2004, Penaranda
et al. 2012). The other AP biomarkers like amplitude, resting potential and APD showed a good
correspondence with CVM. The new estimated parameter values are listed in Table 8.1. Notice
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Figure 8.7: The profile of potassium currents in the models of alternans and no alternans of
caricature Noble model.
Parameters Model 1 (Alternans) Model 2 (No Alternans)
GNa 100/3 100/3
ENa 40.65 40.65
E† -92.0 -92.0
E∗ 1.5 -4.0
k1 0.02987 0.001687
k2 0.001 0.00097
k3 1.803977 1.707082
E1 -94.33 -94.33
fn 0.00592 0.00598
Fh 0.6 0.6
g21 -0.22905 -0.15338
g22 -5.333726 -6.249433
r 1.8 0.95
Table 8.1: Comparison of the parameter sets in the case of alternans and no alternans after fitting
the caricature Noble model to CVM.
that there are two sets of parameter in the table. The first parameter set on the left is the result of
fitting our caricature Noble model to the original CVM. This is the condition where alternans
appear. The second parameter set comes from the fitting result of modified CVM. In the modified
CVM, the IKr was increased in order to suppress the alternans behaviour. IKr has a positive
correlation with APD; hence, increasing the IKr magnitude would decrease the APD. Since the
AP morphology has changed due to alteration in IKr, we fitted the caricature Noble model to
CVM again, giving us a new set of parameter values as listed in the second column of Table 8.1.
This model is used to represent the no alternans case.
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Figure 8.8: (a) The APD restitution curves of caricature Noble model (solid line) and CVM (open
circle) in the case of alternans (top panel) and no alternans (bottom panel) using dynamic pacing
method. The BCL is shortened from 1000 ms to 150 ms and then APD90 is recorded for each
cycle length. (b) The corresponding traces of E (solid line) and n (dotted line) at BCL = 180 ms.
From the Table 8.1, we can observe that most of the parameters are almost similar, with the
exception being for k1, E∗ and r. These parameters have the most significant difference. However,
from our theoretical work in the previous section, we find that k1 and E∗ do not directly contribute
to the alternans. The values were the result of our parameter fitting. Since the caricature Noble
model was fitted to two different AP waveforms (alternans and no alternans case), the parameter
values were expected to be different. Interestingly, r possess value greater than 1 in the case of
alternans, whereas smaller than 1 in the case of no alternans. The finding is consistent with the
bifurcation set in Figure 8.1, highlighting the role of r in inducing the alternans. In caricature
Noble model, r plays an important role in determining the excitation of next action potential as it
controls the speed of n-gating variable during the diastolic phase. When r is less than 1, Fn(E)
decreases, hence slows down the evolution of n-gating variable. In consequence, the n-gating
variable returns slowly to its resting value, which then allows more K+ ions to leave the cell. This
would increase the IK current (as depicted in Figure 8.7), which then cause the APD shortening.
In consequence, the AP has a longer diastolic phase (during rapid BCL) and eventually suppresses
the alternans.
However, when r is larger, the speed of n-gating variable at diastolic phase becomes even
faster and has caused n to have faster return, which will eventually influence the initial condition
of n for next AP. This is even more prominent during shorter BCL as the AP has short diastolic
phase. As a result, this leads to alternans, as shown in Figure 8.8b. Our result regarding the
IK current is consistent with the finding reported by Fox et al. (2002), where in the model of
alternans, the IK current is smaller compared to another model (Figure 8.7).
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8.4.2 APD restitution curve
Using the estimated parameter values in Table 8.1, we then constructed the APD restitution
curves of caricature Noble model by following the dynamic pacing method described in section
6.2.3.3. The APD of the last two action potentials was measured at 90% of repolarization for
each basic cycle length. Figure 8.8a shows the APD restitution curves of both alternans and no
alternans cases. In the top panel of Figure 8.8a, we can see that the alternans in caricature Noble
model and CVM start to appear approximately at 216 ms and 218 ms, respectively. However, in
the bottom panel of Figure 8.8a alternans does not appear.
8.5 Conclusion
In this chapter, we have studied the mechanisms of cardiac alternans using a simplified action
potential model. Following the work by Mitchell and Schaeffer (2003), an explicit formula for
the restitution curve has been derived from the slow-slow-time system of caricature Noble model;
thus the response of the model can be described by an iterated map. The stability of the map and
bifurcations of equilibria of the map have been studied to determine the regions and parameter
space where normal response and alternans occur. From our finding, we found that the parameter
r in the slow gating variable n is responsible for the alternans occurrence. We showed that the
bifurcation map losses its stability at r = 1 and exhibits the 2:2 response when r > 1. We also
validated this theoretical result using numerical simulation. Particularly, we fitted the caricature
Noble model to a canine ventricular model by Fox et al. (2002) and showed that the 2:2 alternans
could be produced when r is greater than unity and vice versa. The other finding that arose
from this study is that the potassium current has a significant role in alternans formation. We
observed that in the case of high IK current, the alternans could be suppressed, in agreement with
earlier work done by Fox et al. (2002). This is because IK plays an important role in the AP
repolarization, and increasing the IK magnitude would shorten the APD. In consequence, this
increases the diastolic phase of an AP and cells have more time to recover before the arrival of the
next stimulus, hence, annihilate the alternans. On the other hand, cardiac alternans can occur due
to other ion mechanisms, for example, fluctuation calcium handling dynamics which is caused by
calcium currents (Tse et al. 2016). This model, however, did not include calcium current in the
first place which limits our ability to study the role of calcium currents in alternans occurrence.
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Chapter 9
Conclusion
We end this thesis by providing a summary of the results presented in the previous chapters. We
also outline the key contributions made to the existing literature. Possible future works are also
described.
9.1 Summary and discussion
Sudden cardiac is a serious global issue and coronary heart disease is the commonest precipitating
factor causing 80k deaths/year (Townsend et al. 2014). Hence, with the aid of experimental and
clinical studies, computational models of action potential propagation are potentially powerful
tools for investigating normal and abnormal myocardial behaviour. This thesis continues the
progress by paving another path to understand and answer some of the related problems in cardiac
modelling. In particular, the thesis looked to focus on the analysis and application of models of
single-cell cardiac electrical excitation. To summarise the thesis, we recall that the main goals of
this work are,
1. to determine the distributions of ion channel conductance values that capture the electro-
physiological heterogeneity measured in large populations of rabbit ventricular cardiomy-
ocytes and assess the effect this heterogeneity has on drug action,
2. to develop parameter estimation method and introduce the ‘modified’ caricature model as a
generic action potential model by fitting the model to several biophysically detailed action
potential models, as well as experimental measurements,
3. to develop an efficient numerical method for solution of the action potential model equa-
tions,
4. to study the mechanism of cardiac alternans and derive an explicit equation of APD
restitution curve.
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Chapter 2 In this chapter, we provided the essential background in cardiac electrophysiology
and generation of an action potential. A review on the development of cardiac electrophysiology
model was provided, beginning with the pioneer action potential model by Hodgkin and Huxley
(1952). Our focus was on some of the ground-breaking models that lead to further development
in computational modelling of cardiac cellular electrophysiology. We then pointed out several
important applications of action potential models in investigating the mechanisms of arrhythmia
and their usage in the pharmaceutical industry as a tool to develop new cardiac drugs. Finally,
we ended this chapter by reviewing some of the experimental techniques ever used to measure
the signal of action potentials in cardiac cells. Limitations and advantages of such experimental
methods were discussed.
Chapter 3 In this chapter, we discussed the experimental measurements of rabbit ventricular
cells provided by our collaborators (lead by Prof. Godfrey Smith). The chapter was begun by
explaining the experimental techniques used to record the signal of APs, under both control and
drug blocks. The heterogeneity of APs between the region of basal and apical of epicardium was
discussed, where both regions showed a comparable level of heterogeneity. We analysed the data
and extracted the calibration ranges for some AP biomarkers. These experimental ranges were
used further to construct the model population in Chapter 4. Besides, in this chapter, the effect of
two drugs that blocking hERG and L-type calcium channels on a population of rabbit ventricular
cells were also studied. Each AP of the cells exhibited a different degree of responses, where
hERG block resulted in APD prolongation and hyper-response. Meanwhile, L-type calcium block
caused APD shortening. The mechanisms of these responses, however, were not fully understood
due to limitation in the information of ionic currents.
Chapter 4 In this chapter, our task was to achieve Goal 1. We have investigated the underlying
effects of action potential variability on hERG and L-type calcium blocks. Three AP models of
rabbit/human ventricular myocytes were used to study the problem, and the individual results
were compared with the experimental measurements. The models were rabbit AP model by
Shannon et al. (2004) and two human AP models by Ten Tusscher et al. (2004) and O’Hara
et al. (2011). An ensemble of 10,000–30,000 variants of each model with different value of
ionic conductances was randomly generated using Latin hypercube sampling method in order
to capture cell-to-cell variability. Each model variant was numerically solved by stimulation
a train of 1000 action potentials at pacing rate 2Hz. Only viable APs that passed our quality
control criteria were kept for further analysis. The model populations were calibrated using
our experimental ranges and distributions. We then demonstrated the ability of these models
populations to predict variability in response to drug blocking of hERG and L-type calcium
channels. Among the three models, the Shannon model exhibited the best correspondence with
our experimental data, highlighting the importance of careful model selection and appropriate
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use for computational studies. The finding also demonstrated that it has become difficult for us to
rely on model output alone without recourse to experimental data.
Blockade of hERG channels exhibited APD prolongation to the majority of the cell models
in the population. No correlation was observed between the baseline APD and amount of APD
prolongation. The highly variable spread of ∆APD in each model highlighted the differences of
ionic currents properties in the respective models. For instance, the Ohara model possessed the
most substantial IKr expression, which then resulted in tremendous APD-prolonging effect. In
addition, following IKr block, some cells models experienced extreme APD prolongation beyond
the basic cycle length (500 ms). We characterised the response as ‘hyper-response’. A possible
cause is due to higher ICaL expression present in these models, which then resulted in more
prolonged AP plateau. Another curious feature was the generation of EADs in Shannon model.
Interestingly, EADs formation was not seen in the other two models and our experimental data.
The response was an unusual behaviour since EADs was more common in slower stimulation
frequency (Cooper et al. 2016, Costabal et al. 2018, Guo et al. 2011, Nalos et al. 2012). Compared
to the other two models, Shannon model was found to have the largest ICaL and INaCa, and we
suspected these two ionic currents were responsible for EADs occurrence.
In addition, we have also studied the effect of ICaL block by nifedipine. In contrast to the
first drug, ICaL blocker did not significantly alter the resting membrane potential, the amplitude
of action potential of rabbit ventricular myocytes but has caused the shortening to the duration of
an action potential. Similar finding was reported in Amlie et al. (1979), Dangman and Hoffman
(1980) and Go et al. (2005). The ∆APD was shown to have a negative linear correlation with the
baseline APD. Models with small AP showed a smaller degree of APD shortening, compared to
models with larger AP which tend to experienced larger ∆APD. A concrete answer to this was that
in models of large AP had larger ICaL expression and larger calcium transient amplitude, which
then contributed to more dynamic responses. Finally, our finding in this chapter has highlighted
two important aspects 1) Model selection is very important in computational modelling as each
model could have a different capability in predicting the AP responses towards channel blocks, 2)
AP variability within cells has significant impact to channel blocks and should not be disregarded.
Chapter 5 In this chapter, we provided a brief introduction to a simplified model of action
potential, the so-called ‘caricature Noble model’ and discussed the advantages of this model
compared to other simplified models. In the thesis (Chapter 5–7), we considered a modified
version of caricature Noble model where the fourth order of variable n in equation (5.2b) was
replaced by linear term in n. We then described the model formulations and then solved the
model as initial and boundary value problem. The exact analytical solutions were derived and
validated with numerical solutions. Next, we presented the asymptotic solutions of the model,
including both fast subsystem and slow subsystem. These asymptotic solutions were used to
develop an asymptotic-numerical method in Chapter 7 and investigated the mechanism of cardiac
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alternans in Chapter 8. Furthermore, the phase portrait of the modified caricature Noble model
and the criteria needed for the AP excitation were also explained.
Chapter 6 We then used the modified caricature Noble model in order to address Goal 2. In
particular, we demonstrated a simple parameter estimation method, the so-called, ‘Nelder-Mead
simplex method’ to fit the model to various biophysically detailed models of action potential and
experimental measurements of healthy and failing rabbit cardio-myocytes. The fitting protocols
and parameter sensitivity analysis were also discussed. Using the optimisation methodologies,
the modified caricature Noble model was shown to have the capability to reproduce the action
potential morphologies of various cell types of the targeted models, with some discrepancies at
a particular part of AP phase. In addition, we also managed to fit the restitution curves of the
respective models and experimental data, hence capturing the model’s AP dynamics at different
pacing cycle lengths. Compared to some other simplified action potential models, the parameters
and variables in this model could have the physiological meaning as it was derived from a genuine
cell model (Noble 1962). Hence, our results could be translated into physiology. For example,
when fitting to experimental measurements of APs of healthy and failing myocytes, we found that
the maximal magnitude of time-dependent potassium current in the healthy model is a bit larger
than the heart failure model. The finding was in agreement with earlier studies in Beuckelmann
et al. (1993), Tsuji et al. (2000) and Akar and Rosenbaum (2003).
Chapter 7 In this chapter, our task was to achieve Goal 3 by developing an efficient numerical
method for the modified caricature Noble model. The numerical method was a combination
of asymptotic solutions of the model and the implementation of the heterogeneous multiscale
method by Weinan and Engquist (2003). The numerical results were validated with the analytical
solutions of the modified caricature Noble model. To test the stability and robustness of this
approach, we compared the method with other conventional numerical methods such as the
explicit Euler method, fourth-order Runge-Kutta method and Rush-Larsen method. From our
analysis, we concluded that this asymptotic-numerical method was significantly efficient than
most of the other numerical solvers, in terms of accuracy and execution time. However, due
to some circumstances, the application of this method requires knowledge of the asymptotic
structure of the AP model solved. For the time being, we only managed to apply this method
on a single cell model and further work is needed in order to implement the method to tissue
simulations. Further investigations need to be done in the future to test its implementation on
more realistic action potential models.
Chapter 8 The asymptotic structures of caricature model were further used in this chapter
by studying the mechanism of cardiac alternans (Goal 4). This work was a continuation work
by Asgari-Targhi (2017) and we revised some of her results. Importantly, from this study, we
were able to identify parameters and variables that were responsible for alternans occurrence. In
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particular, we showed that the time scale at which the slow gating variable evolves is responsible
for inducing alternans. This is because this variable explicitly controls the duration of an action
potential. The duration will be affected if the slow variable fails to return to its initial value
before the arrival of the next external stimulus, hence trigger the alternans. This result is in
agreement with the work done by Mitchell and Schaeffer (2003). Moreover, we also studied the
effect of the superfast variable on the region of alternans. Our finding showed that including the
superfast variable in the system would influence the bifurcation point of the restitution curve.
Also, we have shown that the variable responsible for alternans occurrence is the slow activation
of outward IK current. Using the optimization technique, we have demonstrated that caricature
Noble model with small IK current would promote the alternans behaviour in the model and vice
versa. The connection between potassium current and induction of alternans was shown in an
earlier study by Fox et al. (2002), and the finding was consistent with our own.
9.2 Future directions
Action potential variability In this study, we only included the density of ion channels as
the primary source of AP variation. However, this is not entirely true as the AP variability
could also happen due to difference in the kinetic rate of gating channels. In the future, co-
regulation between kinetic and density of ion channels in influencing the AP variability should
be investigated further. The dynamic changes of these protein expressions may alter the balance
of ionic currents that flow across the cellular membrane, which would give rise to AP variation.
Furthermore, varying conductance or kinetic of gating channels alone would have a different
biological interpretation as altering channel kinetics could be related to genetic mutations.
In this work, our focus was only on the variability of action potentials and their impacts on
channel block. Other than AP, calcium transients also exhibit variation due to fluctuation in
calcium currents. Future work should aim to incorporate the calcium transients measurements,
which can be used to investigate the cell’s contractility in response to pharmacological intervention.
Finally, other possible work that we aim to explore is to examine the responsiveness of APD
variability to cell-to-cell electrical coupling. This can be done by forming a population of cell
models into sufficiently large ventricular region. For our future motivation, we include some
of our preliminary results of this work in the Appendix. In a study by Zaniboni et al. (2000),
they showed that coupling suppressed the AP variability and induced an asymmetric response
in which APD90 shortening of intrinsically long action potentials was more pronounced than
APD90 prolongation of short action potentials and this suppression was crucial in preventing
EADs formation when IKr was blocked. Although this is not thoroughly investigated yet, our
results showed that cell-to-cell variability was reduced in the tissue sample.
In a series of studies by Sarkar and Sobie (2010; 2011), Sobie (2009), the authors have used
multivariable regression analysis to examine the AP variability and gain insight into the factors
156
that are responsible for variability in the response to proarrhythmic drugs. There, regression
analysis was performed to determine how much each model parameter attenuated or exacerbated
the AP prolongation caused by the IKr-blocking drug. However, their results were not supported
by any experimental data. Hence, using our results in Chapter 4 with the combination of our
large AP and calcium measurements of left ventricular myocytes, we aim to use similar approach
and determine the relating changes in parameters when drugs are applied.
Feature of caricature Noble model From our results presented in chapter 6, 7 and 8, we found
that the caricature Noble model has several advantages and could be used for various purposes
in cardiac electrophysiology. In particular, we have shown that this model has the capability to
reproduce the action potential morphologies and restitution curves of various cell types. The
asymptotic solution of the model also offered several uses. In the thesis, we applied the solutions
to develop a robust numerical algorithm for faster simulation and to study the mechanisms of
alternans. These demonstrated the wide application of this model to various cardiac-related
problems.
However, the model feature could still be enhanced in some respective manner. In chapter
8, we have shown that the vital role of potassium current in inducing or suppressing the cardiac
alternans. In literature, the alternans occurrence could be due to other ion mechanisms, for
example, fluctuation in calcium handling dynamics, which is caused by calcium currents (Tse
et al. 2016). Future work should aim to incorporate calcium current into the model, and this could
allow us to investigate the role of the calcium current in the mechanisms of cardiac alternans.
Such modification, however, should also aim to preserve the analytical solutions of the model.
Besides, the incorporation of calcium current in the caricature Noble model will also allow us
to couple the model with a mechanical model. The model then can be further used to study the
cell’s contractility.
In the simulation of electrocardiograms (ECG) for a whole heart with various cell types,
earlier researches have shown that coupling two systems like Purkinje-ventricular system required
the use of two different AP models (Aslanidi et al. 2009b, Vigmond and Clements 2007) or using
a similar model with a different set of parameter values (Berenfeld and Jalife 1998). An obvious
reason is that typical cell model is usually built for specific cell type such as ventricular or atrial
cell model; hence this model cannot be used for different cell type due to difference in action
potential morphologies and duration. Interestingly, caricature Noble model could be explored
to meet the purpose due to the model’s flexibility in reproducing various APs from different
cell types. In the future, we aim to utilise the model for whole heart simulation by coupling the
system of several heart regions. The simplicity of this model may also allow us to have less
demanding computational workload.
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Appendix A
Codes and supplementary materials
A.1 Variability in action potential
This section provides the extended material from Chapter 4.
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A.1.1 Parameter range
The range of parameter used to construct the model population depends on the hypothesis
of a particular study and how good the model population to represent the experimental data.
Wider parameter ranges allow for more extreme parameter values which then result in more
extreme model outputs. In our work, we varied all parameters for ±100% in order to allow for
significance spread of AP biomarkers. Earlier, we used ±30% and ±50% parameter variations,
but the model’s outputs were underachieving and did not accurately capture our experimental
measurements (see Figure 4.5b). Also, parameter ranges have some significant influences on the
outcome of models to channel block. Figure A.1 shows the net effect of drug block on APD90 for
two parameter variations. We can see that when ±30% parameter variation was considered, the
spread of ∆APD90 is confined. There was no model with ∆APD90 smaller than 20 ms for models
with baseline between 230–300 ms. A broader drug effect is shown by the other parameter
variation but the distribution does not yet accurately capture the experimental distribution.
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Figure A.1: Scatter plot of drug effect on APD for (a) ±30% and (b) ±50% parameter variations.
Mean of ∆APD90 in (a) and (b) is 33.6±11.2 ms and 21.7±12.9 ms, respectively.
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A.1.2 Contour plot of APD90
APD is a function of model parameters such that a given APD value can be generated from
infinitely many different parameter combinations. Figure A.2 shows the contour plot of APD90
produced by randomly varying 8 ionic conductances in the Shannon model. As shown in the
figure, various different parameter sets can generate an identical APD90. These sets form a
continuous contour hypersurface in the parameter space.
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Figure A.2: Contour plot of APD90 as a function of parameter space.
160
A.1.3 AP morphologies in models and experiment
Figure A.3 shows the action potential morphologies in the Shannon, TenTusscher and Ohara
models, in comparison to AP observed in experimental measurements from rabbit ventricular
myocyte.
Figure A.3: Typical action potential morphologies of (a) Shannon model, (b) TenTusscher model
and (c) Ohara model, in comparison to APs observed in experimental recordings from rabbit
(black line).
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A.1.4 Archetypal models
As discussed in section 4.5.4.6, we constructed three archetypal models as a representation of
each AP response seen following IKr block. Each archetypal model was built using the median
values of each conductance in the respective model subpopulation (Figure 4.13). The parameter
values for each archetypal model are listed in Table 4.3. Figure A.4 shows the voltage and ionic
currents in the archetypal model of normal response before and after IKr block.
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Figure A.4: The traces of (a) action potential and the corresponding (b) ionic currents in archetypal
model of normal-response. Solid line is the model’s outputs under control condition and the
dashed line is the model’s outputs after the IKr block.
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A.1.5 Tissue sample with cell heterogeneity
In this section, we want to discuss how the reduction of electrophysiological heterogeneity can
be achieved when individual cells are coupled to form sufficiently large ventricular regions. A
likely hypothesis that we wish to investigate is that expression networks exist between key groups
of ion channels/exchangers that act to stabilise regional electric signatures in the face of large
intrinsic variation, essentially protecting the heart from sub-populations of myocytes that would
provoke arrhythmias in healthy hearts at bradycardiac or tachycardiac conditions. To test such
hypotheses and to identify key correlations and co-expression networks, we propose to develop a
mathematical model whereby our experimentally-calibrated large size ensemble of numerical
cells with randomly distributed parameter values are coupled to each other by Newton cooling
terms corresponding to low-resistance gap junctions. Note that finding discussed in this section is
preliminary and potentially require further investigations.
Cell N
Cell 1
Cell j
Cell 2
Figure A.5: Illustration of our cells arrangement in tissue sample. N heterogenous cells are
alligend in a shape of ring and each cell is connected by the gap junctions.
A.1.5.1 Cell synchronisation
The theoretical fibre is composed of N Shannon cell models. Eight ionic currents are varied
randomly using Latin Hypercube sampling method to form a population of cells with different
ionic properties. The cells are aligned in a ring-shaped which every cell are connected to their
nearest neighbour cells (Figure A.5). The membrane potential of each cell is connected by
Newton cooling terms described below,
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for j = 1,2, ...,k :
dV j
dt
=−∑ Iion +µ
( k
∑
i=1
(Vj+i +Vs)−2kVj
)
,
for j = k+1,k+2, ...,N− k :
dV j
dt
=−∑ Iion +µ
( k
∑
i=1
(Vj+i +Vj−i)−2kVj
)
,
for j = N−k+1,N− k+2, ...,N :
dV j
dt
=−∑ Iion +µ
( k
∑
i=1
(Vj−i +Vr)−2kVj
)
,
(A.1)
where
s =
α = mod(N + j− i,N), if 1≤ α ≤ N−1N else (A.2)
and
r =
α = mod( j+ i,N), if 1≤ α ≤ N−1N else. (A.3)
N is the number of cells and j is the position of the cells in the tissue ring. m = 2k is the number
of interaction of a cell to its neighbour cells and max(k) = d(N/2−1)e. max(k) is introduced
such that each cell in the tissue model does not have more than two interactions between similar
neighbour cell. In fact, under physiological conditions, a typical left ventricular myocyte in an
adult working myocardium is electrically coupled to an average of about 9-13 adjacent cells
(Saffitz et al. 1994). In our work, we considered k = 6 (for N ≥ 30) which every cell was
connected to 12 neighbour cells. µ is the gap-junction strength and homogenous throughout the
tissue sample. We applied the explicit Euler method to numerically integrate the system with
time step 0.007 ms and equations (A.1) was solved simultaneously for every time step. The
parameter values for each cell model were randomly taken from the experimentally-calibrated
control population constructed in chapter 4. These cell models were coupled together to form a
sufficiently large ventricular tissue with distinct action potential properties. Figure A.6a shows a
subpopulation of action potentials before the models were coupled to each other. We can see that
large AP variability, mainly in the repolarisation, is shown in the individual model. The resting
membrane potential and action potential amplitude are almost identical.
Electrotonic coupling between cells is established through the formation of gap junctions
between cells and the gap junctions play a pivotal role in the velocity and the safety of action
potential propagation in cardiac tissue. We next examined the responsiveness of APD variability
to cell-to-cell electrical coupling. Figure A.6b shows the coupling effect on cell variability. As
expected, the temporal variability of action potentials in ventricular myocardium is reduced.
Our result is consistent with some earlier works by Walmsley et al. (2015) and Zaniboni et al.
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Figure A.6: Simulated temporal variability in 30 Shannon cell models (a) before the coupling
(µ = 0) and (b) after the coupling (µ = 0.5).
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Figure A.7: Effect of (a) gap-junction strength and number of cell interaction on cell coupling.
(2000). Interestingly, our finding also shows that mean APD90 value in 30 cell models before the
coupling (227.04 ms) is larger than the mean APD90 following cell coupling (209.01 ms). This
demonstrates that there are important interactions occur between the cell models; rather than just
simply averaging of the signals.
Also, we investigate whether the gap-junction strength has any influences on the repolarisation
of these action potentials. We also want to find what is the minimum value of µ , so that the tissue
model is well coupled. In order to do that, the value of µ was varied from 0.01 (the weakest
coupling) to 0.5 (the strongest coupling) and the range of APD90 was measured. From Figure
A.7a, we can see that the range of APD90 decreases as µ increases and the tissue model is well
connected at the strongest µ . As mentioned earlier, each cardiac cell in tissue is connected to
roughly 11 adjacent cells (Saffitz et al. 1994). Using our tissue model, we investigate how the
number of cell interactions may contribute to the mean average of repolarisation of the cells in
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the model. Figure A.7b shows that tissue behaviour is not affected by the number of each cell
interacts with its neighbour cells.
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A.2 Caricature Noble model
This section is extended material from Chapter 8. In particular, we provide the exact analytical
solutions and asymptotic solutions of original caricature Noble model presented in that chapter.
A.2.1 Exact analytical solutions
A.2.1.1 Solution of the initial value problem
In this case, we set the state conditions as following,
E(0) = Estim > E∗, h(0) = h0, n(0) = n0, (A.4)
n(t) =

1
n(t) = 1− (1−n0)exp(− fnt), t ∈ [0, t†]
2
n(t) =
(
1− (1−n0)exp(− fnt†)
)
exp
(
fnr(t†− t)
)
, t ∈ [t†,∞]
(A.5a)
h(t) =

1
h(t) = h0 exp
(
−Fht/(ε1ε2)
)
, t ∈ [0, t†]
2
h(t) = 1− (exp(Fht†/(ε1ε2))−h0)exp(−Fht/(ε1ε2)), t ∈ [t†,∞]
(A.5b)
E(t) =

1
E(t) = exp
(
GNah0
Fh
exp
(
− Fht
ε1ε2
)
− k3t
ε2
)
×[
E0 exp
(
− GNah0
Fh
)
− k3E3 u(−k3ε1, t)
−g22
4
∑
l=0
(
4
l
)
(n0−1)l u(−k3ε1 + ε1 ε2l fn, t)
−GNa h0ENa
ε1
u(−k3ε1 +Fh, t)
]
, t ∈ [0, t∗]
2
E(t) = (E∗−w(t∗)) exp
(
k2
ε2
(t− t∗)
)
+w(t), t ∈ [t∗, t†]
3
E(t) = (E†−m(t†)) exp
(
k1
ε2
(t†− t)
)
+m(t), t ∈ [t†,∞]
(A.5c)
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where
u(κ, t)≡ ε1
Fh
(
Fh
GNah0
) κ
Fh
[
Γ
(
κ
Fh
,
GNah0
Fh
)
−Γ
(
κ
Fh
,
GNah0
Fh
exp
(
− Fht
ε1ε2
))]
, (A.6a)
w(t)≡ E2 +g22
4
∑
l=0
(n0−1)l
(
4
l
)
exp(−l fnt)
−k2− l ε2 fn
, (A.6b)
m(t)≡ E1 +
g21
k1−4ε2 fnr
4
∑
l=0
(n0−1)l
(
4
l
)
exp
(
(4 fnr− l fn)t†
)
exp(−4 fnrt), (A.6c)
for Re(z)> 0 as defined in Abramowitz and Stegun (1965).
A.2.1.2 Solution of the boundary value problem
In this case, we set the state conditions as following,
E(0) = E(t = B) = Estim > E∗, h(0) = h(t = B), n(0) = n(t = B), (A.7)
where B is the basic cycle length. By imposing the above boundary conditions (A.7), the general
solutions are as follows:
n(t) =

1
n(t) = 1−C1 exp(− fnt), t ∈ [0, t†]
2
n(t) =
(
1−C1 exp(− fnt†)
)
exp
(
fnr(t†− t)
)
, t ∈ [t†,∞]
(A.8a)
h(t) =

1
h(t) = D1 exp
(
−Fht/(ε1ε2)
)
, t ∈ [0, t†]
2
h(t) = 1−
(
exp(Fht†/(ε1ε2))−D1
)
exp(−Fht/(ε1ε2)), t ∈ [t†,∞]
(A.8b)
E(t) =

1
E(t) = exp
(
GNaD1
Fh
exp
(
− Fht
ε1ε2
)
− k3t
ε2
)
×[
E0 exp
(
− GNaD1
Fh
)
− k3E3 u(−k3ε1, t)
−g22
4
∑
l=0
(
4
l
)
(−C1)l u(−k3ε1 + ε1 ε2l fn, t)
−GNa D1ENa
ε1
U (−k3ε1 +Fh, t)
]
, t ∈ [0, t∗]
2
E(t) = (E∗−w(t∗)) exp
(
k2
ε2
(t− t∗)
)
+w(t), t ∈ [t∗, t†]
3
E(t) = (E†−m(t†)) exp
(
k1
ε2
(t†− t)
)
+m(t), t ∈ [t†,∞]
(A.8c)
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where
C1 =
(
1− exp
(
fnr(t†−B)
))
/
(
1− exp
(
(− fnt†)− fnr(B− t†)
))
(A.9a)
D1 =
(
1− exp
(Fh(t†−B)
ε1ε2
))
/
(
1− exp
(−FhB
ε1ε2
))
(A.9b)
u(κ, t)≡ ε1
Fh
(
Fh
GNaD1
) κ
Fh
[
Γ
(
κ
Fh
,
GNaD1
Fh
)
−Γ
(
κ
Fh
,
GNaD1
Fh
exp
(
− Fht
ε1ε2
))]
, (A.9c)
w(t)≡ E2 +g22
4
∑
l=0
(−C1)l
(
4
l
)
exp(−l fnt)
−k2− l ε2 fn
, (A.9d)
m(t)≡ E1 +
g21
k1−4ε2 fnr
4
∑
l=0
(−C1)l
(
4
l
)
exp
(
(4 fnr− l fn)t†
)
exp(−4 fnrt), (A.9e)
We now have the exact solutions of the equations (5.1) as a function of B.
A.2.2 Asymptotic decomposition
We include results of Biktashev et al. (2008) on the asymptotic decomposition of the caricature
Noble model. Taking the limit of ε1, ε2→ 0+, the model can be dissected into asymptotically
reduced systems, which then provide much insight into the dynamics of the full model. The
derivation of the asymptotics solutions of this model are explained in the following subsections.
A.2.2.1 Superfast-time system
We assume that our original system has a multiple timescales and consider a ”super-fast” timescale
T which is T = t/(ε1ε2). The time t is stretched into super-fast timescale T as the ε1→ 0. From
the chain rule of differential equation, we have
d
dt
=
1
ε1 ε2
d
dT
. (A.10)
Substitute the above expression into (5.1) and taking the limit of ε1→ 0, we obtain the essential
dynamical variables of E and h,
dE
dT
= GNa (ENa−E)H(E−E∗)h, (A.11a)
dh
dT
= Fh
(
H(E†−E)−h
)
. (A.11b)
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This system describes the fast upstroke of the action potential. Solving the above system (A.11),
we can derive the explicit asymptotic solutions for this stage which are,
E = ENa− (ENa−E0)exp
(
GNa
Fh
(e−FhT −1)
)
, (A.12a)
h = exp−FhT . (A.12b)
The maximal overshoot voltage, Emax is obtained as the fast time T goes to infinity,
Emax = E∞ = lim
T→∞
E(T ) = ENa− (ENa−E0)exp
(
− GNa
Fh
)
(A.13a)
Since exp(−GNa/Fh) ≈ 10−29, the maximal overshoot volage Emax is extremely close to ENa.
The h(T ) = 0 as T tends to infinity.
A.2.2.2 Slow-time system
The slow-time system is obtained by directly taking the limit of ε1→ 0 in (5.1). By doing this,
we have h(t) = H(E†−E). Plucking this into equation (5.1a) will eliminate the first term and
left us with a reduced system as following,
dE
dt
=
1
ε2
(
g2(E)n4 +G(E)
)
(A.14a)
dn
dt
= Fn(E)
(
H(E−E†)−n
)
. (A.14b)
This system describes the post-overshoot drop, plateau and recovery stages of the action potential.
A.2.2.3 Slow-slow-time system
The slow-slow time subsystem is obtained directly from equations (5.1) by taking the limit of
ε1→ 0 and ε2→ 0 simultaneously. The system is described below,
0 = g2(E)n4 +G(E), (A.15a)
dn
dt
= Fn(E)
(
H(E−E†)−n
)
. (A.15b)
This system describes the plateau and the recovery stages of the action potential.
A.3 MATLAB codes for parameter fitting
In this section, we provide several codes used for the optimization problem in Chapter 5 and 7.
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A.3.1 Code 1
This is the main code used to run the entire simulation and fitting algorithms.
1 clear all;
2
3 tStart = tic;
4
5 %% choose the pacing rate
6 BCL = 1500;
7
8 paramEstimation(BCL);
9
10 tEnd = toc(tStart);
11 fprintf(’Elapsed times is %d mins and %.0f secs\n’, ...
12 floor(tEnd/60),rem(tEnd,60));
A.3.2 Code 2
This code was used to carry out the parameter estimation method. Note that the ’fminsearchbnd3’
was downloaded from https://github.com/faiq/findingsolo/blob/master/
fminsearchbnd3.m. This is a modified MATLAB code for MATLAB function ’fminsearch’
where the parameter searching is only considered within the specified interval.
1 function paramEstimation(BCL)
2
3 clearvars -global
4 global VOI_EXACT STATES_EXACT P_NEW APD_EXACT rValue PacingRate
5
6 PacingRate = BCL;
7 rValue = r;
8
9 %% AP data of the targeted model
10 [VOI_EXACT, STATES_EXACT] = LuoRudy(PacingRate);
11
12 %% Measure the APD90 of the targeted model
13 VOI_TEMP = 0:0.05:PacingRate;
14 STATES_INTERP =interp1(VOI_EXACT,STATES_EXACT(:,1), VOI_TEMP,’pchip’);
15 R = STATES_INTERP;
16
17 for j = length(VOI_TEMP):-1:1
18 % we set the APD90 occurs at voltage = -70mV
19 if (R(j) >= -70.0)
20 Repol2 = VOI_TEMP(j);
21 break;
22 end
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23 end
24
25 APD_EXACT = Repol2;
26
27 %% specify the initial guess of each parameter
28 P(1) = g22;
29 P(2) = k1;
30 P(3) = k2;
31 P(4) = k3;
32 P(5) = g21;
33 P(6) = fn;
34
35 % specify the boundary limit of each parameter
36 inf_limit(1) = g22_0; sup_limit(1) = g22_1;
37 inf_limit(2) = k1_0; sup_limit(2) = k1_1;
38 inf_limit(3) = k2_0; sup_limit(3) = k2_1;
39 inf_limit(4) = k3_0; sup_limit(4) = k3_1;
40 inf_limit(5) = g21_0; sup_limit(5) = g21_1;
41 inf_limit(6) = fn_0; sup_limit(6) = fn_1;
42
43 %% minimize AP morphology
44 options = optimset(’PlotFcns’,@optimplotfval, ...
45 ’LargeScale’,’off’,’Display’,’iter’, ...
46 ’MaxFunEvals’,50000,’TolX’,1e-3, ...
47 ’TolFun’,1e-3,’TolCon’,1e-3,’DiffMaxChange’,0.5,...
48 ’DiffMinChange’,1e-4,’MaxIter’,5000);
49
50 [Pmin] = fminsearchbnd3(@Objfun_AP,P,inf_limit,sup_limit,options);
51 Pfinal = Pmin;
52
53 %% print out the value of new estimated parameter
54 format short;
55 disp(’Estimated parameter:’);
56 disp(Pfinal)
57
58 %% generate APD restitution curves using dynamic pacing method
59 [Output] = APDrestitutioncurve(Pfinal);
60
61 %% store the data in a .dat file
62 fileID = fopen(sprintf(’Caric_paramEstimate_PCL_%d.dat’, PacingRate) , ’w’);
63 fprintf(fileID,’%9f \r\n’, Pfinal);
64 fclose(fileID);
65
66 end
172
A.3.3 Code 3
This code was used to optimize the objective function.
1 function Error = Objfun_AP(Parameter)
2
3 global VOI_EXACT STATES_EXACT APD_EXACT PacingRate rValue
4
5 %% Run the caricature model using the estimated parameters
6 [VOI_SOL, STATES_SOL] = Caric_Noble_model(Parameter,PacingRate);
7
8 %% find predicted values x(tdata)
9 STATES_PRED = interp1(VOI_SOL,STATES_SOL(:,1),VOI_EXACT,’pchip’);
10
11 %% plot the fitting result for every iteration
12 k = length(VOI_EXACT);
13
14 figure(1)
15 % plot AP of targeted data
16 plot(VOI_EXACT(),STATES_EXACT(:,1),’b’,’LineWidth’,3);
17 hold on
18 % plot AP of caricature model
19 plot(VOI_SOL,STATES_SOL(:,1),’r’,’LineWidth’,3);
20 hold off
21 drawnow
22
23 %% Measure the APD of caricature model
24 APD_caric = MeasureAPD(VOI_SOL,STATES_SOL);
25
26 %% compute the (global) mean relative error for the AP morphology
27 Error = 0;
28 for i = 1:length(VOI_EXACT)
29 Error = Error + abs((STATES_PRED(i) - ...
30 STATES_EXACT(i))./STATES_EXACT(i));
31 end
32
33 %% Measure the APD difference between Caricature model and the targeted
model
34 APDdiffer = abs(APD_caric - APD_EXACT);
35
36 %% Combine both error
37 Error = Error + APDdiffer;
38
39
40 end
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